[{"path":"https://merck.github.io/metalite.ae/LICENSE.html","id":null,"dir":"","previous_headings":"","what":"GNU General Public License","title":"GNU General Public License","text":"Version 3, 29 June 2007Copyright © 2007 Free Software Foundation, Inc. <http://fsf.org/> Everyone permitted copy distribute verbatim copies license document, changing allowed.","code":""},{"path":"https://merck.github.io/metalite.ae/LICENSE.html","id":"preamble","dir":"","previous_headings":"","what":"Preamble","title":"GNU General Public License","text":"GNU General Public License free, copyleft license software kinds works. licenses software practical works designed take away freedom share change works. contrast, GNU General Public License intended guarantee freedom share change versions program–make sure remains free software users. , Free Software Foundation, use GNU General Public License software; applies also work released way authors. can apply programs, . speak free software, referring freedom, price. General Public Licenses designed make sure freedom distribute copies free software (charge wish), receive source code can get want , can change software use pieces new free programs, know can things. protect rights, need prevent others denying rights asking surrender rights. Therefore, certain responsibilities distribute copies software, modify : responsibilities respect freedom others. example, distribute copies program, whether gratis fee, must pass recipients freedoms received. must make sure , , receive can get source code. must show terms know rights. Developers use GNU GPL protect rights two steps: (1) assert copyright software, (2) offer License giving legal permission copy, distribute /modify . developers’ authors’ protection, GPL clearly explains warranty free software. users’ authors’ sake, GPL requires modified versions marked changed, problems attributed erroneously authors previous versions. devices designed deny users access install run modified versions software inside , although manufacturer can . fundamentally incompatible aim protecting users’ freedom change software. systematic pattern abuse occurs area products individuals use, precisely unacceptable. Therefore, designed version GPL prohibit practice products. problems arise substantially domains, stand ready extend provision domains future versions GPL, needed protect freedom users. Finally, every program threatened constantly software patents. States allow patents restrict development use software general-purpose computers, , wish avoid special danger patents applied free program make effectively proprietary. prevent , GPL assures patents used render program non-free. precise terms conditions copying, distribution modification follow.","code":""},{"path":[]},{"path":"https://merck.github.io/metalite.ae/LICENSE.html","id":"id_0-definitions","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"0. Definitions","title":"GNU General Public License","text":"“License” refers version 3 GNU General Public License. “Copyright” also means copyright-like laws apply kinds works, semiconductor masks. “Program” refers copyrightable work licensed License. licensee addressed “”. “Licensees” “recipients” may individuals organizations. “modify” work means copy adapt part work fashion requiring copyright permission, making exact copy. resulting work called “modified version” earlier work work “based ” earlier work. “covered work” means either unmodified Program work based Program. “propagate” work means anything , without permission, make directly secondarily liable infringement applicable copyright law, except executing computer modifying private copy. Propagation includes copying, distribution (without modification), making available public, countries activities well. “convey” work means kind propagation enables parties make receive copies. Mere interaction user computer network, transfer copy, conveying. interactive user interface displays “Appropriate Legal Notices” extent includes convenient prominently visible feature (1) displays appropriate copyright notice, (2) tells user warranty work (except extent warranties provided), licensees may convey work License, view copy License. interface presents list user commands options, menu, prominent item list meets criterion.","code":""},{"path":"https://merck.github.io/metalite.ae/LICENSE.html","id":"id_1-source-code","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"1. Source Code","title":"GNU General Public License","text":"“source code” work means preferred form work making modifications . “Object code” means non-source form work. “Standard Interface” means interface either official standard defined recognized standards body, , case interfaces specified particular programming language, one widely used among developers working language. “System Libraries” executable work include anything, work whole, () included normal form packaging Major Component, part Major Component, (b) serves enable use work Major Component, implement Standard Interface implementation available public source code form. “Major Component”, context, means major essential component (kernel, window system, ) specific operating system () executable work runs, compiler used produce work, object code interpreter used run . “Corresponding Source” work object code form means source code needed generate, install, (executable work) run object code modify work, including scripts control activities. However, include work’s System Libraries, general-purpose tools generally available free programs used unmodified performing activities part work. example, Corresponding Source includes interface definition files associated source files work, source code shared libraries dynamically linked subprograms work specifically designed require, intimate data communication control flow subprograms parts work. Corresponding Source need include anything users can regenerate automatically parts Corresponding Source. Corresponding Source work source code form work.","code":""},{"path":"https://merck.github.io/metalite.ae/LICENSE.html","id":"id_2-basic-permissions","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"2. Basic Permissions","title":"GNU General Public License","text":"rights granted License granted term copyright Program, irrevocable provided stated conditions met. License explicitly affirms unlimited permission run unmodified Program. output running covered work covered License output, given content, constitutes covered work. License acknowledges rights fair use equivalent, provided copyright law. may make, run propagate covered works convey, without conditions long license otherwise remains force. may convey covered works others sole purpose make modifications exclusively , provide facilities running works, provided comply terms License conveying material control copyright. thus making running covered works must exclusively behalf, direction control, terms prohibit making copies copyrighted material outside relationship . Conveying circumstances permitted solely conditions stated . Sublicensing allowed; section 10 makes unnecessary.","code":""},{"path":"https://merck.github.io/metalite.ae/LICENSE.html","id":"id_3-protecting-users-legal-rights-from-anti-circumvention-law","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"3. Protecting Users’ Legal Rights From Anti-Circumvention Law","title":"GNU General Public License","text":"covered work shall deemed part effective technological measure applicable law fulfilling obligations article 11 WIPO copyright treaty adopted 20 December 1996, similar laws prohibiting restricting circumvention measures. convey covered work, waive legal power forbid circumvention technological measures extent circumvention effected exercising rights License respect covered work, disclaim intention limit operation modification work means enforcing, work’s users, third parties’ legal rights forbid circumvention technological measures.","code":""},{"path":"https://merck.github.io/metalite.ae/LICENSE.html","id":"id_4-conveying-verbatim-copies","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"4. Conveying Verbatim Copies","title":"GNU General Public License","text":"may convey verbatim copies Program’s source code receive , medium, provided conspicuously appropriately publish copy appropriate copyright notice; keep intact notices stating License non-permissive terms added accord section 7 apply code; keep intact notices absence warranty; give recipients copy License along Program. may charge price price copy convey, may offer support warranty protection fee.","code":""},{"path":"https://merck.github.io/metalite.ae/LICENSE.html","id":"id_5-conveying-modified-source-versions","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"5. Conveying Modified Source Versions","title":"GNU General Public License","text":"may convey work based Program, modifications produce Program, form source code terms section 4, provided also meet conditions: ) work must carry prominent notices stating modified , giving relevant date. b) work must carry prominent notices stating released License conditions added section 7. requirement modifies requirement section 4 “keep intact notices”. c) must license entire work, whole, License anyone comes possession copy. License therefore apply, along applicable section 7 additional terms, whole work, parts, regardless packaged. License gives permission license work way, invalidate permission separately received . d) work interactive user interfaces, must display Appropriate Legal Notices; however, Program interactive interfaces display Appropriate Legal Notices, work need make . compilation covered work separate independent works, nature extensions covered work, combined form larger program, volume storage distribution medium, called “aggregate” compilation resulting copyright used limit access legal rights compilation’s users beyond individual works permit. Inclusion covered work aggregate cause License apply parts aggregate.","code":""},{"path":"https://merck.github.io/metalite.ae/LICENSE.html","id":"id_6-conveying-non-source-forms","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"6. Conveying Non-Source Forms","title":"GNU General Public License","text":"may convey covered work object code form terms sections 4 5, provided also convey machine-readable Corresponding Source terms License, one ways: ) Convey object code , embodied , physical product (including physical distribution medium), accompanied Corresponding Source fixed durable physical medium customarily used software interchange. b) Convey object code , embodied , physical product (including physical distribution medium), accompanied written offer, valid least three years valid long offer spare parts customer support product model, give anyone possesses object code either (1) copy Corresponding Source software product covered License, durable physical medium customarily used software interchange, price reasonable cost physically performing conveying source, (2) access copy Corresponding Source network server charge. c) Convey individual copies object code copy written offer provide Corresponding Source. alternative allowed occasionally noncommercially, received object code offer, accord subsection 6b. d) Convey object code offering access designated place (gratis charge), offer equivalent access Corresponding Source way place charge. need require recipients copy Corresponding Source along object code. place copy object code network server, Corresponding Source may different server (operated third party) supports equivalent copying facilities, provided maintain clear directions next object code saying find Corresponding Source. Regardless server hosts Corresponding Source, remain obligated ensure available long needed satisfy requirements. e) Convey object code using peer--peer transmission, provided inform peers object code Corresponding Source work offered general public charge subsection 6d. separable portion object code, whose source code excluded Corresponding Source System Library, need included conveying object code work. “User Product” either (1) “consumer product”, means tangible personal property normally used personal, family, household purposes, (2) anything designed sold incorporation dwelling. determining whether product consumer product, doubtful cases shall resolved favor coverage. particular product received particular user, “normally used” refers typical common use class product, regardless status particular user way particular user actually uses, expects expected use, product. product consumer product regardless whether product substantial commercial, industrial non-consumer uses, unless uses represent significant mode use product. “Installation Information” User Product means methods, procedures, authorization keys, information required install execute modified versions covered work User Product modified version Corresponding Source. information must suffice ensure continued functioning modified object code case prevented interfered solely modification made. convey object code work section , , specifically use , User Product, conveying occurs part transaction right possession use User Product transferred recipient perpetuity fixed term (regardless transaction characterized), Corresponding Source conveyed section must accompanied Installation Information. requirement apply neither third party retains ability install modified object code User Product (example, work installed ROM). requirement provide Installation Information include requirement continue provide support service, warranty, updates work modified installed recipient, User Product modified installed. Access network may denied modification materially adversely affects operation network violates rules protocols communication across network. Corresponding Source conveyed, Installation Information provided, accord section must format publicly documented (implementation available public source code form), must require special password key unpacking, reading copying.","code":""},{"path":"https://merck.github.io/metalite.ae/LICENSE.html","id":"id_7-additional-terms","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"7. Additional Terms","title":"GNU General Public License","text":"“Additional permissions” terms supplement terms License making exceptions one conditions. Additional permissions applicable entire Program shall treated though included License, extent valid applicable law. additional permissions apply part Program, part may used separately permissions, entire Program remains governed License without regard additional permissions. convey copy covered work, may option remove additional permissions copy, part . (Additional permissions may written require removal certain cases modify work.) may place additional permissions material, added covered work, can give appropriate copyright permission. Notwithstanding provision License, material add covered work, may (authorized copyright holders material) supplement terms License terms: ) Disclaiming warranty limiting liability differently terms sections 15 16 License; b) Requiring preservation specified reasonable legal notices author attributions material Appropriate Legal Notices displayed works containing ; c) Prohibiting misrepresentation origin material, requiring modified versions material marked reasonable ways different original version; d) Limiting use publicity purposes names licensors authors material; e) Declining grant rights trademark law use trade names, trademarks, service marks; f) Requiring indemnification licensors authors material anyone conveys material (modified versions ) contractual assumptions liability recipient, liability contractual assumptions directly impose licensors authors. non-permissive additional terms considered “restrictions” within meaning section 10. Program received , part , contains notice stating governed License along term restriction, may remove term. license document contains restriction permits relicensing conveying License, may add covered work material governed terms license document, provided restriction survive relicensing conveying. add terms covered work accord section, must place, relevant source files, statement additional terms apply files, notice indicating find applicable terms. Additional terms, permissive non-permissive, may stated form separately written license, stated exceptions; requirements apply either way.","code":""},{"path":"https://merck.github.io/metalite.ae/LICENSE.html","id":"id_8-termination","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"8. Termination","title":"GNU General Public License","text":"may propagate modify covered work except expressly provided License. attempt otherwise propagate modify void, automatically terminate rights License (including patent licenses granted third paragraph section 11). However, cease violation License, license particular copyright holder reinstated () provisionally, unless copyright holder explicitly finally terminates license, (b) permanently, copyright holder fails notify violation reasonable means prior 60 days cessation. Moreover, license particular copyright holder reinstated permanently copyright holder notifies violation reasonable means, first time received notice violation License (work) copyright holder, cure violation prior 30 days receipt notice. Termination rights section terminate licenses parties received copies rights License. rights terminated permanently reinstated, qualify receive new licenses material section 10.","code":""},{"path":"https://merck.github.io/metalite.ae/LICENSE.html","id":"id_9-acceptance-not-required-for-having-copies","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"9. Acceptance Not Required for Having Copies","title":"GNU General Public License","text":"required accept License order receive run copy Program. Ancillary propagation covered work occurring solely consequence using peer--peer transmission receive copy likewise require acceptance. However, nothing License grants permission propagate modify covered work. actions infringe copyright accept License. Therefore, modifying propagating covered work, indicate acceptance License .","code":""},{"path":"https://merck.github.io/metalite.ae/LICENSE.html","id":"id_10-automatic-licensing-of-downstream-recipients","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"10. Automatic Licensing of Downstream Recipients","title":"GNU General Public License","text":"time convey covered work, recipient automatically receives license original licensors, run, modify propagate work, subject License. responsible enforcing compliance third parties License. “entity transaction” transaction transferring control organization, substantially assets one, subdividing organization, merging organizations. propagation covered work results entity transaction, party transaction receives copy work also receives whatever licenses work party’s predecessor interest give previous paragraph, plus right possession Corresponding Source work predecessor interest, predecessor can get reasonable efforts. may impose restrictions exercise rights granted affirmed License. example, may impose license fee, royalty, charge exercise rights granted License, may initiate litigation (including cross-claim counterclaim lawsuit) alleging patent claim infringed making, using, selling, offering sale, importing Program portion .","code":""},{"path":"https://merck.github.io/metalite.ae/LICENSE.html","id":"id_11-patents","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"11. Patents","title":"GNU General Public License","text":"“contributor” copyright holder authorizes use License Program work Program based. work thus licensed called contributor’s “contributor version”. contributor’s “essential patent claims” patent claims owned controlled contributor, whether already acquired hereafter acquired, infringed manner, permitted License, making, using, selling contributor version, include claims infringed consequence modification contributor version. purposes definition, “control” includes right grant patent sublicenses manner consistent requirements License. contributor grants non-exclusive, worldwide, royalty-free patent license contributor’s essential patent claims, make, use, sell, offer sale, import otherwise run, modify propagate contents contributor version. following three paragraphs, “patent license” express agreement commitment, however denominated, enforce patent (express permission practice patent covenant sue patent infringement). “grant” patent license party means make agreement commitment enforce patent party. convey covered work, knowingly relying patent license, Corresponding Source work available anyone copy, free charge terms License, publicly available network server readily accessible means, must either (1) cause Corresponding Source available, (2) arrange deprive benefit patent license particular work, (3) arrange, manner consistent requirements License, extend patent license downstream recipients. “Knowingly relying” means actual knowledge , patent license, conveying covered work country, recipient’s use covered work country, infringe one identifiable patents country reason believe valid. , pursuant connection single transaction arrangement, convey, propagate procuring conveyance , covered work, grant patent license parties receiving covered work authorizing use, propagate, modify convey specific copy covered work, patent license grant automatically extended recipients covered work works based . patent license “discriminatory” include within scope coverage, prohibits exercise , conditioned non-exercise one rights specifically granted License. may convey covered work party arrangement third party business distributing software, make payment third party based extent activity conveying work, third party grants, parties receive covered work , discriminatory patent license () connection copies covered work conveyed (copies made copies), (b) primarily connection specific products compilations contain covered work, unless entered arrangement, patent license granted, prior 28 March 2007. Nothing License shall construed excluding limiting implied license defenses infringement may otherwise available applicable patent law.","code":""},{"path":"https://merck.github.io/metalite.ae/LICENSE.html","id":"id_12-no-surrender-of-others-freedom","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"12. No Surrender of Others’ Freedom","title":"GNU General Public License","text":"conditions imposed (whether court order, agreement otherwise) contradict conditions License, excuse conditions License. convey covered work satisfy simultaneously obligations License pertinent obligations, consequence may convey . example, agree terms obligate collect royalty conveying convey Program, way satisfy terms License refrain entirely conveying Program.","code":""},{"path":"https://merck.github.io/metalite.ae/LICENSE.html","id":"id_13-use-with-the-gnu-affero-general-public-license","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"13. Use with the GNU Affero General Public License","title":"GNU General Public License","text":"Notwithstanding provision License, permission link combine covered work work licensed version 3 GNU Affero General Public License single combined work, convey resulting work. terms License continue apply part covered work, special requirements GNU Affero General Public License, section 13, concerning interaction network apply combination .","code":""},{"path":"https://merck.github.io/metalite.ae/LICENSE.html","id":"id_14-revised-versions-of-this-license","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"14. Revised Versions of this License","title":"GNU General Public License","text":"Free Software Foundation may publish revised /new versions GNU General Public License time time. new versions similar spirit present version, may differ detail address new problems concerns. version given distinguishing version number. Program specifies certain numbered version GNU General Public License “later version” applies , option following terms conditions either numbered version later version published Free Software Foundation. Program specify version number GNU General Public License, may choose version ever published Free Software Foundation. Program specifies proxy can decide future versions GNU General Public License can used, proxy’s public statement acceptance version permanently authorizes choose version Program. Later license versions may give additional different permissions. However, additional obligations imposed author copyright holder result choosing follow later version.","code":""},{"path":"https://merck.github.io/metalite.ae/LICENSE.html","id":"id_15-disclaimer-of-warranty","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"15. Disclaimer of Warranty","title":"GNU General Public License","text":"WARRANTY PROGRAM, EXTENT PERMITTED APPLICABLE LAW. EXCEPT OTHERWISE STATED WRITING COPYRIGHT HOLDERS /PARTIES PROVIDE PROGRAM “” WITHOUT WARRANTY KIND, EITHER EXPRESSED IMPLIED, INCLUDING, LIMITED , IMPLIED WARRANTIES MERCHANTABILITY FITNESS PARTICULAR PURPOSE. ENTIRE RISK QUALITY PERFORMANCE PROGRAM . PROGRAM PROVE DEFECTIVE, ASSUME COST NECESSARY SERVICING, REPAIR CORRECTION.","code":""},{"path":"https://merck.github.io/metalite.ae/LICENSE.html","id":"id_16-limitation-of-liability","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"16. Limitation of Liability","title":"GNU General Public License","text":"EVENT UNLESS REQUIRED APPLICABLE LAW AGREED WRITING COPYRIGHT HOLDER, PARTY MODIFIES /CONVEYS PROGRAM PERMITTED , LIABLE DAMAGES, INCLUDING GENERAL, SPECIAL, INCIDENTAL CONSEQUENTIAL DAMAGES ARISING USE INABILITY USE PROGRAM (INCLUDING LIMITED LOSS DATA DATA RENDERED INACCURATE LOSSES SUSTAINED THIRD PARTIES FAILURE PROGRAM OPERATE PROGRAMS), EVEN HOLDER PARTY ADVISED POSSIBILITY DAMAGES.","code":""},{"path":"https://merck.github.io/metalite.ae/LICENSE.html","id":"id_17-interpretation-of-sections-15-and-16","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"17. Interpretation of Sections 15 and 16","title":"GNU General Public License","text":"disclaimer warranty limitation liability provided given local legal effect according terms, reviewing courts shall apply local law closely approximates absolute waiver civil liability connection Program, unless warranty assumption liability accompanies copy Program return fee. END TERMS CONDITIONS","code":""},{"path":"https://merck.github.io/metalite.ae/LICENSE.html","id":"how-to-apply-these-terms-to-your-new-programs","dir":"","previous_headings":"","what":"How to Apply These Terms to Your New Programs","title":"GNU General Public License","text":"develop new program, want greatest possible use public, best way achieve make free software everyone can redistribute change terms. , attach following notices program. safest attach start source file effectively state exclusion warranty; file least “copyright” line pointer full notice found. Also add information contact electronic paper mail. program terminal interaction, make output short notice like starts interactive mode: hypothetical commands show w show c show appropriate parts General Public License. course, program’s commands might different; GUI interface, use “box”. also get employer (work programmer) school, , sign “copyright disclaimer” program, necessary. information , apply follow GNU GPL, see <http://www.gnu.org/licenses/>. GNU General Public License permit incorporating program proprietary programs. program subroutine library, may consider useful permit linking proprietary applications library. want , use GNU Lesser General Public License instead License. first, please read <http://www.gnu.org/philosophy/--lgpl.html>.","code":"<one line to give the program's name and a brief idea of what it does.> Copyright (C) <year>  <name of author>  This program is free software: you can redistribute it and/or modify it under the terms of the GNU General Public License as published by the Free Software Foundation, either version 3 of the License, or (at your option) any later version.  This program is distributed in the hope that it will be useful, but WITHOUT ANY WARRANTY; without even the implied warranty of MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE.  See the GNU General Public License for more details.  You should have received a copy of the GNU General Public License along with this program.  If not, see <http://www.gnu.org/licenses/>. <program>  Copyright (C) <year>  <name of author> This program comes with ABSOLUTELY NO WARRANTY; for details type 'show w'. This is free software, and you are welcome to redistribute it under certain conditions; type 'show c' for details."},{"path":"https://merck.github.io/metalite.ae/articles/ae-listing.html","id":"overview","dir":"Articles","previous_headings":"","what":"Overview","title":"AE Listing","text":"objective tutorial generate production-ready adverse events (AE) listing. AE listing offers comprehensive information desired adverse events. two essential functions constructing AE listing tables metalite.ae: prepare_ae_listing(): prepare AE listing datasets. tlf_ae_listing(): transfer output datasets RTF files. example output:","code":""},{"path":"https://merck.github.io/metalite.ae/articles/ae-listing.html","id":"example-data","dir":"Articles","previous_headings":"","what":"Example data","title":"AE Listing","text":"Within metalite.ae, utilized ADSL ADAE datasets metalite package create illustrative dataset. metadata structure remains consistent across analysis examples within metalite.ae. Additional information can accessed metalite package website.","code":"meta <- meta_ae_example() meta #> ADaM metadata:  #>    .$data_population     Population data with 254 subjects  #>    .$data_observation    Observation data with 1191 records  #>    .$plan    Analysis plan with 18 plans  #>  #>  #>   Analysis population type: #>     name        id  group var       subset                         label #> 1 'apat' 'USUBJID' 'TRTA'     SAFFL == 'Y' 'All Participants as Treated' #>  #>  #>   Analysis observation type: #>     name        id  group var          subset           label #> 1 'wk12' 'USUBJID' 'TRTA'        SAFFL == 'Y' 'Weeks 0 to 12' #> 2 'wk24' 'USUBJID' 'TRTA'     AOCC01FL == 'Y' 'Weeks 0 to 24' #>  #>  #>   Analysis parameter type: #>      name                                label #> 1   'rel'        'drug-related adverse events' #> 2 'aeosi' 'adverse events of special interest' #> 3   'any'                 'any adverse events' #> 4   'ser'             'serious adverse events' #>                                 subset #> 1 AEREL %in% c('POSSIBLE', 'PROBABLE') #> 2                         AEOSI == 'Y' #> 3                                      #> 4                         AESER == 'Y' #>  #>  #>   Analysis function: #>            name                             label #> 1  'ae_summary'    'Table: adverse event summary' #> 2  'ae_listing'          'Listing: adverse event' #> 3  'ae_exp_adj' 'Exposure Adjusted Incident Rate' #> 4 'ae_specific'   'Table: specific adverse event'"},{"path":"https://merck.github.io/metalite.ae/articles/ae-listing.html","id":"analysis-preparation","dir":"Articles","previous_headings":"","what":"Analysis preparation","title":"AE Listing","text":"function prepare_ae_listing() used create dataset AE listing utilizing predefined keywords specified example data meta. resulting output function outdata object, comprises collection raw datasets analysis reporting.","code":"tbl <- prepare_ae_listing(   meta,   analysis = \"ae_listing\",   population = \"apat\",   observation = \"wk12\",   parameter = \"ser\" ) head(tbl$tbl) #>          USUBJID ASTDY                                        AEDECOD duration #> 689  01-709-1424     5                                        SYNCOPE    1 Day #> 1131 01-718-1170    27                                        SYNCOPE    2 Day #> 1173 01-718-1371    38 PARTIAL SEIZURES WITH SECONDARY GENERALISATION    4 Day #>         AESEV AESER  related action_taken  outcome      TRTA #> 689  MODERATE     Y Possible         None Resolved High Dose #> 1131   SEVERE     Y Probable         None Resolved  Low Dose #> 1173   SEVERE     Y     None         None Resolved High Dose #>                                                                                  subline #> 689  Subject ID = 01-709-1424, Gender = M, Race = WHITE, AGE = 77 Years, TRT = High Dose #> 1131  Subject ID = 01-718-1170, Gender = F, Race = WHITE, AGE = 80 Years, TRT = Low Dose #> 1173 Subject ID = 01-718-1371, Gender = F, Race = WHITE, AGE = 69 Years, TRT = High Dose head(tbl$col_name) #>                       USUBJID                         ASTDY  #>   \"Unique Subject Identifier\" \"Analysis Start Relative Day\"  #>                       AEDECOD                      duration  #>               \"Adverse Event\"                    \"Duration\"  #>                         AESEV                         AESER  #>                   \"Intensity\"                     \"Serious\""},{"path":"https://merck.github.io/metalite.ae/articles/ae-listing.html","id":"rtf-tables","dir":"Articles","previous_headings":"","what":"RTF tables","title":"AE Listing","text":"last step prepare RTF table using tlf_ae_listing().","code":"footnote <- c(   \"Related: Investigator-assessed relationship of the adverse event to study medication. Y = RELATED, N = NOT RELATED\",   \"Action Taken: Discontinued = DRUG WITHDRAWN, Interrupted = DRUG INTERRUPTED, Reduced = DOSE REDUCED, Increased = DOSE INCREASED, None = DOSE NOT CHANGED, N/A = NOT APPLICABLE.\",   \"Outcome: Resolved = RECOVERED/RESOLVED, Resolving = RECOVERING/RESOLVING, Sequelae = RECOVERED/RESOLVED WITH SEQUELAE, Not resolved = NOT RECOVERED/NOT RESOLVED.\",   \"Adverse event terms are from MedDRA Version 25.0.\" ) tbl |> tlf_ae_listing(   footnotes = footnote,   orientation = \"portrait\",   source = \"Source:  [CDISCpilot: adam-adsl; adae]\",   path_outtable = \"rtf/ae0listing0ser0wk12.rtf\",   path_outdata = NULL ) #> The output is saved in/home/runner/work/metalite.ae/metalite.ae/vignettes/rtf/ae0listing0ser0wk12.rtf"},{"path":"https://merck.github.io/metalite.ae/articles/ae-specific-subgroup.html","id":"overview","dir":"Articles","previous_headings":"","what":"Overview","title":"Subgroup Analysis for Specific AE","text":"AE specific subgroup analysis aims provide tables summarize details adverse events subgroup. development AE specific subgroup analysis involves exported functions: prepare_ae_specific_subgroup(): prepare analysis raw datasets. format_ae_specific_subgroup(): prepare analysis (mock) outdata proper format. tlf_ae_specific_subgroup(): transfer (mock) output dataset RTF table.","code":""},{"path":"https://merck.github.io/metalite.ae/articles/ae-specific-subgroup.html","id":"analysis-preparation","dir":"Articles","previous_headings":"Overview","what":"Analysis preparation","title":"Subgroup Analysis for Specific AE","text":"prepare_ae_specific_subgroup() function designed used multiple purposes. input function meta object created metalite package. output function outdata object containing list analysis raw datasets. Key arguments subgroup_var, subgroup_header, display_subgroup_total. output dataset contains commonly used statistics within subgroup_var. variable indexed order outdata$group outdata$subgroup within subgroup_var. row indexed order name within subgroup_var analysis output. n_pop: participants population within subgroup_var. n: number subjects AE within subgroup_var. prop: proportion subjects AE within subgroup_var. diff: risk difference compared reference_group within subgroup_var.","code":"meta <- meta_ae_example() outdata <- prepare_ae_specific_subgroup(   meta,   population = \"apat\",   observation = \"wk12\",   parameter = \"rel\",   subgroup_var = \"SEX\",   subgroup_header = c(\"TRTA\", \"SEX\"),   display_subgroup_total = TRUE ) outdata #> $components #> [1] \"soc\" \"par\" #>  #> $group #> [1] \"Placebo\"   \"Low Dose\"  \"High Dose\" #>  #> $subgroup #> [1] \"f\" \"m\" #>  #> $display_subgroup_total #> [1] TRUE #>  #> $meta #> ADaM metadata:  #>    .$data_population     Population data with 254 subjects  #>    .$data_observation    Observation data with 1191 records  #>    .$plan    Analysis plan with 18 plans  #>  #>  #>   Analysis population type: #>     name        id  group var       subset                         label #> 1 'apat' 'USUBJID' 'TRTA'     SAFFL == 'Y' 'All Participants as Treated' #>  #>  #>   Analysis observation type: #>     name        id  group var          subset           label #> 1 'wk12' 'USUBJID' 'TRTA'        SAFFL == 'Y' 'Weeks 0 to 12' #> 2 'wk24' 'USUBJID' 'TRTA'     AOCC01FL == 'Y' 'Weeks 0 to 24' #>  #>  #>   Analysis parameter type: #>      name                                label #> 1   'rel'        'drug-related adverse events' #> 2 'aeosi' 'adverse events of special interest' #> 3   'any'                 'any adverse events' #> 4   'ser'             'serious adverse events' #>                                 subset #> 1 AEREL %in% c('POSSIBLE', 'PROBABLE') #> 2                         AEOSI == 'Y' #> 3                                      #> 4                         AESER == 'Y' #>  #>  #>   Analysis function: #>            name                             label #> 1  'ae_summary'    'Table: adverse event summary' #> 2  'ae_listing'          'Listing: adverse event' #> 3  'ae_exp_adj' 'Exposure Adjusted Incident Rate' #> 4 'ae_specific'   'Table: specific adverse event' #>  #>  #> $population #> [1] \"apat\" #>  #> $observation #> [1] \"wk12\" #>  #> $parameter #> [1] \"rel\" #>  #> $out_all #> $out_all$F #> List of 14 #>  $ meta           :List of 7 #>  $ population     : chr \"apat\" #>  $ observation    : chr \"wk12\" #>  $ parameter      : chr \"rel\" #>  $ n              :'data.frame': 138 obs. of  4 variables: #>  $ order          : num [1:138] 1 100 200 900 1000 ... #>  $ group          : chr [1:4] \"Placebo\" \"Low Dose\" \"High Dose\" \"Total\" #>  $ reference_group: num 1 #>  $ prop           :'data.frame': 138 obs. of  4 variables: #>  $ diff           :'data.frame': 138 obs. of  2 variables: #>  $ n_pop          :'data.frame': 1 obs. of  4 variables: #>  $ name           : chr [1:138] \"Participants in population\" \"with one or more drug-related adverse events\" \"with no drug-related adverse events\" \"\" ... #>  $ components     : chr [1:2] \"soc\" \"par\" #>  $ prepare_call   : language FUN(meta = X[[i]], population = ..1, observation = ..2, parameter = ..3,      components = ..4) #>  #> $out_all$M #> List of 14 #>  $ meta           :List of 7 #>  $ population     : chr \"apat\" #>  $ observation    : chr \"wk12\" #>  $ parameter      : chr \"rel\" #>  $ n              :'data.frame': 138 obs. of  4 variables: #>  $ order          : num [1:138] 1 100 200 900 1000 ... #>  $ group          : chr [1:4] \"Placebo\" \"Low Dose\" \"High Dose\" \"Total\" #>  $ reference_group: num 1 #>  $ prop           :'data.frame': 138 obs. of  4 variables: #>  $ diff           :'data.frame': 138 obs. of  2 variables: #>  $ n_pop          :'data.frame': 1 obs. of  4 variables: #>  $ name           : chr [1:138] \"Participants in population\" \"with one or more drug-related adverse events\" \"with no drug-related adverse events\" \"\" ... #>  $ components     : chr [1:2] \"soc\" \"par\" #>  $ prepare_call   : language FUN(meta = X[[i]], population = ..1, observation = ..2, parameter = ..3,      components = ..4) #>  #> $out_all$Total #> List of 14 #>  $ meta           :List of 7 #>  $ population     : chr \"apat\" #>  $ observation    : chr \"wk12\" #>  $ parameter      : chr \"rel\" #>  $ n              :'data.frame': 138 obs. of  4 variables: #>  $ order          : num [1:138] 1 100 200 900 1000 ... #>  $ group          : chr [1:4] \"Placebo\" \"Low Dose\" \"High Dose\" \"Total\" #>  $ reference_group: num 1 #>  $ prop           :'data.frame': 138 obs. of  4 variables: #>  $ diff           :'data.frame': 138 obs. of  2 variables: #>  $ n_pop          :'data.frame': 1 obs. of  4 variables: #>  $ name           : chr [1:138] \"Participants in population\" \"with one or more drug-related adverse events\" \"with no drug-related adverse events\" \"\" ... #>  $ components     : chr [1:2] \"soc\" \"par\" #>  $ prepare_call   : language prepare_ae_specific(meta = meta, population = population, observation = observation,      parameter = parameter, | __truncated__ outdata$out_all$F #> List of 14 #>  $ meta           :List of 7 #>  $ population     : chr \"apat\" #>  $ observation    : chr \"wk12\" #>  $ parameter      : chr \"rel\" #>  $ n              :'data.frame': 138 obs. of  4 variables: #>  $ order          : num [1:138] 1 100 200 900 1000 ... #>  $ group          : chr [1:4] \"Placebo\" \"Low Dose\" \"High Dose\" \"Total\" #>  $ reference_group: num 1 #>  $ prop           :'data.frame': 138 obs. of  4 variables: #>  $ diff           :'data.frame': 138 obs. of  2 variables: #>  $ n_pop          :'data.frame': 1 obs. of  4 variables: #>  $ name           : chr [1:138] \"Participants in population\" \"with one or more drug-related adverse events\" \"with no drug-related adverse events\" \"\" ... #>  $ components     : chr [1:2] \"soc\" \"par\" #>  $ prepare_call   : language FUN(meta = X[[i]], population = ..1, observation = ..2, parameter = ..3,      components = ..4) outdata$out_all$M #> List of 14 #>  $ meta           :List of 7 #>  $ population     : chr \"apat\" #>  $ observation    : chr \"wk12\" #>  $ parameter      : chr \"rel\" #>  $ n              :'data.frame': 138 obs. of  4 variables: #>  $ order          : num [1:138] 1 100 200 900 1000 ... #>  $ group          : chr [1:4] \"Placebo\" \"Low Dose\" \"High Dose\" \"Total\" #>  $ reference_group: num 1 #>  $ prop           :'data.frame': 138 obs. of  4 variables: #>  $ diff           :'data.frame': 138 obs. of  2 variables: #>  $ n_pop          :'data.frame': 1 obs. of  4 variables: #>  $ name           : chr [1:138] \"Participants in population\" \"with one or more drug-related adverse events\" \"with no drug-related adverse events\" \"\" ... #>  $ components     : chr [1:2] \"soc\" \"par\" #>  $ prepare_call   : language FUN(meta = X[[i]], population = ..1, observation = ..2, parameter = ..3,      components = ..4) outdata$out_all$Total #> List of 14 #>  $ meta           :List of 7 #>  $ population     : chr \"apat\" #>  $ observation    : chr \"wk12\" #>  $ parameter      : chr \"rel\" #>  $ n              :'data.frame': 138 obs. of  4 variables: #>  $ order          : num [1:138] 1 100 200 900 1000 ... #>  $ group          : chr [1:4] \"Placebo\" \"Low Dose\" \"High Dose\" \"Total\" #>  $ reference_group: num 1 #>  $ prop           :'data.frame': 138 obs. of  4 variables: #>  $ diff           :'data.frame': 138 obs. of  2 variables: #>  $ n_pop          :'data.frame': 1 obs. of  4 variables: #>  $ name           : chr [1:138] \"Participants in population\" \"with one or more drug-related adverse events\" \"with no drug-related adverse events\" \"\" ... #>  $ components     : chr [1:2] \"soc\" \"par\" #>  $ prepare_call   : language prepare_ae_specific(meta = meta, population = population, observation = observation,      parameter = parameter, | __truncated__ outdata$group #> [1] \"Placebo\"   \"Low Dose\"  \"High Dose\" outdata$subgroup #> [1] \"f\" \"m\" head(data.frame(outdata$out_all$Total$order, outdata$out_all$Total$name)) #>   outdata.out_all.Total.order                   outdata.out_all.Total.name #> 1                           1                   Participants in population #> 2                         100 with one or more drug-related adverse events #> 3                         200          with no drug-related adverse events #> 4                         900                                              #> 5                        1000                            Cardiac disorders #> 6                        1021                          Atrial fibrillation outdata$out_all$F$n_pop #>   n_1 n_2 n_3 n_4 #> 1  53  50  40 143 outdata$out_all$M$n_pop #>   n_1 n_2 n_3 n_4 #> 1  33  34  44 111 outdata$out_all$Total$n_pop #>   n_1 n_2 n_3 n_4 #> 1  86  84  84 254 head(outdata$out_all$F$n) #>     n_1 n_2 n_3 n_4 #> 1    53  50  40 143 #> 2    28  41  32 101 #> 3    25   9   8  42 #> 4    NA  NA  NA  NA #> 122   4   4   4  12 #> 25    1   0   2   3 head(outdata$out_all$M$n) #>     n_1 n_2 n_3 n_4 #> 1    33  34  44 111 #> 2    16  32  38  86 #> 3    17   2   6  25 #> 4    NA  NA  NA  NA #> 122   2   3   0   5 #> 26    0   1   0   1 head(outdata$out_all$Total$n) #>     n_1 n_2 n_3 n_4 #> 1    86  84  84 254 #> 2    44  73  70 187 #> 3    42  11  14  67 #> 4    NA  NA  NA  NA #> 122   6   7   4  17 #> 25    1   0   2   3 head(outdata$out_all$F$prop) #>        prop_1 prop_2 prop_3    prop_4 #> 1          NA     NA     NA        NA #> 2   52.830189     82     80 70.629371 #> 3   47.169811     18     20 29.370629 #> 4          NA     NA     NA        NA #> 122  7.547170      8     10  8.391608 #> 25   1.886792      0      5  2.097902 head(outdata$out_all$M$prop) #>        prop_1    prop_2   prop_3     prop_4 #> 1          NA        NA       NA         NA #> 2   48.484848 94.117647 86.36364 77.4774775 #> 3   51.515152  5.882353 13.63636 22.5225225 #> 4          NA        NA       NA         NA #> 122  6.060606  8.823529  0.00000  4.5045045 #> 26   0.000000  2.941176  0.00000  0.9009009 head(outdata$out_all$Total$prop) #>        prop_1    prop_2    prop_3    prop_4 #> 1          NA        NA        NA        NA #> 2   51.162791 86.904762 83.333333 73.622047 #> 3   48.837209 13.095238 16.666667 26.377953 #> 4          NA        NA        NA        NA #> 122  6.976744  8.333333  4.761905  6.692913 #> 25   1.162791  0.000000  2.380952  1.181102 head(outdata$out_all$Total$diff) #>         diff_2     diff_3 #> 1           NA         NA #> 2    35.741971  32.170543 #> 3   -35.741971 -32.170543 #> 4           NA         NA #> 122   1.356589  -2.214839 #> 25   -1.162791   1.218162"},{"path":"https://merck.github.io/metalite.ae/articles/ae-specific-subgroup.html","id":"format-output","dir":"Articles","previous_headings":"Overview","what":"Format output","title":"Subgroup Analysis for Specific AE","text":"raw analysis results, can use format_ae_specific_subgroup() prepare outdata create RTF tables. can hide total column: Adding risk difference:","code":"tbl <- outdata |> format_ae_specific_subgroup() head(tbl$tbl) #>                                             name Fn_1 Fprop_1 Fn_2 Fprop_2 Fn_3 #> 96                    Participants in population   53    <NA>   50    <NA>   40 #> 135 with one or more drug-related adverse events   28  (52.8)   41  (82.0)   32 #> 134          with no drug-related adverse events   25  (47.2)    9  (18.0)    8 #> 1                                                  NA    <NA>   NA    <NA>   NA #> 33                             Cardiac disorders    4   (7.5)    4   (8.0)    4 #> 22                           Atrial fibrillation    1   (1.9)    0   (0.0)    2 #>     Fprop_3 Mn_1 Mprop_1 Mn_2 Mprop_2 Mn_3 Mprop_3 Totaln_1 Totalprop_1 #> 96     <NA>   33    <NA>   34    <NA>   44    <NA>       86        <NA> #> 135  (80.0)   16  (48.5)   32  (94.1)   38  (86.4)       44      (51.2) #> 134  (20.0)   17  (51.5)    2   (5.9)    6  (13.6)       42      (48.8) #> 1      <NA>   NA    <NA>   NA    <NA>   NA    <NA>       NA        <NA> #> 33   (10.0)    2   (6.1)    3   (8.8)    0   (0.0)        6       (7.0) #> 22    (5.0)    0   (0.0)    0   (0.0)    0   (0.0)        1       (1.2) #>     Totaln_2 Totalprop_2 Totaln_3 Totalprop_3 order #> 96        84        <NA>       84        <NA>     1 #> 135       73      (86.9)       70      (83.3)   100 #> 134       11      (13.1)       14      (16.7)   200 #> 1         NA        <NA>       NA        <NA>   900 #> 33         7       (8.3)        4       (4.8)  1000 #> 22         0       (0.0)        2       (2.4)  1021 tbl <- outdata |> format_ae_specific_subgroup(display = c(\"n\", \"prop\")) head(tbl$tbl) #>                                             name Fn_1 Fprop_1 Fn_2 Fprop_2 Fn_3 #> 96                    Participants in population   53    <NA>   50    <NA>   40 #> 135 with one or more drug-related adverse events   28  (52.8)   41  (82.0)   32 #> 134          with no drug-related adverse events   25  (47.2)    9  (18.0)    8 #> 1                                                  NA    <NA>   NA    <NA>   NA #> 33                             Cardiac disorders    4   (7.5)    4   (8.0)    4 #> 22                           Atrial fibrillation    1   (1.9)    0   (0.0)    2 #>     Fprop_3 Mn_1 Mprop_1 Mn_2 Mprop_2 Mn_3 Mprop_3 Totaln_1 Totalprop_1 #> 96     <NA>   33    <NA>   34    <NA>   44    <NA>       86        <NA> #> 135  (80.0)   16  (48.5)   32  (94.1)   38  (86.4)       44      (51.2) #> 134  (20.0)   17  (51.5)    2   (5.9)    6  (13.6)       42      (48.8) #> 1      <NA>   NA    <NA>   NA    <NA>   NA    <NA>       NA        <NA> #> 33   (10.0)    2   (6.1)    3   (8.8)    0   (0.0)        6       (7.0) #> 22    (5.0)    0   (0.0)    0   (0.0)    0   (0.0)        1       (1.2) #>     Totaln_2 Totalprop_2 Totaln_3 Totalprop_3 order #> 96        84        <NA>       84        <NA>     1 #> 135       73      (86.9)       70      (83.3)   100 #> 134       11      (13.1)       14      (16.7)   200 #> 1         NA        <NA>       NA        <NA>   900 #> 33         7       (8.3)        4       (4.8)  1000 #> 22         0       (0.0)        2       (2.4)  1021 tbl <- outdata |> format_ae_specific_subgroup(display = c(\"n\", \"prop\", \"diff\")) head(tbl$tbl) #>                                             name Fn_1 Fprop_1 Fn_2 Fprop_2 Fn_3 #> 96                    Participants in population   53    <NA>   50    <NA>   40 #> 135 with one or more drug-related adverse events   28  (52.8)   41  (82.0)   32 #> 134          with no drug-related adverse events   25  (47.2)    9  (18.0)    8 #> 1                                                  NA    <NA>   NA    <NA>   NA #> 33                             Cardiac disorders    4   (7.5)    4   (8.0)    4 #> 22                           Atrial fibrillation    1   (1.9)    0   (0.0)    2 #>     Fprop_3 Fdiff_2 Fdiff_3 Mn_1 Mprop_1 Mn_2 Mprop_2 Mn_3 Mprop_3 Mdiff_2 #> 96     <NA>      NA      NA   33    <NA>   34    <NA>   44    <NA>      NA #> 135  (80.0)    29.2    27.2   16  (48.5)   32  (94.1)   38  (86.4)    45.6 #> 134  (20.0)   -29.2   -27.2   17  (51.5)    2   (5.9)    6  (13.6)   -45.6 #> 1      <NA>      NA      NA   NA    <NA>   NA    <NA>   NA    <NA>      NA #> 33   (10.0)     0.5     2.5    2   (6.1)    3   (8.8)    0   (0.0)     2.8 #> 22    (5.0)    -1.9     3.1    0   (0.0)    0   (0.0)    0   (0.0)     0.0 #>     Mdiff_3 Totaln_1 Totalprop_1 Totaln_2 Totalprop_2 Totaln_3 Totalprop_3 #> 96       NA       86        <NA>       84        <NA>       84        <NA> #> 135    37.9       44      (51.2)       73      (86.9)       70      (83.3) #> 134   -37.9       42      (48.8)       11      (13.1)       14      (16.7) #> 1        NA       NA        <NA>       NA        <NA>       NA        <NA> #> 33     -6.1        6       (7.0)        7       (8.3)        4       (4.8) #> 22      0.0        1       (1.2)        0       (0.0)        2       (2.4) #>     Totaldiff_2 Totaldiff_3 order #> 96           NA          NA     1 #> 135        35.7        32.2   100 #> 134       -35.7       -32.2   200 #> 1            NA          NA   900 #> 33          1.4        -2.2  1000 #> 22         -1.2         1.2  1021"},{"path":"https://merck.github.io/metalite.ae/articles/ae-specific-subgroup.html","id":"mock-data-preparation","dir":"Articles","previous_headings":"Overview","what":"Mock data preparation","title":"Subgroup Analysis for Specific AE","text":"can also use format_ae_specific_subgroup() create mock output data. purpose mock argument create comprehensive mock table template, handy way help users create mock table mimics exact output layout. Additional work required develop flexible mock table generation tool (example, dedicated mock table generation package).","code":"tbl <- outdata |> format_ae_specific_subgroup(mock = FALSE) head(tbl$tbl) #>                                             name Fn_1 Fprop_1 Fn_2 Fprop_2 Fn_3 #> 96                    Participants in population   53    <NA>   50    <NA>   40 #> 135 with one or more drug-related adverse events   28  (52.8)   41  (82.0)   32 #> 134          with no drug-related adverse events   25  (47.2)    9  (18.0)    8 #> 1                                                  NA    <NA>   NA    <NA>   NA #> 33                             Cardiac disorders    4   (7.5)    4   (8.0)    4 #> 22                           Atrial fibrillation    1   (1.9)    0   (0.0)    2 #>     Fprop_3 Mn_1 Mprop_1 Mn_2 Mprop_2 Mn_3 Mprop_3 Totaln_1 Totalprop_1 #> 96     <NA>   33    <NA>   34    <NA>   44    <NA>       86        <NA> #> 135  (80.0)   16  (48.5)   32  (94.1)   38  (86.4)       44      (51.2) #> 134  (20.0)   17  (51.5)    2   (5.9)    6  (13.6)       42      (48.8) #> 1      <NA>   NA    <NA>   NA    <NA>   NA    <NA>       NA        <NA> #> 33   (10.0)    2   (6.1)    3   (8.8)    0   (0.0)        6       (7.0) #> 22    (5.0)    0   (0.0)    0   (0.0)    0   (0.0)        1       (1.2) #>     Totaln_2 Totalprop_2 Totaln_3 Totalprop_3 order #> 96        84        <NA>       84        <NA>     1 #> 135       73      (86.9)       70      (83.3)   100 #> 134       11      (13.1)       14      (16.7)   200 #> 1         NA        <NA>       NA        <NA>   900 #> 33         7       (8.3)        4       (4.8)  1000 #> 22         0       (0.0)        2       (2.4)  1021"},{"path":"https://merck.github.io/metalite.ae/articles/ae-specific-subgroup.html","id":"rtf-tables","dir":"Articles","previous_headings":"Overview","what":"RTF tables","title":"Subgroup Analysis for Specific AE","text":"using tlf_ae_specific_subgroup(), can transfer output format_ae_specific_subgroup() RTF PDF table.","code":"outdata |>   format_ae_specific_subgroup() |>   tlf_ae_specific_subgroup(     meddra_version = \"24.0\",     source = \"Source:  [CDISCpilot: adam-adsl; adae]\",     path_outtable = \"rtf/ae0specific0sub0gender1.rtf\"   ) #> The output is saved in/home/runner/work/metalite.ae/metalite.ae/vignettes/rtf/ae0specific0sub0gender1.rtf"},{"path":"https://merck.github.io/metalite.ae/articles/ae-specific.html","id":"overview","dir":"Articles","previous_headings":"","what":"Overview","title":"AE Specification","text":"objective tutorial generate production-ready AE specification analyses. extends examples shown specific AE chapter R Clinical Study Reports Submission book. AE specification analysis entails creation tables summarize details different types adverse events. accomplish using metalite.ae, three essential functions required: prepare_ae_specific(): prepare analysis raw datasets. format_ae_specific(): prepare analysis (mock) outdata proper format. tlf_ae_specific(): transfer (mock) output dataset RTF table. three optional functions extend AE specification analysis. extend_ae_specific_inference(): add risk difference inference results based M&N method. extend_ae_specific_duration(): add average duration AE. extend_ae_specific_events(): add average number AE events. example output:","code":""},{"path":"https://merck.github.io/metalite.ae/articles/ae-specific.html","id":"example-data","dir":"Articles","previous_headings":"","what":"Example data","title":"AE Specification","text":"Within metalite.ae, utilized ADSL ADAE datasets metalite package create illustrative dataset. metadata structure remains consistent across analysis examples within metalite.ae. Additional information can accessed metalite package website.","code":"meta <- meta_ae_example() meta #> ADaM metadata:  #>    .$data_population     Population data with 254 subjects  #>    .$data_observation    Observation data with 1191 records  #>    .$plan    Analysis plan with 18 plans  #>  #>  #>   Analysis population type: #>     name        id  group var       subset                         label #> 1 'apat' 'USUBJID' 'TRTA'     SAFFL == 'Y' 'All Participants as Treated' #>  #>  #>   Analysis observation type: #>     name        id  group var          subset           label #> 1 'wk12' 'USUBJID' 'TRTA'        SAFFL == 'Y' 'Weeks 0 to 12' #> 2 'wk24' 'USUBJID' 'TRTA'     AOCC01FL == 'Y' 'Weeks 0 to 24' #>  #>  #>   Analysis parameter type: #>      name                                label #> 1   'rel'        'drug-related adverse events' #> 2 'aeosi' 'adverse events of special interest' #> 3   'any'                 'any adverse events' #> 4   'ser'             'serious adverse events' #>                                 subset #> 1 AEREL %in% c('POSSIBLE', 'PROBABLE') #> 2                         AEOSI == 'Y' #> 3                                      #> 4                         AESER == 'Y' #>  #>  #>   Analysis function: #>            name                             label #> 1  'ae_summary'    'Table: adverse event summary' #> 2  'ae_listing'          'Listing: adverse event' #> 3  'ae_exp_adj' 'Exposure Adjusted Incident Rate' #> 4 'ae_specific'   'Table: specific adverse event'"},{"path":"https://merck.github.io/metalite.ae/articles/ae-specific.html","id":"analysis-preparation","dir":"Articles","previous_headings":"Example data","what":"Analysis preparation","title":"AE Specification","text":"function prepare_ae_specific() used create dataset AE summary analysis utilizing predefined keywords specified example data meta. resulting output function outdata object, comprises collection raw datasets analysis reporting. resulting dataset contains frequently used statistics, variables indexed according order specified outdata$group. row indexed according order outdata$name. n_pop: number participants population. n: number subjects AE. prop: proportion subjects AE. diff: risk difference compared reference_group.","code":"outdata <- prepare_ae_specific(   meta,   population = \"apat\",   observation = \"wk12\",   parameter = \"rel\" ) outdata #> List of 14 #>  $ meta           :List of 7 #>  $ population     : chr \"apat\" #>  $ observation    : chr \"wk12\" #>  $ parameter      : chr \"rel\" #>  $ n              :'data.frame': 138 obs. of  4 variables: #>  $ order          : num [1:138] 1 100 200 900 1000 ... #>  $ group          : chr [1:4] \"Placebo\" \"Low Dose\" \"High Dose\" \"Total\" #>  $ reference_group: num 1 #>  $ prop           :'data.frame': 138 obs. of  4 variables: #>  $ diff           :'data.frame': 138 obs. of  2 variables: #>  $ n_pop          :'data.frame': 1 obs. of  4 variables: #>  $ name           : chr [1:138] \"Participants in population\" \"with one or more drug-related adverse events\" \"with no drug-related adverse events\" \"\" ... #>  $ components     : chr [1:2] \"soc\" \"par\" #>  $ prepare_call   : language prepare_ae_specific(meta = meta, population = \"apat\", observation = \"wk12\",      parameter = \"rel\") outdata$group #> [1] \"Placebo\"   \"Low Dose\"  \"High Dose\" \"Total\" head(data.frame(outdata$order, outdata$name)) #>   outdata.order                                 outdata.name #> 1             1                   Participants in population #> 2           100 with one or more drug-related adverse events #> 3           200          with no drug-related adverse events #> 4           900                                              #> 5          1000                            Cardiac disorders #> 6          1021                          Atrial fibrillation outdata$n_pop #>   n_1 n_2 n_3 n_4 #> 1  86  84  84 254 head(outdata$n) #>     n_1 n_2 n_3 n_4 #> 1    86  84  84 254 #> 2    44  73  70 187 #> 3    42  11  14  67 #> 4    NA  NA  NA  NA #> 122   6   7   4  17 #> 25    1   0   2   3 head(outdata$prop) #>        prop_1    prop_2    prop_3    prop_4 #> 1          NA        NA        NA        NA #> 2   51.162791 86.904762 83.333333 73.622047 #> 3   48.837209 13.095238 16.666667 26.377953 #> 4          NA        NA        NA        NA #> 122  6.976744  8.333333  4.761905  6.692913 #> 25   1.162791  0.000000  2.380952  1.181102 head(outdata$diff) #>         diff_2     diff_3 #> 1           NA         NA #> 2    35.741971  32.170543 #> 3   -35.741971 -32.170543 #> 4           NA         NA #> 122   1.356589  -2.214839 #> 25   -1.162791   1.218162"},{"path":"https://merck.github.io/metalite.ae/articles/ae-specific.html","id":"format-output","dir":"Articles","previous_headings":"","what":"Format output","title":"AE Specification","text":"raw analysis results obtained, format_ae_specific() function can employed prepare outdata, ensuring compatibility production-ready RTF tables.","code":"tbl <- outdata |> format_ae_specific() head(tbl$tbl) #>                                             name n_1 prop_1 n_2 prop_2 n_3 #> 1                     Participants in population  86   <NA>  84   <NA>  84 #> 2   with one or more drug-related adverse events  44 (51.2)  73 (86.9)  70 #> 3            with no drug-related adverse events  42 (48.8)  11 (13.1)  14 #> 4                                                 NA   <NA>  NA   <NA>  NA #> 122                            Cardiac disorders   6  (7.0)   7  (8.3)   4 #> 25                           Atrial fibrillation   1  (1.2)   0  (0.0)   2 #>     prop_3 n_4 prop_4 #> 1     <NA> 254   <NA> #> 2   (83.3) 187 (73.6) #> 3   (16.7)  67 (26.4) #> 4     <NA>  NA   <NA> #> 122  (4.8)  17  (6.7) #> 25   (2.4)   3  (1.2)"},{"path":"https://merck.github.io/metalite.ae/articles/ae-specific.html","id":"additional-statistics","dir":"Articles","previous_headings":"Format output","what":"Additional statistics","title":"AE Specification","text":"using display argument, can choose specific statistics include. instance, option incorporate risk difference. perform advanced analysis, extend_ae_specific_inference() function utilized. instance, can incorporate 95% confidence interval based Miettinen Nurminen (M&N) method. information regarding M&N method can found rate compare vignette. can use extend_ae_specific_duration() add average duration AE. can use extend_ae_specific_events() add average number AE per subject.","code":"tbl <- outdata |> format_ae_specific(display = c(\"n\", \"prop\", \"diff\")) head(tbl$tbl) #>                                             name n_1 prop_1 n_2 prop_2 n_3 #> 1                     Participants in population  86   <NA>  84   <NA>  84 #> 2   with one or more drug-related adverse events  44 (51.2)  73 (86.9)  70 #> 3            with no drug-related adverse events  42 (48.8)  11 (13.1)  14 #> 4                                                 NA   <NA>  NA   <NA>  NA #> 122                            Cardiac disorders   6  (7.0)   7  (8.3)   4 #> 25                           Atrial fibrillation   1  (1.2)   0  (0.0)   2 #>     prop_3 diff_2 diff_3 #> 1     <NA>     NA     NA #> 2   (83.3)   35.7   32.2 #> 3   (16.7)  -35.7  -32.2 #> 4     <NA>     NA     NA #> 122  (4.8)    1.4   -2.2 #> 25   (2.4)   -1.2    1.2 tbl <- outdata |>   extend_ae_specific_inference() |>   format_ae_specific(display = c(\"n\", \"prop\", \"diff\", \"diff_ci\")) head(tbl$tbl) #>                                             name n_1 prop_1 n_2 prop_2 n_3 #> 1                     Participants in population  86   <NA>  84   <NA>  84 #> 2   with one or more drug-related adverse events  44 (51.2)  73 (86.9)  70 #> 3            with no drug-related adverse events  42 (48.8)  11 (13.1)  14 #> 4                                                 NA   <NA>  NA   <NA>  NA #> 122                            Cardiac disorders   6  (7.0)   7  (8.3)   4 #> 25                           Atrial fibrillation   1  (1.2)   0  (0.0)   2 #>     prop_3 diff_2           ci_2 diff_3           ci_3 #> 1     <NA>     NA   (-4.4,  0.0)     NA   (-4.4,  0.0) #> 2   (83.3)   35.7   (22.4, 48.0)   32.2   (18.4, 44.8) #> 3   (16.7)  -35.7 (-48.0, -22.4)  -32.2 (-44.8, -18.4) #> 4     <NA>     NA           <NA>     NA           <NA> #> 122  (4.8)    1.4   (-7.3, 10.2)   -2.2  (-10.3,  5.6) #> 25   (2.4)   -1.2   (-6.3,  3.3)    1.2   (-4.2,  7.3) tbl <- outdata |>   extend_ae_specific_duration(duration_var = \"ADURN\") |>   format_ae_specific(display = c(\"n\", \"prop\", \"dur\"))  head(tbl$tbl) #>                                             name n_1 prop_1        dur_1 n_2 #> 1                     Participants in population  86   <NA>           NA  84 #> 2   with one or more drug-related adverse events  44 (51.2)  29.0 ( 3.5)  73 #> 3            with no drug-related adverse events  42 (48.8)           NA  11 #> 4                                                 NA   <NA>           NA  NA #> 122                            Cardiac disorders   6  (7.0)  19.1 ( 3.6)   7 #> 25                           Atrial fibrillation   1  (1.2)          NaN   0 #>     prop_2        dur_2 n_3 prop_3        dur_3 #> 1     <NA>           NA  84   <NA>           NA #> 2   (86.9)  27.2 ( 3.2)  70 (83.3)  30.6 ( 2.2) #> 3   (13.1)           NA  14 (16.7)           NA #> 4     <NA>           NA  NA   <NA>           NA #> 122  (8.3)  34.8 ( 3.4)   4  (4.8)  32.3 ( 4.1) #> 25   (0.0)  39.0 ( 7.0)   2  (2.4)  26.2 ( 4.5) tbl <- outdata |>   extend_ae_specific_events() |>   format_ae_specific(display = c(\"n\", \"prop\", \"events\"))  head(tbl$tbl) #>                                             name n_1 prop_1     events_1 n_2 #> 1                     Participants in population  86   <NA>           NA  84 #> 2   with one or more drug-related adverse events  44 (51.2)   0.7 ( 0.1)  73 #> 3            with no drug-related adverse events  42 (48.8)           NA  11 #> 4                                                 NA   <NA>           NA  NA #> 122                            Cardiac disorders   6  (7.0)   2.3 ( 0.4)   7 #> 25                           Atrial fibrillation   1  (1.2)   1.0 ( 0.0)   0 #>     prop_2     events_2 n_3 prop_3     events_3 #> 1     <NA>           NA  84   <NA>           NA #> 2   (86.9)   1.6 ( 0.2)  70 (83.3)   1.5 ( 0.2) #> 3   (13.1)           NA  14 (16.7)           NA #> 4     <NA>           NA  NA   <NA>           NA #> 122  (8.3)   2.5 ( 0.3)   4  (4.8)   3.2 ( 0.3) #> 25   (0.0)   1.7 ( 0.1)   2  (2.4)   1.5 ( 0.1)"},{"path":"https://merck.github.io/metalite.ae/articles/ae-specific.html","id":"mock-data-preparation","dir":"Articles","previous_headings":"Format output","what":"Mock data preparation","title":"AE Specification","text":"mock argument facilitates creation mock table ease. Please note intention mock argument provide -encompassing mock table template. Instead, serves convenient method assist users generating mock table closely resembles desired output layout. develop versatile mock table generation tool, efforts necessary. potentially involve creation dedicated mock table generation package similar solutions.","code":"tbl <- outdata |> format_ae_specific(mock = TRUE) head(tbl$tbl) #>                                           name  n_1 prop_1  n_2 prop_2  n_3 #> 1                   Participants in population   xx   <NA>   xx   <NA>   xx #> 2 with one or more drug-related adverse events   xx (xx.x)   xx (xx.x)   xx #> 3          with no drug-related adverse events   xx (xx.x)   xx (xx.x)   xx #> 4                                              <NA>   <NA> <NA>   <NA> <NA> #> 5                            Cardiac disorders    x  (x.x)    x  (x.x)    x #> 6                          Atrial fibrillation    x  (x.x)    x  (x.x)    x #>   prop_3  n_4 prop_4 #> 1   <NA>  xxx   <NA> #> 2 (xx.x)  xxx (xx.x) #> 3 (xx.x)   xx (xx.x) #> 4   <NA> <NA>   <NA> #> 5  (x.x)   xx  (x.x) #> 6  (x.x)    x  (x.x)"},{"path":"https://merck.github.io/metalite.ae/articles/ae-specific.html","id":"rtf-tables","dir":"Articles","previous_headings":"","what":"RTF tables","title":"AE Specification","text":"last step prepare RTF table using tlf_ae_summary(). tlf_ae_specific() function also provides commonly used arguments customize table. mock table can also generated.","code":"outdata |>   format_ae_specific() |>   tlf_ae_specific(     meddra_version = \"24.0\",     source = \"Source:  [CDISCpilot: adam-adsl; adae]\",     path_outtable = \"rtf/ae0specific1.rtf\"   ) #> The output is saved in/home/runner/work/metalite.ae/metalite.ae/vignettes/rtf/ae0specific1.rtf outdata |>   format_ae_specific() |>   tlf_ae_specific(     meddra_version = \"24.0\",     source = \"Source:  [CDISCpilot: adam-adsl; adae]\",     col_rel_width = c(6, rep(1, 8)),     text_font_size = 8,     orientation = \"landscape\",     path_outtable = \"rtf/ae0specific2.rtf\"   ) #> The output is saved in/home/runner/work/metalite.ae/metalite.ae/vignettes/rtf/ae0specific2.rtf outdata |>   format_ae_specific(mock = TRUE) |>   tlf_ae_specific(     meddra_version = \"24.0\",     source = \"Source:  [CDISCpilot: adam-adsl; adae]\",     path_outtable = \"rtf/mock_ae0specific1.rtf\"   ) #> The output is saved in/home/runner/work/metalite.ae/metalite.ae/vignettes/rtf/mock_ae0specific1.rtf"},{"path":"https://merck.github.io/metalite.ae/articles/ae-summary.html","id":"overview","dir":"Articles","previous_headings":"","what":"Overview","title":"AE Summary","text":"objective tutorial generate production-ready AE summary. extends examples shown AE summary chapter R Clinical Study Reports Submission book. AE summary analysis entails creation tables summarize adverse events information. accomplish using metalite.ae, three essential functions required: prepare_ae_summary(): prepare analysis raw datasets. format_ae_summary(): prepare analysis (mock) outdata proper format. tlf_ae_summary(): transfer (mock) output dataset RTF files. one optional function extend AE summary analysis: extend_ae_specific_inference(): add risk difference inference results based M&N method. example output:","code":""},{"path":"https://merck.github.io/metalite.ae/articles/ae-summary.html","id":"example-data","dir":"Articles","previous_headings":"","what":"Example data","title":"AE Summary","text":"Within metalite.ae, utilized ADSL ADAE datasets metalite package create illustrative dataset. metadata structure remains consistent across analysis examples within metalite.ae. Additional information can accessed metalite package website.","code":"meta <- meta_ae_example() meta #> ADaM metadata:  #>    .$data_population     Population data with 254 subjects  #>    .$data_observation    Observation data with 1191 records  #>    .$plan    Analysis plan with 18 plans  #>  #>  #>   Analysis population type: #>     name        id  group var       subset                         label #> 1 'apat' 'USUBJID' 'TRTA'     SAFFL == 'Y' 'All Participants as Treated' #>  #>  #>   Analysis observation type: #>     name        id  group var          subset           label #> 1 'wk12' 'USUBJID' 'TRTA'        SAFFL == 'Y' 'Weeks 0 to 12' #> 2 'wk24' 'USUBJID' 'TRTA'     AOCC01FL == 'Y' 'Weeks 0 to 24' #>  #>  #>   Analysis parameter type: #>      name                                label #> 1   'rel'        'drug-related adverse events' #> 2 'aeosi' 'adverse events of special interest' #> 3   'any'                 'any adverse events' #> 4   'ser'             'serious adverse events' #>                                 subset #> 1 AEREL %in% c('POSSIBLE', 'PROBABLE') #> 2                         AEOSI == 'Y' #> 3                                      #> 4                         AESER == 'Y' #>  #>  #>   Analysis function: #>            name                             label #> 1  'ae_summary'    'Table: adverse event summary' #> 2  'ae_listing'          'Listing: adverse event' #> 3  'ae_exp_adj' 'Exposure Adjusted Incident Rate' #> 4 'ae_specific'   'Table: specific adverse event'"},{"path":"https://merck.github.io/metalite.ae/articles/ae-summary.html","id":"analysis-preparation","dir":"Articles","previous_headings":"","what":"Analysis preparation","title":"AE Summary","text":"function prepare_ae_summary() used create dataset AE summary analysis utilizing predefined keywords specified example data meta. resulting output function outdata object, comprises collection raw datasets analysis reporting. resulting dataset contains frequently used statistics, variables indexed according order specified outdata$group. row indexed according order outdata$name. n_pop: number participants population. n: number subjects AE. prop: proportion subjects AE. diff: risk difference compared reference_group.","code":"outdata <- prepare_ae_summary(   meta,   population = \"apat\",   observation = \"wk12\",   parameter = \"any;rel;ser\" ) outdata #> List of 13 #>  $ meta           :List of 7 #>  $ population     : chr \"apat\" #>  $ observation    : chr \"wk12\" #>  $ parameter      : chr \"any;rel;ser\" #>  $ n              :'data.frame': 5 obs. of  4 variables: #>  $ order          : num [1:5] 1 100 200 300 400 #>  $ group          : chr [1:4] \"Placebo\" \"Low Dose\" \"High Dose\" \"Total\" #>  $ reference_group: num 1 #>  $ prop           :'data.frame': 5 obs. of  4 variables: #>  $ diff           :'data.frame': 5 obs. of  2 variables: #>  $ n_pop          :'data.frame': 1 obs. of  4 variables: #>  $ name           : chr [1:5] \"Participants in population\" \"with one or more adverse events\" \"with no adverse events\" \"with drug-related{^a} adverse events\" ... #>  $ prepare_call   : language prepare_ae_summary(meta = meta, population = \"apat\", observation = \"wk12\",      parameter = \"any;rel;ser\") outdata$group #> [1] \"Placebo\"   \"Low Dose\"  \"High Dose\" \"Total\" head(data.frame(outdata$order, outdata$name)) #>   outdata.order                         outdata.name #> 1             1           Participants in population #> 2           100      with one or more adverse events #> 3           200               with no adverse events #> 4           300 with drug-related{^a} adverse events #> 5           400          with serious adverse events outdata$n_pop #>   n_1 n_2 n_3 n_4 #> 1  86  84  84 254 head(outdata$n) #>    n_1 n_2 n_3 n_4 #> 1   86  84  84 254 #> 2   69  77  79 225 #> 3   17   7   5  29 #> 21  44  73  70 187 #> 22   0   1   2   3 head(outdata$prop) #>      prop_1    prop_2    prop_3    prop_4 #> 1        NA        NA        NA        NA #> 2  80.23256 91.666667 94.047619 88.582677 #> 3  19.76744  8.333333  5.952381 11.417323 #> 21 51.16279 86.904762 83.333333 73.622047 #> 22  0.00000  1.190476  2.380952  1.181102 head(outdata$diff) #>        diff_2     diff_3 #> 1          NA         NA #> 2   11.434109  13.815061 #> 21  35.741971  32.170543 #> 22   1.190476   2.380952 #> 3  -11.434109 -13.815061"},{"path":"https://merck.github.io/metalite.ae/articles/ae-summary.html","id":"format-output","dir":"Articles","previous_headings":"","what":"Format output","title":"AE Summary","text":"raw analysis results obtained, format_ae_summary() function can employed prepare outdata, ensuring compatibility production-ready RTF tables.","code":"tbl <- outdata |> format_ae_summary() tbl$tbl #>                                    name n_1 prop_1 n_2 prop_2 n_3 prop_3 n_4 #> 1            Participants in population  86   <NA>  84   <NA>  84   <NA> 254 #> 2       with one or more adverse events  69 (80.2)  77 (91.7)  79 (94.0) 225 #> 3                with no adverse events  17 (19.8)   7  (8.3)   5  (6.0)  29 #> 21 with drug-related{^a} adverse events  44 (51.2)  73 (86.9)  70 (83.3) 187 #> 22          with serious adverse events   0  (0.0)   1  (1.2)   2  (2.4)   3 #>    prop_4 #> 1    <NA> #> 2  (88.6) #> 3  (11.4) #> 21 (73.6) #> 22  (1.2)"},{"path":"https://merck.github.io/metalite.ae/articles/ae-summary.html","id":"additional-statistics","dir":"Articles","previous_headings":"Format output","what":"Additional statistics","title":"AE Summary","text":"using display argument, can choose specific statistics include. instance, option incorporate risk difference. perform advanced analysis, extend_ae_specific_inference() function utilized. instance, can incorporate 95% confidence interval based Miettinen Nurminen (M&N) method. information regarding M&N method can found rate compare vignette.","code":"tbl <- outdata |> format_ae_summary(display = c(\"n\", \"prop\", \"diff\")) tbl$tbl #>                                    name n_1 prop_1 n_2 prop_2 n_3 prop_3 diff_2 #> 1            Participants in population  86   <NA>  84   <NA>  84   <NA>     NA #> 2       with one or more adverse events  69 (80.2)  77 (91.7)  79 (94.0)   11.4 #> 3                with no adverse events  17 (19.8)   7  (8.3)   5  (6.0)   35.7 #> 21 with drug-related{^a} adverse events  44 (51.2)  73 (86.9)  70 (83.3)    1.2 #> 22          with serious adverse events   0  (0.0)   1  (1.2)   2  (2.4)  -11.4 #>    diff_3 #> 1      NA #> 2    13.8 #> 3    32.2 #> 21    2.4 #> 22  -13.8 tbl <- outdata |>   extend_ae_specific_inference() |>   format_ae_summary(display = c(\"n\", \"prop\", \"diff\", \"diff_ci\"))  tbl$tbl #>                                    name n_1 prop_1 n_2 prop_2 n_3 prop_3 diff_2 #> 1            Participants in population  86   <NA>  84   <NA>  84   <NA>     NA #> 2       with one or more adverse events  69 (80.2)  77 (91.7)  79 (94.0)   11.4 #> 3                with no adverse events  17 (19.8)   7  (8.3)   5  (6.0)   35.7 #> 21 with drug-related{^a} adverse events  44 (51.2)  73 (86.9)  70 (83.3)    1.2 #> 22          with serious adverse events   0  (0.0)   1  (1.2)   2  (2.4)  -11.4 #>             ci_2 diff_3          ci_3 #> 1   (-4.4,  0.0)     NA  (-4.4,  0.0) #> 2   ( 1.0, 22.2)   13.8  ( 4.0, 24.3) #> 3  (-22.2, -1.0)   32.2 (-24.3, -4.0) #> 21  (22.4, 48.0)    2.4  (18.4, 44.8) #> 22  (-3.1,  6.5)  -13.8  (-2.0,  8.3)"},{"path":"https://merck.github.io/metalite.ae/articles/ae-summary.html","id":"mock-data-preparation","dir":"Articles","previous_headings":"Format output","what":"Mock data preparation","title":"AE Summary","text":"mock argument facilitates creation mock table ease. Please note intention mock argument provide -encompassing mock table template. Instead, serves convenient method assist users generating mock table closely resembles desired output layout. develop versatile mock table generation tool, efforts necessary. potentially involve creation dedicated mock table generation package similar solutions.","code":"tbl <- outdata |> format_ae_summary(mock = TRUE) tbl$tbl #>                                   name n_1 prop_1 n_2 prop_2 n_3 prop_3 n_4 #> 1           Participants in population  xx   <NA>  xx   <NA>  xx   <NA> xxx #> 2      with one or more adverse events  xx (xx.x)  xx (xx.x)  xx (xx.x) xxx #> 3               with no adverse events  xx (xx.x)   x  (x.x)   x  (x.x)  xx #> 4 with drug-related{^a} adverse events  xx (xx.x)  xx (xx.x)  xx (xx.x) xxx #> 5          with serious adverse events   x  (x.x)   x  (x.x)   x  (x.x)   x #>   prop_4 #> 1   <NA> #> 2 (xx.x) #> 3 (xx.x) #> 4 (xx.x) #> 5  (x.x)"},{"path":"https://merck.github.io/metalite.ae/articles/ae-summary.html","id":"rtf-tables","dir":"Articles","previous_headings":"","what":"RTF tables","title":"AE Summary","text":"last step prepare RTF table using tlf_ae_summary(). tlf_ae_summary() function also provides commonly used argument customize table. mock table can also generated.","code":"outdata |>   format_ae_summary() |>   tlf_ae_summary(     source = \"Source:  [CDISCpilot: adam-adsl; adae]\",     path_outtable = \"rtf/ae0summary1.rtf\"   ) #> The output is saved in/home/runner/work/metalite.ae/metalite.ae/vignettes/rtf/ae0summary1.rtf outdata |>   format_ae_summary() |>   tlf_ae_summary(     source = \"Source:  [CDISCpilot: adam-adsl; adae]\",     col_rel_width = c(6, rep(1, 8)),     text_font_size = 8,     orientation = \"landscape\",     path_outtable = \"rtf/ae0summary2.rtf\"   ) #> The output is saved in/home/runner/work/metalite.ae/metalite.ae/vignettes/rtf/ae0summary2.rtf outdata |>   format_ae_summary(mock = TRUE) |>   tlf_ae_summary(     source = \"Source:  [CDISCpilot: adam-adsl; adae]\",     path_outtable = \"rtf/mock_ae0summary1.rtf\"   ) #> The output is saved in/home/runner/work/metalite.ae/metalite.ae/vignettes/rtf/mock_ae0summary1.rtf"},{"path":[]},{"path":"https://merck.github.io/metalite.ae/articles/exposure-adjusted-event-rate.html","id":"eaer-formula","dir":"Articles","previous_headings":"EAER formula explanation","what":"EAER formula","title":"Exposure Adjusted Event Rate","text":"\\[ \\begin{aligned} EAER_j (\\text{EAER } Trt_j) &= \\frac{\\text{total number events } Trt_j}{\\text{total person-days } Trt_j/(\\text{exp factor})}  \\\\ &= \\frac{\\text{total number events } Trt_j \\times \\text{exp factor}}{\\text{total person-days } Trt_j} \\end{aligned} \\] exposure factor (exp factor) adjusted depending adjustment unit defined users. instance, adjustment unit ‘100 person-month’, EAER computed follows: \\[ \\begin{aligned} EAER_j (\\text{100 person-months}) &= \\frac{\\text{total number events } Trt_j \\times \\text{exp factor} (=100\\times30.4367)}{\\text{total person-days } Trt_j}  \\\\ &= \\frac{\\text{total number events } Trt_j \\times 3043.67}{\\text{total person-days } Trt_j} \\end{aligned} \\]","code":""},{"path":"https://merck.github.io/metalite.ae/articles/exposure-adjusted-event-rate.html","id":"eaer-for-different-types-of-aes","dir":"Articles","previous_headings":"EAER formula explanation","what":"EAER for different types of AEs","title":"Exposure Adjusted Event Rate","text":"example, EAER definitions three types AEs using three treatment groups (PBO, Low Dose, High Dose).","code":""},{"path":"https://merck.github.io/metalite.ae/articles/exposure-adjusted-event-rate.html","id":"any-ae-adj-rate","dir":"Articles","previous_headings":"EAER formula explanation > EAER for different types of AEs","what":"ANY AE adj rate","title":"Exposure Adjusted Event Rate","text":"\\[ EAER_{PBO} (\\text{100 person-months}) =\\frac{\\text{total number AEs PBO} \\times 3043.67}{\\text{total person-days PBO}} \\] \\[ EAER_{LD} (\\text{100 person-months}) =\\frac{\\text{total number AEs Low Dose} \\times 3043.67}{\\text{total person-days Low Dose}} \\] \\[ EAER_{HD} (\\text{100 person-months}) =\\frac{\\text{total number AEs High Dose} \\times 3043.67}{\\text{total person-days High Dose}} \\]","code":""},{"path":"https://merck.github.io/metalite.ae/articles/exposure-adjusted-event-rate.html","id":"serious-ae-adj-rate","dir":"Articles","previous_headings":"EAER formula explanation > EAER for different types of AEs","what":"Serious AE adj rate","title":"Exposure Adjusted Event Rate","text":"\\[ EAER_{PBO} (\\text{100 person-months}) =\\frac{\\text{total number SAEs PBO} \\times 3043.67}{\\text{total person-days PBO}} \\] \\[ EAER_{LD} (\\text{100 person-months}) =\\frac{\\text{total number SAEs Low Dose} \\times 3043.67}{\\text{total person-days Low Dose}} \\] \\[ EAER_{HD} (\\text{100 person-months}) =\\frac{\\text{total number SAEs High Dose} \\times 3043.67}{\\text{total person-days High Dose}} \\]","code":""},{"path":"https://merck.github.io/metalite.ae/articles/exposure-adjusted-event-rate.html","id":"rel-ae-adj-rate","dir":"Articles","previous_headings":"EAER formula explanation > EAER for different types of AEs","what":"REL AE adj rate","title":"Exposure Adjusted Event Rate","text":"\\[ EAER_{PBO} (\\text{100 person-months}) =\\frac{\\text{total number Drug-Related AEs PBO} \\times 3043.67}{\\text{total person-days PBO}} \\] \\[ EAER_{LD} (\\text{100 person-months}) =\\frac{\\text{total number Drug-Related AEs Low Dose} \\times 3043.67}{\\text{total person-days Low Dose}} \\] \\[ EAER_{HD} (\\text{100 person-months}) =\\frac{\\text{total number Drug-Related AEs High Dose} \\times 3043.67}{\\text{total person-days High Dose}} \\]","code":""},{"path":"https://merck.github.io/metalite.ae/articles/exposure-adjusted-event-rate.html","id":"programming-steps-of-eaer","dir":"Articles","previous_headings":"","what":"Programming steps of EAER","title":"Exposure Adjusted Event Rate","text":"Data preprocessing: end step, adae created. Build metadata object: end step, meta created. Call function prepare_ae_exp_adj(). function following arguments: meta, population, observation, parameter, adj_unit. output list: Run x$adj_rate get EAER:","code":"library(metalite.ae) meta <- meta_ae_example()  x <- prepare_ae_exp_adj(   meta,   population = \"apat\",   observation = \"wk12\",   parameter = \"any;rel;ser\",   adj_unit = \"month\" )  x ## List of 11 ##  $ meta           :List of 7 ##  $ population     : chr \"apat\" ##  $ observation    : chr \"wk12\" ##  $ parameter      : chr \"any;rel;ser\" ##  $ n              :'data.frame': 1 obs. of  3 variables: ##  $ order          : NULL ##  $ group          : chr \"TRTA\" ##  $ reference_group: NULL ##  $ total_exposure : num [1:3(1d)] 12820 8318 8349 ##  $ adj_rate       :List of 3 ##  $ group_label    : Factor w/ 3 levels \"Placebo\",\"Low Dose\",..: 1 3 2 x$adj_rate ## [[1]] ##   Placebo  Low Dose High Dose  ##  110.1400  159.1725  166.4907  ##  ## [[2]] ## [1]  48.66652 106.84679 102.08992 ##  ## [[3]] ## [1] 0.0000000 0.3659137 0.7318274"},{"path":"https://merck.github.io/metalite.ae/articles/metalite-ae.html","id":"overview","dir":"Articles","previous_headings":"","what":"Overview","title":"Introduction to metalite.ae","text":"metalite.ae R package designed analysis adverse events (AE) clinical trials. operates ADaM datasets adheres metalite structure. package encompasses following components: R package streamlines process generating production-ready tables, listings, figures outlined AE summary chapter specific AE chapter R Clinical Study Reports Submission book. ensures complete traceability throughout development lifecycle, leveraging metalite data structure. R package offers comprehensive software development lifecycle (SDLC) solution, encompassing activities definition, development, validation, finalization analysis.","code":""},{"path":"https://merck.github.io/metalite.ae/articles/metalite-ae.html","id":"highlighted-features","dir":"Articles","previous_headings":"","what":"Highlighted features","title":"Introduction to metalite.ae","text":"example, define analysis population use adverse events analysis. Consistent input output standard functions. Streamlines mock table generation.","code":""},{"path":"https://merck.github.io/metalite.ae/articles/metalite-ae.html","id":"workflow","dir":"Articles","previous_headings":"","what":"Workflow","title":"Introduction to metalite.ae","text":"overall workflow includes following steps: Define metadata information using metalite R package. Prepare outdata using prepare_*() functions. Extend outdata using extend_*() functions (optional). Format outdata using format_*() functions. Create TLFs using tlf_*() functions. instance, can illustrate creation straightforward AE summary table shown . Additional examples tutorials can found package website, offering guidance illustrations.","code":"meta_ae_example() |> # Example AE data created using metalite   prepare_ae_summary(     population = \"apat\", # Select population by keywords     observation = \"wk12\", # Select observation by keywords     parameter = \"any;rel;ser\" # Select AE terms by keywords   ) |>   format_ae_summary() |>   tlf_ae_summary(     source = \"Source:  [CDISCpilot: adam-adsl; adae]\", # Define data source     path_outtable = \"ae0summary.rtf\" # Define output   )"},{"path":"https://merck.github.io/metalite.ae/articles/metalite-ae.html","id":"input","dir":"Articles","previous_headings":"","what":"Input","title":"Introduction to metalite.ae","text":"implement workflow metalite.ae, necessary establish metadata structure using metalite R package. detailed instructions, please consult metalite tutorial refer source code function meta_ae_example().","code":""},{"path":"https://merck.github.io/metalite.ae/articles/rate-compare.html","id":"overview","dir":"Articles","previous_headings":"","what":"Overview","title":"Unstratified and Stratified Miettinen and Nurminen Test","text":"Binary outcome commonly used endpoint clinical trials. page illustrates conduct unstratified stratified analysis Miettinen Nurminen (M&N) method (Miettinen Nurminen 1985) risk difference analysis R. following statistics can calculated function rate_compare(): Estimated risk difference. Test statistic. Confidence interval risk difference. p-value risk difference.","code":""},{"path":[]},{"path":"https://merck.github.io/metalite.ae/articles/rate-compare.html","id":"unstratified-analysis-of-mn-method","dir":"Articles","previous_headings":"Statistical methods","what":"Unstratified analysis of M&N method","title":"Unstratified and Stratified Miettinen and Nurminen Test","text":"Assume data includes two independent binomial samples binary response variables analyzed/summarized data collected clinical design without stratification. Also approach applicable case data collected using stratified clinical design statistician like ignore stratification pooling data strata assuming two independent binomial samples. Assume \\(P_i\\) proportion success responses test (\\(=1\\)) control (\\(=0\\)) group.","code":""},{"path":"https://merck.github.io/metalite.ae/articles/rate-compare.html","id":"confidence-interval","dir":"Articles","previous_headings":"Statistical methods > Unstratified analysis of M&N method","what":"Confidence interval","title":"Unstratified and Stratified Miettinen and Nurminen Test","text":"confidence interval based M&N method given roots \\(PD=P_1-P_0\\) equation: \\[\\chi_\\alpha^2 = \\frac{(\\hat{p}_1-\\hat{p}_0-PD)^2}{\\tilde{V}}\\], \\(\\hat{p}_1\\) \\(\\hat{p}_0\\) observed values \\(P_1\\) \\(P_0\\), respectively; \\(\\chi_\\alpha^2\\) = upper cut point size \\(\\alpha\\) central chi-square distribution 1 degree freedom (\\(\\chi_\\alpha^2 = 3.84\\) \\(95\\)% confidence interval); \\(PD\\) = difference two population proportions (\\(PD=P_1-P_0\\)); \\[\\tilde{V}=\\bigg[\\frac{\\tilde{p}_1(1-\\tilde{p}_1)}{n_1}+ \\frac{\\tilde{p}_0(1-\\tilde{p}_0)}{n_0}\\bigg]\\frac{n_1+n_0}{n_1+n_0-1}\\]; \\(n_1\\) \\(n_0\\) sample sizes test control group, respectively; \\(\\tilde{p}_1\\) = maximum likelihood estimate proportion test computed \\(\\tilde{p}_0+PD\\); \\(\\tilde{p}_0\\) = maximum likelihood estimate proportion control constraint \\(\\tilde{p}_1-\\tilde{p}_0=PD\\). stated 2-sided \\(100(1-\\alpha)\\)% CI given roots \\(PD=P_1-P_0\\). bisection algorithm used function obtain two roots (confidence interval) \\(PD\\).","code":""},{"path":"https://merck.github.io/metalite.ae/articles/rate-compare.html","id":"p-value-and-z-statistic","dir":"Articles","previous_headings":"Statistical methods > Unstratified analysis of M&N method","what":"p-value and Z-statistic","title":"Unstratified and Stratified Miettinen and Nurminen Test","text":"Z-statistic computed : \\[Z_\\text{diff}=\\frac{\\hat{p}_1-\\hat{p}_0+S_0}{\\sqrt{\\tilde{V}}}\\] \\(\\hat{p}_1\\) \\(\\hat{p}_0\\) observed values \\(P_1\\) \\(P_0\\) respectively, \\(S_0\\) pre-specified proportion difference null; \\(\\tilde{p}_1\\) = maximum likelihood estimate proportion test computed \\(\\tilde{p}_0+S_0\\); \\(\\tilde{p}_0\\) = maximum likelihood estimate proportion control constraint \\(\\tilde{p}_1-\\tilde{p}_0=S_0\\). non-inferiority one-sided equivalence hypothesis \\(S_0>0\\), p-value, \\(\\Pr(Z \\geq Z_\\text{diff} \\, | \\, H_0)\\), computed based \\(Z_\\text{diff}\\) using standard normal distribution. non-inferiority one-sided equivalence hypothesis \\(S_0<0\\), p-value, \\(\\Pr(Z \\leq Z_\\text{diff} \\, | \\, H_0)\\), computed based \\(Z_\\text{diff}\\) using standard normal distribution. two-sided superiority test, p-value \\(\\Pr(\\chi_\\text{diff}^2 \\leq \\chi_1^2 \\, | \\, H_0)\\), computed based \\(\\chi_\\text{diff}^2\\) using chi-square distribution 1 degree freedom, \\(\\chi_\\text{diff}^2=Z_\\text{diff}^2\\).","code":""},{"path":"https://merck.github.io/metalite.ae/articles/rate-compare.html","id":"stratified-analysis-of-mn-method","dir":"Articles","previous_headings":"Statistical methods","what":"Stratified analysis of M&N method","title":"Unstratified and Stratified Miettinen and Nurminen Test","text":"Assume data includes two treatment groups, test control, collected based stratified design. Within stratum two independent binomial samples binary response variables analyzed/summarized. parameter interest difference population proportions test control groups. analysis summaries need performed adjusting stratifying variables.","code":""},{"path":"https://merck.github.io/metalite.ae/articles/rate-compare.html","id":"confidence-interval-1","dir":"Articles","previous_headings":"Statistical methods > Stratified analysis of M&N method","what":"Confidence interval","title":"Unstratified and Stratified Miettinen and Nurminen Test","text":"confidence interval based M&N method given roots \\(PD=P_1-P_0\\) equation: \\[\\chi_\\alpha^2 = \\frac{(\\hat{p}_1^*-\\hat{p}_0^*-PD)^2}{\\sum_{=1}^(W_i/\\sum_{k=1}^{K}W_k)^2\\tilde{V}_i}\\], \\(\\hat{p}_s^* = \\sum_{=1}^(W_i/\\sum_{k=1}^KW_k)\\hat{p}_{s }\\) \\(s = 0, 1\\); \\[\\tilde{V}_i=\\bigg[\\frac{\\tilde{p}_{1i}(1-\\tilde{p}_{1i})}{n_{1i}}+\\frac{\\tilde{p}_{0i}(1-\\tilde{p}_{0i})}{n_{0i}}\\bigg]\\frac{n_{1i}+n_{0i}}{n_{1i}+n_{0i}-1}\\]; \\(W_i\\) weight \\(\\)-th strata; $= K = $ number strata, \\(=k=\\) strata; \\(n_{1i}\\) \\(n_{0i}\\) sample sizes \\(\\)-th strata test control group, respectively; \\(\\hat{p}_{1i}\\) \\(\\hat{p}_{0i}\\) = observed proportion \\(\\)-th strata test control, respectively; \\(\\tilde{p}_{0i}\\) \\(\\tilde{p}_{1i}\\) MLE \\(P_{0i}\\) \\(P_{1i}\\), respectively, computed constraint \\(\\tilde{p}_{1i}=\\tilde{p}_{0i}+PD\\). Similarly unstratified analysis,2-sided \\(100(1 - \\alpha)\\)% CI given roots \\(PD = P_1 - P_0\\), bisection algorithm used function obtain two roots (confidence interval) \\(PD\\).","code":""},{"path":"https://merck.github.io/metalite.ae/articles/rate-compare.html","id":"p-value-and-z-statistic-1","dir":"Articles","previous_headings":"Statistical methods > Stratified analysis of M&N method","what":"p-value and Z-statistic","title":"Unstratified and Stratified Miettinen and Nurminen Test","text":"Z-statistic computed : \\[Z_\\text{diff}=\\frac{\\hat{p}_1^*-\\hat{p}^*_0+S_0}{\\sqrt{\\sum_{=1}^(W_i/\\sum_{k=1}^{K}W_k)^2\\tilde{V}_i}}\\] \\(S_0\\) pre-specified proportion difference null; \\(\\tilde{p}_{0i}\\) \\(\\tilde{p}_{1i}\\) MLE \\(P_{0i}\\) \\(P_{1i}\\), respectively, computed constraint \\(\\tilde{p}_{1i} = \\tilde{p}_{0i} + S_0\\). p-value can calculated stated .","code":""},{"path":[]},{"path":"https://merck.github.io/metalite.ae/articles/rate-compare.html","id":"load-package","dir":"Articles","previous_headings":"Example","what":"Load package","title":"Unstratified and Stratified Miettinen and Nurminen Test","text":"","code":"library(metalite.ae)"},{"path":"https://merck.github.io/metalite.ae/articles/rate-compare.html","id":"data-simulation","dir":"Articles","previous_headings":"Example","what":"Data simulation","title":"Unstratified and Stratified Miettinen and Nurminen Test","text":"simulated dataset 2 treatment group binary output. stratum used, considered 4 stratum.","code":"ana <- data.frame(   treatment = c(rep(0, 100), rep(1, 100)),   response  = c(rep(0, 80), rep(1, 20), rep(0, 40), rep(1, 60)),   stratum   = c(rep(1:4, 12), 1, 3, 3, 1, rep(1:4, 12), rep(1:4, 25)) )  head(ana) #>   treatment response stratum #> 1         0        0       1 #> 2         0        0       2 #> 3         0        0       3 #> 4         0        0       4 #> 5         0        0       1 #> 6         0        0       2"},{"path":"https://merck.github.io/metalite.ae/articles/rate-compare.html","id":"unstratified-analysis","dir":"Articles","previous_headings":"Example","what":"Unstratified analysis","title":"Unstratified and Stratified Miettinen and Nurminen Test","text":"function computes risk difference, Z-statistic, p-value given type test, two-sided \\(100(1 - \\alpha)\\)% confidence interval difference two rates.","code":"rate_compare(response ~ treatment, data = ana) #>   est  z_score            p    lower     upper #> 1 0.4 5.759051 4.229411e-09 0.269662 0.5165743"},{"path":"https://merck.github.io/metalite.ae/articles/rate-compare.html","id":"stratified-analysis","dir":"Articles","previous_headings":"Example","what":"Stratified analysis","title":"Unstratified and Stratified Miettinen and Nurminen Test","text":"sample size weighting often used clinical trial. function conduct stratified MN analysis sample size weights. also support weight \"equal\" \"cmh\". details can found rate_compare() documentation.","code":"rate_compare(   formula = response ~ treatment, strata = stratum, data = ana,   weight = \"ss\" ) #>         est  z_score            p     lower     upper #> 1 0.3998397 5.712797 5.556727e-09 0.2684383 0.5172779"},{"path":[]},{"path":"https://merck.github.io/metalite.ae/authors.html","id":null,"dir":"","previous_headings":"","what":"Authors","title":"Authors and Citation","text":"Yilong Zhang. Author. Yujie Zhao. Author, maintainer. Benjamin Wang. Author. Nan Xiao. Author. Sarad Nepal. Author. Madhusudhan Ginnaram. Author. Venkatesh Burla. Contributor. Ruchitbhai Patel. Author. Brian Lang. Author. Xuan Deng. Author. Merck Sharp & Dohme Corp. Copyright holder.","code":""},{"path":"https://merck.github.io/metalite.ae/authors.html","id":"citation","dir":"","previous_headings":"","what":"Citation","title":"Authors and Citation","text":"Zhang Y, Zhao Y, Wang B, Xiao N, Nepal S, Ginnaram M, Patel R, Lang B, Deng X (2023). metalite.ae: Adverse Events Analysis Using 'metalite'. R package version 0.1.1, https://github.com/Merck/metalite.ae, https://merck.github.io/metalite.ae/.","code":"@Manual{,   title = {metalite.ae: Adverse Events Analysis Using 'metalite'},   author = {Yilong Zhang and Yujie Zhao and Benjamin Wang and Nan Xiao and Sarad Nepal and Madhusudhan Ginnaram and Ruchitbhai Patel and Brian Lang and Xuan Deng},   year = {2023},   note = {R package version 0.1.1, https://github.com/Merck/metalite.ae},   url = {https://merck.github.io/metalite.ae/}, }"},{"path":[]},{"path":"https://merck.github.io/metalite.ae/index.html","id":"installation","dir":"","previous_headings":"","what":"Installation","title":"Adverse Events Analysis Using metalite","text":"easiest way get metalite.ae install CRAN: Alternatively, use new feature get bug fix, can install development version metalite.ae GitHub:","code":"install.packages(\"metalite.ae\") # install.packages(\"remotes\") remotes::install_github(\"Merck/metalite.ae\")"},{"path":"https://merck.github.io/metalite.ae/index.html","id":"overview","dir":"","previous_headings":"","what":"Overview","title":"Adverse Events Analysis Using metalite","text":"metalite.ae R package designed analysis adverse events (AE) clinical trials. operates ADaM datasets adheres metalite structure. R package streamlines process generating production-ready tables, listings, figures outlined AE summary chapter specific AE chapter R Clinical Study Reports Submission book. package encompasses following components:","code":""},{"path":[]},{"path":[]},{"path":[]},{"path":"https://merck.github.io/metalite.ae/index.html","id":"highlighted-features","dir":"","previous_headings":"","what":"Highlighted features","title":"Adverse Events Analysis Using metalite","text":"example, define analysis population use adverse events analysis. Consistent input output standard functions. Streamlines mock table generation.","code":""},{"path":"https://merck.github.io/metalite.ae/index.html","id":"example","dir":"","previous_headings":"","what":"Example","title":"Adverse Events Analysis Using metalite","text":"Additional tutorials","code":"meta_ae_example() |> # Example AE data created using metalite   prepare_ae_summary(     population = \"apat\", # Select population by keywords     observation = \"wk12\", # Select observation by keywords     parameter = \"any;rel;ser\" # Select AE terms by keywords   ) |>   format_ae_summary() |>   tlf_ae_summary(     source = \"Source:  [CDISCpilot: adam-adsl; adae]\", # Define data source     path_outtable = \"ae0summary.rtf\" # Define output   )"},{"path":"https://merck.github.io/metalite.ae/reference/extend_ae_specific_duration.html","id":null,"dir":"Reference","previous_headings":"","what":"Add average duration information for AE specific analysis — extend_ae_specific_duration","title":"Add average duration information for AE specific analysis — extend_ae_specific_duration","text":"Add average duration information AE specific analysis","code":""},{"path":"https://merck.github.io/metalite.ae/reference/extend_ae_specific_duration.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Add average duration information for AE specific analysis — extend_ae_specific_duration","text":"","code":"extend_ae_specific_duration(outdata, duration_var, duration_unit = \"Day\")"},{"path":"https://merck.github.io/metalite.ae/reference/extend_ae_specific_duration.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Add average duration information for AE specific analysis — extend_ae_specific_duration","text":"outdata outdata object created prepare_ae_specific(). duration_var character value variable name AE duration. duration_unit character value AE duration unit.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/extend_ae_specific_duration.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Add average duration information for AE specific analysis — extend_ae_specific_duration","text":"list analysis raw datasets.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/extend_ae_specific_duration.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Add average duration information for AE specific analysis — extend_ae_specific_duration","text":"","code":"meta <- meta_ae_example() tbl <- prepare_ae_specific(meta,   population = \"apat\",   observation = \"wk12\",   parameter = \"rel\" ) |>   extend_ae_specific_duration(duration_var = \"ADURN\") |>   format_ae_specific(display = c(\"n\", \"prop\", \"dur\")) head(tbl$tbl) #>                                             name n_1 prop_1        dur_1 n_2 #> 1                     Participants in population  86   <NA>           NA  84 #> 2   with one or more drug-related adverse events  44 (51.2)  29.0 ( 3.5)  73 #> 3            with no drug-related adverse events  42 (48.8)           NA  11 #> 4                                                 NA   <NA>           NA  NA #> 122                            Cardiac disorders   6  (7.0)  19.1 ( 3.6)   7 #> 25                           Atrial fibrillation   1  (1.2)          NaN   0 #>     prop_2        dur_2 n_3 prop_3        dur_3 #> 1     <NA>           NA  84   <NA>           NA #> 2   (86.9)  27.2 ( 3.2)  70 (83.3)  30.6 ( 2.2) #> 3   (13.1)           NA  14 (16.7)           NA #> 4     <NA>           NA  NA   <NA>           NA #> 122  (8.3)  34.8 ( 3.4)   4  (4.8)  32.3 ( 4.1) #> 25   (0.0)  39.0 ( 7.0)   2  (2.4)  26.2 ( 4.5)"},{"path":"https://merck.github.io/metalite.ae/reference/extend_ae_specific_events.html","id":null,"dir":"Reference","previous_headings":"","what":"Add average number of events information for AE specific analysis — extend_ae_specific_events","title":"Add average number of events information for AE specific analysis — extend_ae_specific_events","text":"Add average number events information AE specific analysis","code":""},{"path":"https://merck.github.io/metalite.ae/reference/extend_ae_specific_events.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Add average number of events information for AE specific analysis — extend_ae_specific_events","text":"","code":"extend_ae_specific_events(outdata)"},{"path":"https://merck.github.io/metalite.ae/reference/extend_ae_specific_events.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Add average number of events information for AE specific analysis — extend_ae_specific_events","text":"outdata outdata object created prepare_ae_specific().","code":""},{"path":"https://merck.github.io/metalite.ae/reference/extend_ae_specific_events.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Add average number of events information for AE specific analysis — extend_ae_specific_events","text":"list analysis raw datasets.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/extend_ae_specific_events.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Add average number of events information for AE specific analysis — extend_ae_specific_events","text":"","code":"meta <- meta_ae_example() tbl <- prepare_ae_specific(meta,   population = \"apat\",   observation = \"wk12\",   parameter = \"rel\" ) |>   extend_ae_specific_events() |>   format_ae_specific(display = c(\"n\", \"prop\", \"events\")) head(tbl$tbl) #>                                             name n_1 prop_1     events_1 n_2 #> 1                     Participants in population  86   <NA>           NA  84 #> 2   with one or more drug-related adverse events  44 (51.2)   0.7 ( 0.1)  73 #> 3            with no drug-related adverse events  42 (48.8)           NA  11 #> 4                                                 NA   <NA>           NA  NA #> 122                            Cardiac disorders   6  (7.0)   2.3 ( 0.4)   7 #> 25                           Atrial fibrillation   1  (1.2)   1.0 ( 0.0)   0 #>     prop_2     events_2 n_3 prop_3     events_3 #> 1     <NA>           NA  84   <NA>           NA #> 2   (86.9)   1.6 ( 0.2)  70 (83.3)   1.5 ( 0.2) #> 3   (13.1)           NA  14 (16.7)           NA #> 4     <NA>           NA  NA   <NA>           NA #> 122  (8.3)   2.5 ( 0.3)   4  (4.8)   3.2 ( 0.3) #> 25   (0.0)   1.7 ( 0.1)   2  (2.4)   1.5 ( 0.1)"},{"path":"https://merck.github.io/metalite.ae/reference/extend_ae_specific_inference.html","id":null,"dir":"Reference","previous_headings":"","what":"Add inference information for AE specific analysis — extend_ae_specific_inference","title":"Add inference information for AE specific analysis — extend_ae_specific_inference","text":"Add inference information AE specific analysis","code":""},{"path":"https://merck.github.io/metalite.ae/reference/extend_ae_specific_inference.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Add inference information for AE specific analysis — extend_ae_specific_inference","text":"","code":"extend_ae_specific_inference(outdata, ci = 0.95)"},{"path":"https://merck.github.io/metalite.ae/reference/extend_ae_specific_inference.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Add inference information for AE specific analysis — extend_ae_specific_inference","text":"outdata outdata object created prepare_ae_specific(). ci numeric value percentile confidence interval.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/extend_ae_specific_inference.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Add inference information for AE specific analysis — extend_ae_specific_inference","text":"list analysis raw datasets.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/extend_ae_specific_inference.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Add inference information for AE specific analysis — extend_ae_specific_inference","text":"","code":"meta <- meta_ae_example() tbl <- prepare_ae_specific(meta,   population = \"apat\",   observation = \"wk12\",   parameter = \"rel\" ) |>   extend_ae_specific_inference() |>   format_ae_specific(display = c(\"n\", \"prop\", \"diff\", \"diff_ci\")) head(tbl$tbl) #>                                             name n_1 prop_1 n_2 prop_2 n_3 #> 1                     Participants in population  86   <NA>  84   <NA>  84 #> 2   with one or more drug-related adverse events  44 (51.2)  73 (86.9)  70 #> 3            with no drug-related adverse events  42 (48.8)  11 (13.1)  14 #> 4                                                 NA   <NA>  NA   <NA>  NA #> 122                            Cardiac disorders   6  (7.0)   7  (8.3)   4 #> 25                           Atrial fibrillation   1  (1.2)   0  (0.0)   2 #>     prop_3 diff_2           ci_2 diff_3           ci_3 #> 1     <NA>     NA   (-4.4,  0.0)     NA   (-4.4,  0.0) #> 2   (83.3)   35.7   (22.4, 48.0)   32.2   (18.4, 44.8) #> 3   (16.7)  -35.7 (-48.0, -22.4)  -32.2 (-44.8, -18.4) #> 4     <NA>     NA           <NA>     NA           <NA> #> 122  (4.8)    1.4   (-7.3, 10.2)   -2.2  (-10.3,  5.6) #> 25   (2.4)   -1.2   (-6.3,  3.3)    1.2   (-4.2,  7.3)"},{"path":"https://merck.github.io/metalite.ae/reference/fmt_ci.html","id":null,"dir":"Reference","previous_headings":"","what":"Format confidence interval — fmt_ci","title":"Format confidence interval — fmt_ci","text":"Format confidence interval","code":""},{"path":"https://merck.github.io/metalite.ae/reference/fmt_ci.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Format confidence interval — fmt_ci","text":"","code":"fmt_ci(lower, upper, digits = 2, width = 3 + digits)"},{"path":"https://merck.github.io/metalite.ae/reference/fmt_ci.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Format confidence interval — fmt_ci","text":"lower numeric value lower value CI. upper numeric value upper value CI. digits Digits column, .e., format (x.x, x.x). width Width column.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/fmt_ci.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Format confidence interval — fmt_ci","text":"numeric vector expected format.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/fmt_ci.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Format confidence interval — fmt_ci","text":"","code":"fmt_ci(0.2356, 0.3871) #> [1] \"( 0.24,  0.39)\""},{"path":"https://merck.github.io/metalite.ae/reference/fmt_est.html","id":null,"dir":"Reference","previous_headings":"","what":"Format model estimator — fmt_est","title":"Format model estimator — fmt_est","text":"Formats mean sd/se format x.x x.x (x.xx) mean sd/sd defined.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/fmt_est.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Format model estimator — fmt_est","text":"","code":"fmt_est(   mean,   sd = rep(NA, length(mean)),   digits = c(1, 1),   width = c(4, 3) + digits )"},{"path":"https://merck.github.io/metalite.ae/reference/fmt_est.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Format model estimator — fmt_est","text":"mean numeric vector mean value. sd numeric vector sd value. digits Digits column, .e., format x.x (x.xx). width Width column.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/fmt_est.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Format model estimator — fmt_est","text":"data frame additional attributes page features.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/fmt_est.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Format model estimator — fmt_est","text":"function assumes 1 column 2 columns: 1 column, represent mean. 2 columns, represent mean (sd) mean(se). Decimals understand number formatted x.x (x.xx).","code":""},{"path":"https://merck.github.io/metalite.ae/reference/fmt_est.html","id":"specification","dir":"Reference","previous_headings":"","what":"Specification","title":"Format model estimator — fmt_est","text":"contents section shown PDF user manual .","code":""},{"path":"https://merck.github.io/metalite.ae/reference/fmt_est.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Format model estimator — fmt_est","text":"","code":"fmt_est(mean(iris$Petal.Length), sd(iris$Petal.Length)) #> [1] \"  3.8 ( 1.8)\" fmt_est(mean(iris$Petal.Length), sd(iris$Petal.Length), digits = c(2, 3)) #> [1] \"  3.76 ( 1.765)\""},{"path":"https://merck.github.io/metalite.ae/reference/fmt_pct.html","id":null,"dir":"Reference","previous_headings":"","what":"Format percentage — fmt_pct","title":"Format percentage — fmt_pct","text":"Format percentage","code":""},{"path":"https://merck.github.io/metalite.ae/reference/fmt_pct.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Format percentage — fmt_pct","text":"","code":"fmt_pct(x, digits = 1, pre = \"(\", post = \")\")"},{"path":"https://merck.github.io/metalite.ae/reference/fmt_pct.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Format percentage — fmt_pct","text":"x numeric vector. digits Number digits. pre Text number. post Text number.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/fmt_pct.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Format percentage — fmt_pct","text":"numeric vector expected format.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/fmt_pct.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Format percentage — fmt_pct","text":"","code":"fmt_pct(c(1, 1.52, 0.3, 100)) #> [1] \"  (1.0)\" \"  (1.5)\" \"  (0.3)\" \"(100.0)\""},{"path":"https://merck.github.io/metalite.ae/reference/fmt_pval.html","id":null,"dir":"Reference","previous_headings":"","what":"Format p-value — fmt_pval","title":"Format p-value — fmt_pval","text":"Format p-value","code":""},{"path":"https://merck.github.io/metalite.ae/reference/fmt_pval.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Format p-value — fmt_pval","text":"","code":"fmt_pval(p, digits = 3, width = 3 + digits)"},{"path":"https://merck.github.io/metalite.ae/reference/fmt_pval.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Format p-value — fmt_pval","text":"p numeric vector p-values. digits Digits column, .e., format x.xxx. width Width column.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/fmt_pval.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Format p-value — fmt_pval","text":"numeric vector expected format.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/fmt_pval.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Format p-value — fmt_pval","text":"","code":"fmt_pval(c(0.1234, 0.00002)) #> [1] \" 0.123\" \"<0.001\""},{"path":"https://merck.github.io/metalite.ae/reference/format_ae_specific.html","id":null,"dir":"Reference","previous_headings":"","what":"Format AE specific analysis — format_ae_specific","title":"Format AE specific analysis — format_ae_specific","text":"Format AE specific analysis","code":""},{"path":"https://merck.github.io/metalite.ae/reference/format_ae_specific.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Format AE specific analysis — format_ae_specific","text":"","code":"format_ae_specific(   outdata,   display = c(\"n\", \"prop\", \"total\"),   digits_prop = 1,   digits_ci = 1,   digits_p = 3,   digits_dur = c(1, 1),   digits_events = c(1, 1),   mock = FALSE )"},{"path":"https://merck.github.io/metalite.ae/reference/format_ae_specific.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Format AE specific analysis — format_ae_specific","text":"outdata outdata object created prepare_ae_specific(). display character vector measurement displayed: n: Number subjects AE. prop: Proportion subjects AE. total: Total columns. diff: Risk difference. diff_ci: 95% confidence interval risk difference using M&N method. diff_p: p-value risk difference using M&N method. dur: Average AE duration. events: Average number AE per subject. digits_prop numeric value number digits proportion value. digits_ci numeric value number digits confidence interval. digits_p numeric value number digits p-value. digits_dur numeric value number digits average duration AE. digits_events numeric value number digits average number AE per subjects. mock boolean value display mock table.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/format_ae_specific.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Format AE specific analysis — format_ae_specific","text":"list analysis raw datasets.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/format_ae_specific.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Format AE specific analysis — format_ae_specific","text":"","code":"meta <- meta_ae_example()  outdata <- prepare_ae_specific(meta,   population = \"apat\",   observation = \"wk12\",   parameter = \"rel\" )  # Basic example tbl <- outdata |>   format_ae_specific() head(tbl$tbl) #>                                             name n_1 prop_1 n_2 prop_2 n_3 #> 1                     Participants in population  86   <NA>  84   <NA>  84 #> 2   with one or more drug-related adverse events  44 (51.2)  73 (86.9)  70 #> 3            with no drug-related adverse events  42 (48.8)  11 (13.1)  14 #> 4                                                 NA   <NA>  NA   <NA>  NA #> 122                            Cardiac disorders   6  (7.0)   7  (8.3)   4 #> 25                           Atrial fibrillation   1  (1.2)   0  (0.0)   2 #>     prop_3 n_4 prop_4 #> 1     <NA> 254   <NA> #> 2   (83.3) 187 (73.6) #> 3   (16.7)  67 (26.4) #> 4     <NA>  NA   <NA> #> 122  (4.8)  17  (6.7) #> 25   (2.4)   3  (1.2)  # Display different measurements tbl <- outdata |>   extend_ae_specific_events() |>   format_ae_specific(display = c(\"n\", \"prop\", \"events\")) head(tbl$tbl) #>                                             name n_1 prop_1     events_1 n_2 #> 1                     Participants in population  86   <NA>           NA  84 #> 2   with one or more drug-related adverse events  44 (51.2)   0.7 ( 0.1)  73 #> 3            with no drug-related adverse events  42 (48.8)           NA  11 #> 4                                                 NA   <NA>           NA  NA #> 122                            Cardiac disorders   6  (7.0)   2.3 ( 0.4)   7 #> 25                           Atrial fibrillation   1  (1.2)   1.0 ( 0.0)   0 #>     prop_2     events_2 n_3 prop_3     events_3 #> 1     <NA>           NA  84   <NA>           NA #> 2   (86.9)   1.6 ( 0.2)  70 (83.3)   1.5 ( 0.2) #> 3   (13.1)           NA  14 (16.7)           NA #> 4     <NA>           NA  NA   <NA>           NA #> 122  (8.3)   2.5 ( 0.3)   4  (4.8)   3.2 ( 0.3) #> 25   (0.0)   1.7 ( 0.1)   2  (2.4)   1.5 ( 0.1)"},{"path":"https://merck.github.io/metalite.ae/reference/format_ae_specific_subgroup.html","id":null,"dir":"Reference","previous_headings":"","what":"Format AE specific analysis — format_ae_specific_subgroup","title":"Format AE specific analysis — format_ae_specific_subgroup","text":"Format AE specific analysis","code":""},{"path":"https://merck.github.io/metalite.ae/reference/format_ae_specific_subgroup.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Format AE specific analysis — format_ae_specific_subgroup","text":"","code":"format_ae_specific_subgroup(   outdata,   display = c(\"n\", \"prop\"),   digits_prop = 1,   digits_ci = 1,   digits_p = 3,   digits_dur = c(1, 1),   digits_events = c(1, 1),   mock = FALSE )"},{"path":"https://merck.github.io/metalite.ae/reference/format_ae_specific_subgroup.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Format AE specific analysis — format_ae_specific_subgroup","text":"outdata outdata object created prepare_ae_specific(). display character vector measurement displayed. n: Number subjects AE. prop: Proportion subjects AE. total: Total columns. dur: Average AE duration. events: Average number AE per subject. digits_prop numeric value number digits proportion value. digits_ci numeric value number digits confidence interval digits_p numeric value number digits p-value . digits_dur numeric value number digits average duration AE. digits_events numeric value number digits average number AE per subjects. mock Logical. Display mock table .","code":""},{"path":"https://merck.github.io/metalite.ae/reference/format_ae_specific_subgroup.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Format AE specific analysis — format_ae_specific_subgroup","text":"list analysis raw datasets.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/format_ae_specific_subgroup.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Format AE specific analysis — format_ae_specific_subgroup","text":"","code":"meta <- meta_ae_example() prepare_ae_specific_subgroup(meta,   population = \"apat\",   observation = \"wk12\",   parameter = \"rel\",   subgroup_var = \"SEX\",   display_subgroup_total = TRUE ) |>   format_ae_specific_subgroup() #> $components #> [1] \"soc\" \"par\" #>  #> $group #> [1] \"Placebo\"   \"Low Dose\"  \"High Dose\" #>  #> $subgroup #> [1] \"f\" \"m\" #>  #> $display_subgroup_total #> [1] TRUE #>  #> $meta #> ADaM metadata:  #>    .$data_population \tPopulation data with 254 subjects  #>    .$data_observation \tObservation data with 1191 records  #>    .$plan \tAnalysis plan with 18 plans  #>  #>  #>   Analysis population type: #>     name        id  group var       subset                         label #> 1 'apat' 'USUBJID' 'TRTA'     SAFFL == 'Y' 'All Participants as Treated' #>  #>  #>   Analysis observation type: #>     name        id  group var          subset           label #> 1 'wk12' 'USUBJID' 'TRTA'        SAFFL == 'Y' 'Weeks 0 to 12' #> 2 'wk24' 'USUBJID' 'TRTA'     AOCC01FL == 'Y' 'Weeks 0 to 24' #>  #>  #>   Analysis parameter type: #>      name                                label #> 1   'rel'        'drug-related adverse events' #> 2 'aeosi' 'adverse events of special interest' #> 3   'any'                 'any adverse events' #> 4   'ser'             'serious adverse events' #>                                 subset #> 1 AEREL %in% c('POSSIBLE', 'PROBABLE') #> 2                         AEOSI == 'Y' #> 3                                      #> 4                         AESER == 'Y' #>  #>  #>   Analysis function: #>            name                             label #> 1  'ae_summary'    'Table: adverse event summary' #> 2  'ae_listing'          'Listing: adverse event' #> 3  'ae_exp_adj' 'Exposure Adjusted Incident Rate' #> 4 'ae_specific'   'Table: specific adverse event' #>  #>  #> $population #> [1] \"apat\" #>  #> $observation #> [1] \"wk12\" #>  #> $parameter #> [1] \"rel\" #>  #> $out_all #> $out_all$F #> List of 14 #>  $ meta           :List of 7 #>  $ population     : chr \"apat\" #>  $ observation    : chr \"wk12\" #>  $ parameter      : chr \"rel\" #>  $ n              :'data.frame':\t138 obs. of  4 variables: #>  $ order          : num [1:138] 1 100 200 900 1000 ... #>  $ group          : chr [1:4] \"Placebo\" \"Low Dose\" \"High Dose\" \"Total\" #>  $ reference_group: num 1 #>  $ prop           :'data.frame':\t138 obs. of  4 variables: #>  $ diff           :'data.frame':\t138 obs. of  2 variables: #>  $ n_pop          :'data.frame':\t1 obs. of  4 variables: #>  $ name           : chr [1:138] \"Participants in population\" \"with one or more drug-related adverse events\" \"with no drug-related adverse events\" \"\" ... #>  $ components     : chr [1:2] \"soc\" \"par\" #>  $ prepare_call   : language FUN(meta = X[[i]], population = ..1, observation = ..2, parameter = ..3,      components = ..4) #>  #> $out_all$M #> List of 14 #>  $ meta           :List of 7 #>  $ population     : chr \"apat\" #>  $ observation    : chr \"wk12\" #>  $ parameter      : chr \"rel\" #>  $ n              :'data.frame':\t138 obs. of  4 variables: #>  $ order          : num [1:138] 1 100 200 900 1000 ... #>  $ group          : chr [1:4] \"Placebo\" \"Low Dose\" \"High Dose\" \"Total\" #>  $ reference_group: num 1 #>  $ prop           :'data.frame':\t138 obs. of  4 variables: #>  $ diff           :'data.frame':\t138 obs. of  2 variables: #>  $ n_pop          :'data.frame':\t1 obs. of  4 variables: #>  $ name           : chr [1:138] \"Participants in population\" \"with one or more drug-related adverse events\" \"with no drug-related adverse events\" \"\" ... #>  $ components     : chr [1:2] \"soc\" \"par\" #>  $ prepare_call   : language FUN(meta = X[[i]], population = ..1, observation = ..2, parameter = ..3,      components = ..4) #>  #> $out_all$Total #> List of 14 #>  $ meta           :List of 7 #>  $ population     : chr \"apat\" #>  $ observation    : chr \"wk12\" #>  $ parameter      : chr \"rel\" #>  $ n              :'data.frame':\t138 obs. of  4 variables: #>  $ order          : num [1:138] 1 100 200 900 1000 ... #>  $ group          : chr [1:4] \"Placebo\" \"Low Dose\" \"High Dose\" \"Total\" #>  $ reference_group: num 1 #>  $ prop           :'data.frame':\t138 obs. of  4 variables: #>  $ diff           :'data.frame':\t138 obs. of  2 variables: #>  $ n_pop          :'data.frame':\t1 obs. of  4 variables: #>  $ name           : chr [1:138] \"Participants in population\" \"with one or more drug-related adverse events\" \"with no drug-related adverse events\" \"\" ... #>  $ components     : chr [1:2] \"soc\" \"par\" #>  $ prepare_call   : language prepare_ae_specific(meta = meta, population = population, observation = observation,      parameter = parameter, | __truncated__ #>  #>  #> $tbl #>                                                     name Fn_1 Fprop_1 Fn_2 #> 96                            Participants in population   53    <NA>   50 #> 138         with one or more drug-related adverse events   28  (52.8)   41 #> 137                  with no drug-related adverse events   25  (47.2)    9 #> 1                                                          NA    <NA>   NA #> 33                                     Cardiac disorders    4   (7.5)    4 #> 22                                   Atrial fibrillation    1   (1.9)    0 #> 23                                        Atrial flutter    0   (0.0)    0 #> 24                   Atrioventricular block first degree    1   (1.9)    0 #> 25                  Atrioventricular block second degree    0   (0.0)    0 #> 30                                           Bradycardia    1   (1.9)    0 #> 31                             Bundle branch block right    0   (0.0)    0 #> 34                            Cardiac failure congestive    1   (1.9)    0 #> 86                                 Myocardial infarction    2   (3.8)    1 #> 93                                          Palpitations    0   (0.0)    0 #> 112                                     Sinus arrhythmia    0   (0.0)    0 #> 113                                    Sinus bradycardia    2   (3.8)    1 #> 122                       Supraventricular extrasystoles    0   (0.0)    1 #> 129                            Ventricular extrasystoles    0   (0.0)    1 #> 134                       Wolff-parkinson-white syndrome    0   (0.0)    1 #> 40            Congenital, familial and genetic disorders    0   (0.0)    0 #> 130                            Ventricular septal defect    0   (0.0)    0 #> 50                           Ear and labyrinth disorders    0   (0.0)    2 #> 125                                             Tinnitus    0   (0.0)    1 #> 131                                              Vertigo    0   (0.0)    1 #> 57                                         Eye disorders    0   (0.0)    0 #> 132                                       Vision blurred    0   (0.0)    0 #> 62                            Gastrointestinal disorders    1   (1.9)    6 #> 2                                         Abdominal pain    0   (0.0)    1 #> 46                                             Diarrhoea    0   (0.0)    3 #> 48                                             Dyspepsia    1   (1.9)    0 #> 63                      Gastrooesophageal reflux disease    1   (1.9)    0 #> 87                                                Nausea    0   (0.0)    2 #> 110                              Salivary hypersecretion    0   (0.0)    0 #> 120                                   Stomach discomfort    0   (0.0)    0 #> 133                                             Vomiting    0   (0.0)    2 #> 64  General disorders and administration site conditions   11  (20.8)   23 #> 5                              Application site bleeding    0   (0.0)    1 #> 6                            Application site dermatitis    2   (3.8)    5 #> 7                          Application site desquamation    0   (0.0)    0 #> 8                             Application site discharge    0   (0.0)    0 #> 9                        Application site discolouration    0   (0.0)    0 #> 10                             Application site erythema    2   (3.8)    5 #> 11                           Application site induration    0   (0.0)    0 #> 12                           Application site irritation    3   (5.7)    6 #> 13                                 Application site pain    0   (0.0)    0 #> 14                         Application site perspiration    0   (0.0)    0 #> 15                             Application site pruritus    4   (7.5)   12 #> 16                             Application site reaction    0   (0.0)    0 #> 17                             Application site swelling    0   (0.0)    0 #> 18                            Application site urticaria    0   (0.0)    0 #> 19                             Application site vesicles    0   (0.0)    1 #> 20                               Application site warmth    0   (0.0)    1 #> 21                                              Asthenia    1   (1.9)    0 #> 35                                      Chest discomfort    0   (0.0)    0 #> 36                                                Chills    0   (0.0)    0 #> 59                                               Fatigue    1   (1.9)    1 #> 60                                      Feeling abnormal    0   (0.0)    0 #> 81                                               Malaise    0   (0.0)    0 #> 89                                                Oedema    0   (0.0)    1 #> 90                                     Oedema peripheral    0   (0.0)    0 #> 92                                                  Pain    0   (0.0)    1 #> 74        Injury, poisoning and procedural complications    0   (0.0)    2 #> 56                                           Excoriation    0   (0.0)    0 #> 58                                                  Fall    0   (0.0)    1 #> 117                                      Skin laceration    0   (0.0)    1 #> 135                                                Wound    0   (0.0)    1 #> 76                                        Investigations    2   (3.8)    2 #> 28                Blood creatine phosphokinase increased    0   (0.0)    0 #> 29                            Body temperature increased    0   (0.0)    1 #> 51               Electrocardiogram st segment depression    1   (1.9)    1 #> 52                    Electrocardiogram t wave inversion    0   (0.0)    0 #> 67                                  Heart rate increased    0   (0.0)    0 #> 68                                  Heart rate irregular    1   (1.9)    0 #> 82                    Metabolism and nutrition disorders    3   (5.7)    0 #> 42                                    Decreased appetite    1   (1.9)    0 #> 61                                          Food craving    1   (1.9)    0 #> 73                                    Increased appetite    1   (1.9)    0 #> 84       Musculoskeletal and connective tissue disorders    0   (0.0)    0 #> 85                                               Myalgia    0   (0.0)    0 #> 111                                        Shoulder pain    0   (0.0)    0 #> 88                              Nervous system disorders    3   (5.7)    8 #> 26                                      Balance disorder    0   (0.0)    1 #> 32                                     Burning sensation    0   (0.0)    0 #> 38                              Complex partial seizures    0   (0.0)    1 #> 41                                 Coordination abnormal    0   (0.0)    1 #> 47                                             Dizziness    1   (1.9)    3 #> 66                                              Headache    2   (3.8)    0 #> 70                                           Hypersomnia    0   (0.0)    0 #> 78                                              Lethargy    0   (0.0)    0 #> 94                                     Paraesthesia oral    0   (0.0)    1 #> 95                                              Parosmia    0   (0.0)    0 #> 119                                           Somnolence    0   (0.0)    0 #> 121                                               Stupor    0   (0.0)    0 #> 123                                              Syncope    0   (0.0)    4 #> 124                                    Syncope vasovagal    0   (0.0)    0 #> 126                           Transient ischaemic attack    0   (0.0)    0 #> 100                                Psychiatric disorders    1   (1.9)    6 #> 3                                              Agitation    0   (0.0)    2 #> 4                                                Anxiety    0   (0.0)    3 #> 39                                     Confusional state    0   (0.0)    1 #> 43                                              Delirium    0   (0.0)    0 #> 44                                        Depressed mood    0   (0.0)    0 #> 65                                 Hallucination, visual    0   (0.0)    0 #> 75                                              Insomnia    0   (0.0)    0 #> 77                                          Irritability    1   (1.9)    1 #> 79                                      Libido decreased    0   (0.0)    0 #> 80                                              Listless    0   (0.0)    0 #> 109                                         Restlessness    0   (0.0)    0 #> 106                          Renal and urinary disorders    0   (0.0)    1 #> 54                                              Enuresis    0   (0.0)    1 #> 83                                   Micturition urgency    0   (0.0)    0 #> 107             Reproductive system and breast disorders    1   (1.9)    0 #> 97                                           Pelvic pain    1   (1.9)    0 #> 108      Respiratory, thoracic and mediastinal disorders    2   (3.8)    0 #> 49                                              Dyspnoea    1   (1.9)    0 #> 53                                             Emphysema    1   (1.9)    0 #> 114               Skin and subcutaneous tissue disorders   12  (22.6)   21 #> 27                                               Blister    0   (0.0)    2 #> 37                                            Cold sweat    0   (0.0)    0 #> 45                                    Dermatitis contact    0   (0.0)    0 #> 55                                              Erythema    6  (11.3)    7 #> 69                                         Hyperhidrosis    1   (1.9)    1 #> 98                                              Pruritus    6  (11.3)   12 #> 99                                  Pruritus generalised    0   (0.0)    0 #> 101                                                 Rash    2   (3.8)    6 #> 102                                    Rash erythematous    0   (0.0)    1 #> 103                                  Rash maculo-papular    0   (0.0)    0 #> 104                                         Rash papular    0   (0.0)    0 #> 105                                        Rash pruritic    0   (0.0)    1 #> 115                                     Skin exfoliation    0   (0.0)    1 #> 116                                      Skin irritation    2   (3.8)    5 #> 118                                           Skin ulcer    0   (0.0)    0 #> 127                                            Urticaria    0   (0.0)    0 #> 128                                   Vascular disorders    0   (0.0)    2 #> 71                                          Hypertension    0   (0.0)    1 #> 72                                           Hypotension    0   (0.0)    1 #> 91                               Orthostatic hypotension    0   (0.0)    0 #> 136                                    Wound haemorrhage    0   (0.0)    0 #>     Fprop_2 Fn_3 Fprop_3 Mn_1 Mprop_1 Mn_2 Mprop_2 Mn_3 Mprop_3 Totaln_1 #> 96     <NA>   40    <NA>   33    <NA>   34    <NA>   44    <NA>       86 #> 138  (82.0)   32  (80.0)   16  (48.5)   32  (94.1)   38  (86.4)       44 #> 137  (18.0)    8  (20.0)   17  (51.5)    2   (5.9)    6  (13.6)       42 #> 1      <NA>   NA    <NA>   NA    <NA>   NA    <NA>   NA    <NA>       NA #> 33    (8.0)    4  (10.0)    2   (6.1)    3   (8.8)    0   (0.0)        6 #> 22    (0.0)    2   (5.0)    0   (0.0)    0   (0.0)    0   (0.0)        1 #> 23    (0.0)    0   (0.0)    0   (0.0)    1   (2.9)    0   (0.0)        0 #> 24    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        1 #> 25    (0.0)    0   (0.0)    1   (3.0)    0   (0.0)    0   (0.0)        1 #> 30    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        1 #> 31    (0.0)    0   (0.0)    0   (0.0)    1   (2.9)    0   (0.0)        0 #> 34    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        1 #> 86    (2.0)    1   (2.5)    0   (0.0)    0   (0.0)    0   (0.0)        2 #> 93    (0.0)    0   (0.0)    0   (0.0)    1   (2.9)    0   (0.0)        0 #> 112   (0.0)    0   (0.0)    1   (3.0)    0   (0.0)    0   (0.0)        1 #> 113   (2.0)    0   (0.0)    0   (0.0)    1   (2.9)    0   (0.0)        2 #> 122   (2.0)    1   (2.5)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 129   (2.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 134   (2.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 40    (0.0)    0   (0.0)    0   (0.0)    1   (2.9)    0   (0.0)        0 #> 130   (0.0)    0   (0.0)    0   (0.0)    1   (2.9)    0   (0.0)        0 #> 50    (4.0)    1   (2.5)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 125   (2.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 131   (2.0)    1   (2.5)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 57    (0.0)    1   (2.5)    0   (0.0)    1   (2.9)    0   (0.0)        0 #> 132   (0.0)    1   (2.5)    0   (0.0)    1   (2.9)    0   (0.0)        0 #> 62   (12.0)    3   (7.5)    3   (9.1)    2   (5.9)    7  (15.9)        4 #> 2     (2.0)    1   (2.5)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 46    (6.0)    0   (0.0)    3   (9.1)    0   (0.0)    2   (4.5)        3 #> 48    (0.0)    0   (0.0)    0   (0.0)    1   (2.9)    0   (0.0)        1 #> 63    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        1 #> 87    (4.0)    2   (5.0)    0   (0.0)    1   (2.9)    1   (2.3)        0 #> 110   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    3   (6.8)        0 #> 120   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    1   (2.3)        0 #> 133   (4.0)    0   (0.0)    0   (0.0)    0   (0.0)    3   (6.8)        0 #> 64   (46.0)   17  (42.5)    7  (21.2)   20  (58.8)   18  (40.9)       18 #> 5     (2.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 6    (10.0)    4  (10.0)    3   (9.1)    4  (11.8)    3   (6.8)        5 #> 7     (0.0)    0   (0.0)    0   (0.0)    1   (2.9)    0   (0.0)        0 #> 8     (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    1   (2.3)        0 #> 9     (0.0)    0   (0.0)    0   (0.0)    1   (2.9)    0   (0.0)        0 #> 10   (10.0)    5  (12.5)    1   (3.0)    7  (20.6)   10  (22.7)        3 #> 11    (0.0)    0   (0.0)    1   (3.0)    0   (0.0)    0   (0.0)        1 #> 12   (12.0)    5  (12.5)    0   (0.0)    3   (8.8)    4   (9.1)        3 #> 13    (0.0)    2   (5.0)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 14    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    2   (4.5)        0 #> 15   (24.0)   10  (25.0)    2   (6.1)   10  (29.4)   12  (27.3)        6 #> 16    (0.0)    1   (2.5)    1   (3.0)    0   (0.0)    0   (0.0)        1 #> 17    (0.0)    1   (2.5)    0   (0.0)    1   (2.9)    1   (2.3)        0 #> 18    (0.0)    1   (2.5)    0   (0.0)    2   (5.9)    0   (0.0)        0 #> 19    (2.0)    3   (7.5)    1   (3.0)    3   (8.8)    3   (6.8)        1 #> 20    (2.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 21    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        1 #> 35    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    1   (2.3)        0 #> 36    (0.0)    0   (0.0)    1   (3.0)    1   (2.9)    0   (0.0)        1 #> 59    (2.0)    4  (10.0)    0   (0.0)    1   (2.9)    0   (0.0)        1 #> 60    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    1   (2.3)        0 #> 81    (0.0)    0   (0.0)    0   (0.0)    1   (2.9)    1   (2.3)        0 #> 89    (2.0)    0   (0.0)    0   (0.0)    1   (2.9)    0   (0.0)        0 #> 90    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    1   (2.3)        0 #> 92    (2.0)    0   (0.0)    0   (0.0)    0   (0.0)    1   (2.3)        0 #> 74    (4.0)    1   (2.5)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 56    (0.0)    1   (2.5)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 58    (2.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 117   (2.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 135   (2.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 76    (4.0)    1   (2.5)    2   (6.1)    0   (0.0)    0   (0.0)        4 #> 28    (0.0)    0   (0.0)    1   (3.0)    0   (0.0)    0   (0.0)        1 #> 29    (2.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 51    (2.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        1 #> 52    (0.0)    1   (2.5)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 67    (0.0)    0   (0.0)    1   (3.0)    0   (0.0)    0   (0.0)        1 #> 68    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        1 #> 82    (0.0)    1   (2.5)    0   (0.0)    0   (0.0)    0   (0.0)        3 #> 42    (0.0)    1   (2.5)    0   (0.0)    0   (0.0)    0   (0.0)        1 #> 61    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        1 #> 73    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        1 #> 84    (0.0)    0   (0.0)    1   (3.0)    0   (0.0)    1   (2.3)        1 #> 85    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    1   (2.3)        0 #> 111   (0.0)    0   (0.0)    1   (3.0)    0   (0.0)    0   (0.0)        1 #> 88   (16.0)    7  (17.5)    2   (6.1)    4  (11.8)    8  (18.2)        5 #> 26    (2.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 32    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    2   (4.5)        0 #> 38    (2.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 41    (2.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 47    (6.0)    2   (5.0)    1   (3.0)    3   (8.8)    4   (9.1)        2 #> 66    (0.0)    1   (2.5)    0   (0.0)    1   (2.9)    0   (0.0)        2 #> 70    (0.0)    1   (2.5)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 78    (0.0)    1   (2.5)    0   (0.0)    1   (2.9)    0   (0.0)        0 #> 94    (2.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 95    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    1   (2.3)        0 #> 119   (0.0)    0   (0.0)    1   (3.0)    0   (0.0)    0   (0.0)        1 #> 121   (0.0)    0   (0.0)    0   (0.0)    1   (2.9)    0   (0.0)        0 #> 123   (8.0)    2   (5.0)    0   (0.0)    0   (0.0)    1   (2.3)        0 #> 124   (0.0)    1   (2.5)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 126   (0.0)    0   (0.0)    0   (0.0)    1   (2.9)    0   (0.0)        0 #> 100  (12.0)    1   (2.5)    1   (3.0)    3   (8.8)    4   (9.1)        2 #> 3     (4.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 4     (6.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 39    (2.0)    0   (0.0)    1   (3.0)    1   (2.9)    0   (0.0)        1 #> 43    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    1   (2.3)        0 #> 44    (0.0)    0   (0.0)    0   (0.0)    1   (2.9)    0   (0.0)        0 #> 65    (0.0)    1   (2.5)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 75    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    2   (4.5)        0 #> 77    (2.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        1 #> 79    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    1   (2.3)        0 #> 80    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    1   (2.3)        0 #> 109   (0.0)    0   (0.0)    0   (0.0)    1   (2.9)    0   (0.0)        0 #> 106   (2.0)    0   (0.0)    0   (0.0)    0   (0.0)    1   (2.3)        0 #> 54    (2.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 83    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    1   (2.3)        0 #> 107   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        1 #> 97    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        1 #> 108   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        2 #> 49    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        1 #> 53    (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        1 #> 114  (42.0)   13  (32.5)    5  (15.2)   18  (52.9)   26  (59.1)       17 #> 27    (4.0)    0   (0.0)    0   (0.0)    3   (8.8)    1   (2.3)        0 #> 37    (0.0)    0   (0.0)    1   (3.0)    0   (0.0)    0   (0.0)        1 #> 45    (0.0)    0   (0.0)    0   (0.0)    1   (2.9)    0   (0.0)        0 #> 55   (14.0)    7  (17.5)    3   (9.1)    6  (17.6)    7  (15.9)        9 #> 69    (2.0)    2   (5.0)    0   (0.0)    3   (8.8)    6  (13.6)        1 #> 98   (24.0)   11  (27.5)    1   (3.0)    9  (26.5)   15  (34.1)        7 #> 99    (0.0)    0   (0.0)    0   (0.0)    1   (2.9)    1   (2.3)        0 #> 101  (12.0)    2   (5.0)    1   (3.0)    5  (14.7)    5  (11.4)        3 #> 102   (2.0)    0   (0.0)    0   (0.0)    1   (2.9)    0   (0.0)        0 #> 103   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    1   (2.3)        0 #> 104   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)    1   (2.3)        0 #> 105   (2.0)    1   (2.5)    0   (0.0)    0   (0.0)    1   (2.3)        0 #> 115   (2.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 116  (10.0)    1   (2.5)    0   (0.0)    1   (2.9)    4   (9.1)        2 #> 118   (0.0)    0   (0.0)    1   (3.0)    0   (0.0)    0   (0.0)        1 #> 127   (0.0)    1   (2.5)    0   (0.0)    1   (2.9)    0   (0.0)        0 #> 128   (4.0)    1   (2.5)    1   (3.0)    0   (0.0)    0   (0.0)        1 #> 71    (2.0)    0   (0.0)    0   (0.0)    0   (0.0)    0   (0.0)        0 #> 72    (2.0)    0   (0.0)    1   (3.0)    0   (0.0)    0   (0.0)        1 #> 91    (0.0)    0   (0.0)    1   (3.0)    0   (0.0)    0   (0.0)        1 #> 136   (0.0)    1   (2.5)    0   (0.0)    0   (0.0)    0   (0.0)        0 #>     Totalprop_1 Totaln_2 Totalprop_2 Totaln_3 Totalprop_3 order #> 96         <NA>       84        <NA>       84        <NA>     1 #> 138      (51.2)       73      (86.9)       70      (83.3)   100 #> 137      (48.8)       11      (13.1)       14      (16.7)   200 #> 1          <NA>       NA        <NA>       NA        <NA>   900 #> 33        (7.0)        7       (8.3)        4       (4.8)  1000 #> 22        (1.2)        0       (0.0)        2       (2.4)  1021 #> 23        (0.0)        1       (1.2)        0       (0.0)  1022 #> 24        (1.2)        0       (0.0)        0       (0.0)  1023 #> 25        (1.2)        0       (0.0)        0       (0.0)  1024 #> 30        (1.2)        0       (0.0)        0       (0.0)  1029 #> 31        (0.0)        1       (1.2)        0       (0.0)  1030 #> 34        (1.2)        0       (0.0)        0       (0.0)  1032 #> 86        (2.3)        1       (1.2)        1       (1.2)  1075 #> 93        (0.0)        1       (1.2)        0       (0.0)  1081 #> 112       (1.2)        0       (0.0)        0       (0.0)  1095 #> 113       (2.3)        2       (2.4)        0       (0.0)  1096 #> 122       (0.0)        1       (1.2)        1       (1.2)  1104 #> 129       (0.0)        1       (1.2)        0       (0.0)  1110 #> 134       (0.0)        1       (1.2)        0       (0.0)  1115 #> 40        (0.0)        1       (1.2)        0       (0.0)  2000 #> 130       (0.0)        1       (1.2)        0       (0.0)  2111 #> 50        (0.0)        2       (2.4)        1       (1.2)  3000 #> 125       (0.0)        1       (1.2)        0       (0.0)  3107 #> 131       (0.0)        1       (1.2)        1       (1.2)  3112 #> 57        (0.0)        1       (1.2)        1       (1.2)  4000 #> 132       (0.0)        1       (1.2)        1       (1.2)  4113 #> 62        (4.7)        8       (9.5)       10      (11.9)  5000 #> 2         (0.0)        1       (1.2)        1       (1.2)  5001 #> 46        (3.5)        3       (3.6)        2       (2.4)  5043 #> 48        (1.2)        1       (1.2)        0       (0.0)  5045 #> 63        (1.2)        0       (0.0)        0       (0.0)  5057 #> 87        (0.0)        3       (3.6)        3       (3.6)  5076 #> 110       (0.0)        0       (0.0)        3       (3.6)  5093 #> 120       (0.0)        0       (0.0)        1       (1.2)  5102 #> 133       (0.0)        2       (2.4)        3       (3.6)  5114 #> 64       (20.9)       43      (51.2)       35      (41.7)  6000 #> 5         (0.0)        1       (1.2)        0       (0.0)  6004 #> 6         (5.8)        9      (10.7)        7       (8.3)  6005 #> 7         (0.0)        1       (1.2)        0       (0.0)  6006 #> 8         (0.0)        0       (0.0)        1       (1.2)  6007 #> 9         (0.0)        1       (1.2)        0       (0.0)  6008 #> 10        (3.5)       12      (14.3)       15      (17.9)  6009 #> 11        (1.2)        0       (0.0)        0       (0.0)  6010 #> 12        (3.5)        9      (10.7)        9      (10.7)  6011 #> 13        (0.0)        0       (0.0)        2       (2.4)  6012 #> 14        (0.0)        0       (0.0)        2       (2.4)  6013 #> 15        (7.0)       22      (26.2)       22      (26.2)  6014 #> 16        (1.2)        0       (0.0)        1       (1.2)  6015 #> 17        (0.0)        1       (1.2)        2       (2.4)  6016 #> 18        (0.0)        2       (2.4)        1       (1.2)  6017 #> 19        (1.2)        4       (4.8)        6       (7.1)  6018 #> 20        (0.0)        1       (1.2)        0       (0.0)  6019 #> 21        (1.2)        0       (0.0)        0       (0.0)  6020 #> 35        (0.0)        0       (0.0)        1       (1.2)  6033 #> 36        (1.2)        1       (1.2)        0       (0.0)  6034 #> 59        (1.2)        2       (2.4)        4       (4.8)  6054 #> 60        (0.0)        0       (0.0)        1       (1.2)  6055 #> 81        (0.0)        1       (1.2)        1       (1.2)  6072 #> 89        (0.0)        2       (2.4)        0       (0.0)  6077 #> 90        (0.0)        0       (0.0)        1       (1.2)  6078 #> 92        (0.0)        1       (1.2)        1       (1.2)  6080 #> 74        (0.0)        2       (2.4)        1       (1.2)  7000 #> 56        (0.0)        0       (0.0)        1       (1.2)  7052 #> 58        (0.0)        1       (1.2)        0       (0.0)  7053 #> 117       (0.0)        1       (1.2)        0       (0.0)  7099 #> 135       (0.0)        1       (1.2)        0       (0.0)  7116 #> 76        (4.7)        2       (2.4)        1       (1.2)  8000 #> 28        (1.2)        0       (0.0)        0       (0.0)  8027 #> 29        (0.0)        1       (1.2)        0       (0.0)  8028 #> 51        (1.2)        1       (1.2)        0       (0.0)  8047 #> 52        (0.0)        0       (0.0)        1       (1.2)  8048 #> 67        (1.2)        0       (0.0)        0       (0.0)  8060 #> 68        (1.2)        0       (0.0)        0       (0.0)  8061 #> 82        (3.5)        0       (0.0)        1       (1.2)  9000 #> 42        (1.2)        0       (0.0)        1       (1.2)  9039 #> 61        (1.2)        0       (0.0)        0       (0.0)  9056 #> 73        (1.2)        0       (0.0)        0       (0.0)  9066 #> 84        (1.2)        0       (0.0)        1       (1.2) 10000 #> 85        (0.0)        0       (0.0)        1       (1.2) 10074 #> 111       (1.2)        0       (0.0)        0       (0.0) 10094 #> 88        (5.8)       12      (14.3)       15      (17.9) 11000 #> 26        (0.0)        1       (1.2)        0       (0.0) 11025 #> 32        (0.0)        0       (0.0)        2       (2.4) 11031 #> 38        (0.0)        1       (1.2)        0       (0.0) 11036 #> 41        (0.0)        1       (1.2)        0       (0.0) 11038 #> 47        (2.3)        6       (7.1)        6       (7.1) 11044 #> 66        (2.3)        1       (1.2)        1       (1.2) 11059 #> 70        (0.0)        0       (0.0)        1       (1.2) 11063 #> 78        (0.0)        1       (1.2)        1       (1.2) 11069 #> 94        (0.0)        1       (1.2)        0       (0.0) 11082 #> 95        (0.0)        0       (0.0)        1       (1.2) 11083 #> 119       (1.2)        0       (0.0)        0       (0.0) 11101 #> 121       (0.0)        1       (1.2)        0       (0.0) 11103 #> 123       (0.0)        4       (4.8)        3       (3.6) 11105 #> 124       (0.0)        0       (0.0)        1       (1.2) 11106 #> 126       (0.0)        1       (1.2)        0       (0.0) 11108 #> 100       (2.3)        9      (10.7)        5       (6.0) 12000 #> 3         (0.0)        2       (2.4)        0       (0.0) 12002 #> 4         (0.0)        3       (3.6)        0       (0.0) 12003 #> 39        (1.2)        2       (2.4)        0       (0.0) 12037 #> 43        (0.0)        0       (0.0)        1       (1.2) 12040 #> 44        (0.0)        1       (1.2)        0       (0.0) 12041 #> 65        (0.0)        0       (0.0)        1       (1.2) 12058 #> 75        (0.0)        0       (0.0)        2       (2.4) 12067 #> 77        (1.2)        1       (1.2)        0       (0.0) 12068 #> 79        (0.0)        0       (0.0)        1       (1.2) 12070 #> 80        (0.0)        0       (0.0)        1       (1.2) 12071 #> 109       (0.0)        1       (1.2)        0       (0.0) 12092 #> 106       (0.0)        1       (1.2)        1       (1.2) 13000 #> 54        (0.0)        1       (1.2)        0       (0.0) 13050 #> 83        (0.0)        0       (0.0)        1       (1.2) 13073 #> 107       (1.2)        0       (0.0)        0       (0.0) 14000 #> 97        (1.2)        0       (0.0)        0       (0.0) 14084 #> 108       (2.3)        0       (0.0)        0       (0.0) 15000 #> 49        (1.2)        0       (0.0)        0       (0.0) 15046 #> 53        (1.2)        0       (0.0)        0       (0.0) 15049 #> 114      (19.8)       39      (46.4)       39      (46.4) 16000 #> 27        (0.0)        5       (6.0)        1       (1.2) 16026 #> 37        (1.2)        0       (0.0)        0       (0.0) 16035 #> 45        (0.0)        1       (1.2)        0       (0.0) 16042 #> 55       (10.5)       13      (15.5)       14      (16.7) 16051 #> 69        (1.2)        4       (4.8)        8       (9.5) 16062 #> 98        (8.1)       21      (25.0)       26      (31.0) 16085 #> 99        (0.0)        1       (1.2)        1       (1.2) 16086 #> 101       (3.5)       11      (13.1)        7       (8.3) 16087 #> 102       (0.0)        2       (2.4)        0       (0.0) 16088 #> 103       (0.0)        0       (0.0)        1       (1.2) 16089 #> 104       (0.0)        0       (0.0)        1       (1.2) 16090 #> 105       (0.0)        1       (1.2)        2       (2.4) 16091 #> 115       (0.0)        1       (1.2)        0       (0.0) 16097 #> 116       (2.3)        6       (7.1)        5       (6.0) 16098 #> 118       (1.2)        0       (0.0)        0       (0.0) 16100 #> 127       (0.0)        1       (1.2)        1       (1.2) 16109 #> 128       (1.2)        2       (2.4)        1       (1.2) 17000 #> 71        (0.0)        1       (1.2)        0       (0.0) 17064 #> 72        (1.2)        1       (1.2)        0       (0.0) 17065 #> 91        (1.2)        0       (0.0)        0       (0.0) 17079 #> 136       (0.0)        0       (0.0)        1       (1.2) 17117 #>  #> $display #> [1] \"n\"    \"prop\" #>"},{"path":"https://merck.github.io/metalite.ae/reference/format_ae_summary.html","id":null,"dir":"Reference","previous_headings":"","what":"Format AE summary analysis — format_ae_summary","title":"Format AE summary analysis — format_ae_summary","text":"Format AE summary analysis","code":""},{"path":"https://merck.github.io/metalite.ae/reference/format_ae_summary.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Format AE summary analysis — format_ae_summary","text":"","code":"format_ae_summary(   outdata,   display = c(\"n\", \"prop\", \"total\"),   digits_prop = 1,   digits_ci = 1,   digits_p = 3,   digits_dur = c(1, 1),   digits_events = c(1, 1),   mock = FALSE )"},{"path":"https://merck.github.io/metalite.ae/reference/format_ae_summary.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Format AE summary analysis — format_ae_summary","text":"outdata outdata object created prepare_ae_specific(). display character vector measurement displayed: n: Number subjects AE. prop: Proportion subjects AE. total: Total columns. diff: Risk difference. diff_ci: 95% confidence interval risk difference using M&N method. diff_p: p-value risk difference using M&N method. dur: Average AE duration. events: Average number AE per subject. digits_prop numeric value number digits proportion value. digits_ci numeric value number digits confidence interval. digits_p numeric value number digits p-value. digits_dur numeric value number digits average duration AE. digits_events numeric value number digits average number AE per subjects. mock boolean value display mock table.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/format_ae_summary.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Format AE summary analysis — format_ae_summary","text":"list analysis raw datasets.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/format_ae_summary.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Format AE summary analysis — format_ae_summary","text":"","code":"meta <- meta_ae_example() outdata <- prepare_ae_summary(meta,   population = \"apat\",   observation = \"wk12\",   parameter = \"any;rel;ser\" ) #> any #> rel #> ser tbl <- outdata |>   format_ae_summary() head(tbl$tbl) #>                                    name n_1 prop_1 n_2 prop_2 n_3 prop_3 n_4 #> 1            Participants in population  86   <NA>  84   <NA>  84   <NA> 254 #> 2       with one or more adverse events  69 (80.2)  77 (91.7)  79 (94.0) 225 #> 3                with no adverse events  17 (19.8)   7  (8.3)   5  (6.0)  29 #> 21 with drug-related{^a} adverse events  44 (51.2)  73 (86.9)  70 (83.3) 187 #> 22          with serious adverse events   0  (0.0)   1  (1.2)   2  (2.4)   3 #>    prop_4 #> 1    <NA> #> 2  (88.6) #> 3  (11.4) #> 21 (73.6) #> 22  (1.2)"},{"path":"https://merck.github.io/metalite.ae/reference/meta_ae_example.html","id":null,"dir":"Reference","previous_headings":"","what":"Create an example meta_adam object — meta_ae_example","title":"Create an example meta_adam object — meta_ae_example","text":"function illustration purpose. r2rtf required.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/meta_ae_example.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Create an example meta_adam object — meta_ae_example","text":"","code":"meta_ae_example()"},{"path":"https://merck.github.io/metalite.ae/reference/meta_ae_example.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Create an example meta_adam object — meta_ae_example","text":"metadata object.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/meta_ae_example.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Create an example meta_adam object — meta_ae_example","text":"","code":"meta <- meta_ae_example()"},{"path":"https://merck.github.io/metalite.ae/reference/metalite.ae-package.html","id":null,"dir":"Reference","previous_headings":"","what":"metalite.ae: Adverse Events Analysis Using 'metalite' — metalite.ae-package","title":"metalite.ae: Adverse Events Analysis Using 'metalite' — metalite.ae-package","text":"Analyzes adverse events clinical trials using 'metalite' data structure. package simplifies workflow create production-ready tables, listings, figures discussed adverse events analysis chapters \"R Clinical Study Reports Submission\" Zhang et al. (2022) https://r4csr.org/.","code":""},{"path":[]},{"path":"https://merck.github.io/metalite.ae/reference/metalite.ae-package.html","id":"author","dir":"Reference","previous_headings":"","what":"Author","title":"metalite.ae: Adverse Events Analysis Using 'metalite' — metalite.ae-package","text":"Maintainer: Yujie Zhao yujie.zhao@merck.com Authors: Yilong Zhang Benjamin Wang Nan Xiao Sarad Nepal Madhusudhan Ginnaram Ruchitbhai Patel Brian Lang Xuan Deng contributors: Venkatesh Burla [contributor] Merck Sharp & Dohme Corp [copyright holder]","code":""},{"path":"https://merck.github.io/metalite.ae/reference/metalite_ae_adex.html","id":null,"dir":"Reference","previous_headings":"","what":"ADEX dataset — metalite_ae_adex","title":"ADEX dataset — metalite_ae_adex","text":"dataset containing exposure details.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/metalite_ae_adex.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"ADEX dataset — metalite_ae_adex","text":"","code":"metalite_ae_adex"},{"path":"https://merck.github.io/metalite.ae/reference/metalite_ae_adex.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"ADEX dataset — metalite_ae_adex","text":"data frame 591 rows 41 variables.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/metalite_ae_adex.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"ADEX dataset — metalite_ae_adex","text":"https://github.com/phuse-org/phuse-scripts/tree/master/data/sdtm/cdiscpilot01","code":""},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_exp_adj.html","id":null,"dir":"Reference","previous_headings":"","what":"Prepare datasets for AE specific analysis — prepare_ae_exp_adj","title":"Prepare datasets for AE specific analysis — prepare_ae_exp_adj","text":"Prepare datasets AE specific analysis","code":""},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_exp_adj.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Prepare datasets for AE specific analysis — prepare_ae_exp_adj","text":"","code":"prepare_ae_exp_adj(   meta,   population = \"apat\",   observation = \"wk12\",   parameter = \"any;rel;ser\",   duration_var = \"TRTDUR\",   adj_unit = c(\"year\", \"month\", \"week\", \"day\") )"},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_exp_adj.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Prepare datasets for AE specific analysis — prepare_ae_exp_adj","text":"meta metadata object created metalite. population character value population term name. term name used key link information. observation character value observation term name. term name used key link information. parameter character value parameter term name. term name used key link information. duration_var character value duration variable name. default, \"TRTDUR\" used. adj_unit character value exposure adjusted unit. select \"year\", \"month\", \"week\", \"day\".","code":""},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_exp_adj.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Prepare datasets for AE specific analysis — prepare_ae_exp_adj","text":"list analysis raw datasets.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_exp_adj.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Prepare datasets for AE specific analysis — prepare_ae_exp_adj","text":"","code":"meta <- meta_ae_example() prepare_ae_exp_adj(meta) #> List of 11 #>  $ meta           :List of 7 #>  $ population     : chr \"apat\" #>  $ observation    : chr \"wk12\" #>  $ parameter      : chr \"any;rel;ser\" #>  $ n              :'data.frame':\t1 obs. of  3 variables: #>  $ order          : NULL #>  $ group          : chr \"TRTA\" #>  $ reference_group: NULL #>  $ total_exposure : num [1:3(1d)] 12820 8318 8349 #>  $ adj_rate       :List of 3 #>  $ group_label    : Factor w/ 3 levels \"Placebo\",\"Low Dose\",..: 1 3 2"},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_listing.html","id":null,"dir":"Reference","previous_headings":"","what":"Prepare datasets for AE specific analysis — prepare_ae_listing","title":"Prepare datasets for AE specific analysis — prepare_ae_listing","text":"Prepare datasets AE specific analysis","code":""},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_listing.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Prepare datasets for AE specific analysis — prepare_ae_listing","text":"","code":"prepare_ae_listing(meta, analysis, population, observation, parameter)"},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_listing.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Prepare datasets for AE specific analysis — prepare_ae_listing","text":"meta metadata object created metalite. analysis Analysis name meta. population character value population term name. term name used key link information. observation character value observation term name. term name used key link information. parameter character value parameter term name. term name used key link information.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_listing.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Prepare datasets for AE specific analysis — prepare_ae_listing","text":"list analysis raw datasets.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_listing.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Prepare datasets for AE specific analysis — prepare_ae_listing","text":"","code":"meta <- meta_ae_example() str(prepare_ae_listing(meta, \"ae_listing\", \"apat\", \"wk12\", \"ser\")) #> List of 11 #>  $ meta           :List of 7 #>   ..$ data_population :'data.frame':\t254 obs. of  49 variables: #>   .. ..$ STUDYID : chr [1:254] \"CDISCPILOT01\" \"CDISCPILOT01\" \"CDISCPILOT01\" \"CDISCPILOT01\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Study Identifier\" #>   .. ..$ USUBJID : chr [1:254] \"01-701-1015\" \"01-701-1023\" \"01-701-1028\" \"01-701-1033\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Unique Subject Identifier\" #>   .. ..$ SUBJID  : chr [1:254] \"1015\" \"1023\" \"1028\" \"1033\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Subject Identifier for the Study\" #>   .. ..$ SITEID  : chr [1:254] \"701\" \"701\" \"701\" \"701\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Study Site Identifier\" #>   .. ..$ SITEGR1 : chr [1:254] \"701\" \"701\" \"701\" \"701\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Pooled Site Group 1\" #>   .. ..$ ARM     : chr [1:254] \"Placebo\" \"Placebo\" \"Xanomeline High Dose\" \"Xanomeline Low Dose\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Description of Planned Arm\" #>   .. ..$ TRT01P  : chr [1:254] \"Placebo\" \"Placebo\" \"Xanomeline High Dose\" \"Xanomeline Low Dose\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Planned Treatment for Period 01\" #>   .. ..$ TRT01PN : num [1:254] 0 0 81 54 81 0 54 54 54 0 ... #>   .. .. ..- attr(*, \"label\")= chr \"Planned Treatment for Period 01 (N)\" #>   .. ..$ TRT01A  : chr [1:254] \"Placebo\" \"Placebo\" \"Xanomeline High Dose\" \"Xanomeline Low Dose\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Actual Treatment for Period 01\" #>   .. ..$ TRT01AN : num [1:254] 0 0 81 54 81 0 54 54 54 0 ... #>   .. .. ..- attr(*, \"label\")= chr \"Actual Treatment for Period 01 (N)\" #>   .. ..$ TRTSDT  : Date[1:254], format: \"2014-01-02\" \"2012-08-05\" ... #>   .. ..$ TRTEDT  : Date[1:254], format: \"2014-07-02\" \"2012-09-01\" ... #>   .. ..$ TRTDUR  : num [1:254] 182 28 180 14 183 26 190 10 55 182 ... #>   .. .. ..- attr(*, \"label\")= chr \"Duration of Treatment (days)\" #>   .. ..$ AVGDD   : num [1:254] 0 0 77.7 54 76.9 0 54 54 54 0 ... #>   .. .. ..- attr(*, \"label\")= chr \"Avg Daily Dose (as planned)\" #>   .. ..$ CUMDOSE : num [1:254] 0 0 13986 756 14067 ... #>   .. .. ..- attr(*, \"label\")= chr \"Cumulative Dose (as planned)\" #>   .. ..$ AGE     : num [1:254] 63 64 71 74 77 85 68 81 84 52 ... #>   .. .. ..- attr(*, \"label\")= chr \"Age\" #>   .. ..$ AGEGR1  : chr [1:254] \"<65\" \"<65\" \"65-80\" \"65-80\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Pooled Age Group 1\" #>   .. ..$ AGEGR1N : num [1:254] 1 1 2 2 2 3 2 3 3 1 ... #>   .. .. ..- attr(*, \"label\")= chr \"Pooled Age Group 1 (N)\" #>   .. ..$ AGEU    : chr [1:254] \"YEARS\" \"YEARS\" \"YEARS\" \"YEARS\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Age Units\" #>   .. ..$ RACE    : chr [1:254] \"WHITE\" \"WHITE\" \"WHITE\" \"WHITE\" ... #>   .. ..$ RACEN   : num [1:254] 1 1 1 1 1 1 1 1 1 1 ... #>   .. .. ..- attr(*, \"label\")= chr \"Race (N)\" #>   .. ..$ SEX     : chr [1:254] \"F\" \"M\" \"M\" \"M\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Sex\" #>   .. ..$ ETHNIC  : chr [1:254] \"HISPANIC OR LATINO\" \"HISPANIC OR LATINO\" \"NOT HISPANIC OR LATINO\" \"NOT HISPANIC OR LATINO\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Ethnicity\" #>   .. ..$ SAFFL   : chr [1:254] \"Y\" \"Y\" \"Y\" \"Y\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Safety Population Flag\" #>   .. ..$ ITTFL   : chr [1:254] \"Y\" \"Y\" \"Y\" \"Y\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Intent-To-Treat Population Flag\" #>   .. ..$ EFFFL   : chr [1:254] \"Y\" \"Y\" \"Y\" \"Y\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Efficacy Population Flag\" #>   .. ..$ COMP8FL : chr [1:254] \"Y\" \"N\" \"Y\" \"N\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Completers of Week 8 Population Flag\" #>   .. ..$ COMP16FL: chr [1:254] \"Y\" \"N\" \"Y\" \"N\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Completers of Week 16 Population Flag\" #>   .. ..$ COMP24FL: chr [1:254] \"Y\" \"N\" \"Y\" \"N\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Completers of Week 24 Population Flag\" #>   .. ..$ DISCONFL: chr [1:254] \"\" \"Y\" \"\" \"Y\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Did the Subject Discontinue the Study?\" #>   .. ..$ DSRAEFL : chr [1:254] \"\" \"Y\" \"\" \"\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Discontinued due to AE?\" #>   .. ..$ DTHFL   : chr [1:254] \"\" \"\" \"\" \"\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Subject Died?\" #>   .. ..$ BMIBL   : num [1:254] 25.1 30.4 31.4 28.8 26.1 30.4 27.3 23.9 23.9 21.9 ... #>   .. .. ..- attr(*, \"label\")= chr \"Baseline BMI (kg/m^2)\" #>   .. ..$ BMIBLGR1: chr [1:254] \"25-<30\" \">=30\" \">=30\" \"25-<30\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Pooled Baseline BMI Group 1\" #>   .. ..$ HEIGHTBL: num [1:254] 147 163 178 175 155 ... #>   .. .. ..- attr(*, \"label\")= chr \"Baseline Height (cm)\" #>   .. ..$ WEIGHTBL: num [1:254] 54.4 80.3 99.3 88.5 62.6 67.1 78 59.9 78.9 71.2 ... #>   .. .. ..- attr(*, \"label\")= chr \"Baseline Weight (kg)\" #>   .. ..$ EDUCLVL : num [1:254] 16 14 16 12 9 8 18 22 12 14 ... #>   .. .. ..- attr(*, \"label\")= chr \"Years of Education\" #>   .. ..$ DISONSDT: Date[1:254], format: \"2010-04-30\" \"2006-03-11\" ... #>   .. ..$ DURDIS  : num [1:254] 43.9 76.4 42.8 55.3 32.9 ... #>   .. .. ..- attr(*, \"label\")= chr \"Duration of Disease (Months)\" #>   .. ..$ DURDSGR1: chr [1:254] \">=12\" \">=12\" \">=12\" \">=12\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Pooled Disease Duration Group 1\" #>   .. ..$ VISIT1DT: Date[1:254], format: \"2013-12-26\" \"2012-07-22\" ... #>   .. ..$ RFSTDTC : chr [1:254] \"2014-01-02\" \"2012-08-05\" \"2013-07-19\" \"2014-03-18\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Subject Reference Start Date/Time\" #>   .. ..$ RFENDTC : chr [1:254] \"2014-07-02\" \"2012-09-02\" \"2014-01-14\" \"2014-04-14\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Subject Reference End Date/Time\" #>   .. ..$ VISNUMEN: num [1:254] 12 5 12 5 12 6 12 4 8 12 ... #>   .. .. ..- attr(*, \"label\")= chr \"End of Trt Visit (Vis 12 or Early Term.)\" #>   .. ..$ RFENDT  : Date[1:254], format: \"2014-07-02\" \"2012-09-02\" ... #>   .. ..$ DCDECOD : chr [1:254] \"COMPLETED\" \"ADVERSE EVENT\" \"COMPLETED\" \"STUDY TERMINATED BY SPONSOR\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Standardized Disposition Term\" #>   .. ..$ DCREASCD: chr [1:254] \"Completed\" \"Adverse Event\" \"Completed\" \"Sponsor Decision\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Reason for Discontinuation\" #>   .. ..$ MMSETOT : num [1:254] 23 23 23 23 21 23 10 23 20 20 ... #>   .. .. ..- attr(*, \"label\")= chr \"MMSE Total\" #>   .. ..$ TRTA    : Factor w/ 3 levels \"Placebo\",\"Low Dose\",..: 1 1 3 2 3 1 2 2 2 1 ... #>   .. ..- attr(*, \"data_name\")= chr \"adsl\" #>   ..$ data_observation:'data.frame':\t1191 obs. of  60 variables: #>   .. ..$ STUDYID     : chr [1:1191] \"CDISCPILOT01\" \"CDISCPILOT01\" \"CDISCPILOT01\" \"CDISCPILOT01\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Study Identifier\" #>   .. ..$ SITEID      : chr [1:1191] \"701\" \"701\" \"701\" \"701\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Study Site Identifier\" #>   .. ..$ USUBJID     : chr [1:1191] \"01-701-1015\" \"01-701-1015\" \"01-701-1015\" \"01-701-1023\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Unique Subject Identifier\" #>   .. ..$ TRTA        : Factor w/ 3 levels \"Placebo\",\"Low Dose\",..: 1 1 1 1 1 1 1 3 3 3 ... #>   .. ..$ TRTAN       : num [1:1191] 0 0 0 0 0 0 0 81 81 81 ... #>   .. .. ..- attr(*, \"label\")= chr \"Actual Treatment (N)\" #>   .. ..$ AGE         : num [1:1191] 63 63 63 64 64 64 64 71 71 77 ... #>   .. .. ..- attr(*, \"label\")= chr \"Age\" #>   .. ..$ AGEGR1      : chr [1:1191] \"<65\" \"<65\" \"<65\" \"<65\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Pooled Age Group 1\" #>   .. ..$ AGEGR1N     : num [1:1191] 1 1 1 1 1 1 1 2 2 2 ... #>   .. .. ..- attr(*, \"label\")= chr \"Pooled Age Group 1 (N)\" #>   .. ..$ RACE        : chr [1:1191] \"WHITE\" \"WHITE\" \"WHITE\" \"WHITE\" ... #>   .. ..$ RACEN       : num [1:1191] 1 1 1 1 1 1 1 1 1 1 ... #>   .. .. ..- attr(*, \"label\")= chr \"Race (N)\" #>   .. ..$ SEX         : chr [1:1191] \"F\" \"F\" \"F\" \"M\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Sex\" #>   .. ..$ SAFFL       : chr [1:1191] \"Y\" \"Y\" \"Y\" \"Y\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Safety Population Flag\" #>   .. ..$ TRTSDT      : Date[1:1191], format: \"2014-01-02\" \"2014-01-02\" ... #>   .. ..$ TRTEDT      : Date[1:1191], format: \"2014-07-02\" \"2014-07-02\" ... #>   .. ..$ ASTDT       : Date[1:1191], format: \"2014-01-03\" \"2014-01-03\" ... #>   .. ..$ ASTDTF      : chr [1:1191] \"\" \"\" \"\" \"\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Analysis Start Date Imputation Flag\" #>   .. ..$ ASTDY       : num [1:1191] 2 2 8 3 3 22 3 3 21 58 ... #>   .. .. ..- attr(*, \"label\")= chr \"Analysis Start Relative Day\" #>   .. ..$ AENDT       : Date[1:1191], format: NA NA ... #>   .. ..$ AENDY       : num [1:1191] NA NA 10 26 NA NA 26 NA NA NA ... #>   .. .. ..- attr(*, \"label\")= chr \"Analysis End Relative Day\" #>   .. ..$ ADURN       : num [1:1191] NA NA 3 24 NA NA 24 NA NA NA ... #>   .. .. ..- attr(*, \"label\")= chr \"AE Duration (N)\" #>   .. ..$ ADURU       : chr [1:1191] \"\" \"\" \"DAY\" \"DAY\" ... #>   .. .. ..- attr(*, \"label\")= chr \"AE Duration Units\" #>   .. ..$ AETERM      : chr [1:1191] \"APPLICATION SITE ERYTHEMA\" \"APPLICATION SITE PRURITUS\" \"DIARRHOEA\" \"ERYTHEMA\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Reported Term for the Adverse Event\" #>   .. ..$ AELLT       : chr [1:1191] \"APPLICATION SITE REDNESS\" \"APPLICATION SITE ITCHING\" \"DIARRHEA\" \"ERYTHEMA\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Lowest Level Term\" #>   .. ..$ AELLTCD     : num [1:1191] NA NA NA NA NA NA NA NA NA NA ... #>   .. .. ..- attr(*, \"label\")= chr \"Lowest Level Term Code\" #>   .. ..$ AEDECOD     : chr [1:1191] \"APPLICATION SITE ERYTHEMA\" \"APPLICATION SITE PRURITUS\" \"DIARRHOEA\" \"ERYTHEMA\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Adverse Event\" #>   .. ..$ AEPTCD      : num [1:1191] NA NA NA NA NA NA NA NA NA NA ... #>   .. .. ..- attr(*, \"label\")= chr \"Preferred Term Code\" #>   .. ..$ AEHLT       : chr [1:1191] \"HLT_0617\" \"HLT_0317\" \"HLT_0148\" \"HLT_0284\" ... #>   .. .. ..- attr(*, \"label\")= chr \"High Level Term\" #>   .. ..$ AEHLTCD     : num [1:1191] NA NA NA NA NA NA NA NA NA NA ... #>   .. .. ..- attr(*, \"label\")= chr \"High Level Term Code\" #>   .. ..$ AEHLGT      : chr [1:1191] \"HLGT_0152\" \"HLGT_0338\" \"HLGT_0588\" \"HLGT_0192\" ... #>   .. .. ..- attr(*, \"label\")= chr \"High Level Group Term\" #>   .. ..$ AEHLGTCD    : num [1:1191] NA NA NA NA NA NA NA NA NA NA ... #>   .. .. ..- attr(*, \"label\")= chr \"High Level Group Term Code\" #>   .. ..$ AEBODSYS    : chr [1:1191] \"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\" \"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\" \"GASTROINTESTINAL DISORDERS\" \"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Body System or Organ Class\" #>   .. ..$ AESOC       : chr [1:1191] \"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\" \"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\" \"GASTROINTESTINAL DISORDERS\" \"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Primary System Organ Class\" #>   .. ..$ AESOCCD     : num [1:1191] NA NA NA NA NA NA NA NA NA NA ... #>   .. .. ..- attr(*, \"label\")= chr \"Primary System Organ Class Code\" #>   .. ..$ AESEV       : chr [1:1191] \"MILD\" \"MILD\" \"MILD\" \"MILD\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Intensity\" #>   .. ..$ AESER       : chr [1:1191] \"N\" \"N\" \"N\" \"N\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Serious\" #>   .. ..$ AESCAN      : chr [1:1191] \"N\" \"N\" \"N\" \"N\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Involves Cancer\" #>   .. ..$ AESCONG     : chr [1:1191] \"N\" \"N\" \"N\" \"N\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Congenital Anomaly or Birth Defect\" #>   .. ..$ AESDISAB    : chr [1:1191] \"N\" \"N\" \"N\" \"N\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Persist or Signif Disability/Incapacity\" #>   .. ..$ AESDTH      : chr [1:1191] \"N\" \"N\" \"N\" \"N\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Results in Death\" #>   .. ..$ AESHOSP     : chr [1:1191] \"N\" \"N\" \"N\" \"N\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Requires or Prolongs Hospitalization\" #>   .. ..$ AESLIFE     : chr [1:1191] \"N\" \"N\" \"N\" \"N\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Is Life Threatening\" #>   .. ..$ AESOD       : chr [1:1191] \"N\" \"N\" \"N\" \"N\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Occurred with Overdose\" #>   .. ..$ AEREL       : chr [1:1191] \"PROBABLE\" \"PROBABLE\" \"REMOTE\" \"POSSIBLE\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Causality\" #>   .. ..$ AEACN       : chr [1:1191] \"DOSE NOT CHANGED\" \"DOSE NOT CHANGED\" \"DOSE NOT CHANGED\" \"DOSE NOT CHANGED\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Action Taken with Study Treatment\" #>   .. ..$ AEOUT       : chr [1:1191] \"NOT RECOVERED/NOT RESOLVED\" \"NOT RECOVERED/NOT RESOLVED\" \"RECOVERED/RESOLVED\" \"NOT RECOVERED/NOT RESOLVED\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Outcome of Adverse Event\" #>   .. ..$ AESEQ       : num [1:1191] 1 2 3 1 2 3 4 1 2 1 ... #>   .. .. ..- attr(*, \"label\")= chr \"Sequence Number\" #>   .. ..$ TRTEMFL     : chr [1:1191] \"Y\" \"Y\" \"Y\" \"Y\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Treatment Emergent Analysis Flag\" #>   .. ..$ AOCCFL      : chr [1:1191] \"Y\" \"\" \"\" \"Y\" ... #>   .. .. ..- attr(*, \"label\")= chr \"1st Occurrence of Any AE Flag\" #>   .. ..$ AOCCSFL     : chr [1:1191] \"Y\" \"\" \"Y\" \"Y\" ... #>   .. .. ..- attr(*, \"label\")= chr \"1st Occurrence of SOC Flag\" #>   .. ..$ AOCCPFL     : chr [1:1191] \"Y\" \"Y\" \"Y\" \"Y\" ... #>   .. .. ..- attr(*, \"label\")= chr \"1st Occurrence of Preferred Term Flag\" #>   .. ..$ AOCC02FL    : chr [1:1191] \"\" \"\" \"\" \"\" ... #>   .. .. ..- attr(*, \"label\")= chr \"1st Occurrence 02 Flag for Serious\" #>   .. ..$ AOCC03FL    : chr [1:1191] \"\" \"\" \"\" \"\" ... #>   .. .. ..- attr(*, \"label\")= chr \"1st Occurrence 03 Flag for Serious SOC\" #>   .. ..$ AOCC04FL    : chr [1:1191] \"\" \"\" \"\" \"\" ... #>   .. .. ..- attr(*, \"label\")= chr \"1st Occurrence 04 Flag for Serious PT\" #>   .. ..$ CQ01NAM     : chr [1:1191] \"DERMATOLOGIC EVENTS\" \"DERMATOLOGIC EVENTS\" \"\" \"DERMATOLOGIC EVENTS\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Customized Query 01 Name\" #>   .. ..$ AOCC01FL    : chr [1:1191] \"Y\" \"\" \"\" \"Y\" ... #>   .. .. ..- attr(*, \"label\")= chr \"1st Occurrence 01 Flag for CQ01\" #>   .. ..$ related     : chr [1:1191] \"Probable\" \"Probable\" \"Remote\" \"Possible\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Related\" #>   .. ..$ outcome     : chr [1:1191] \"Resolved\" \"Resolved\" \"Resolved\" \"Resolved\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Outcome\" #>   .. ..$ action_taken: chr [1:1191] \"None\" \"None\" \"None\" \"None\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Action Taken\" #>   .. ..$ duration    : chr [1:1191] \"Continuing\" \"Continuing\" \"3 Day\" \"24 Day\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Duration\" #>   .. ..$ subline     : chr [1:1191] \"Subject ID = 01-701-1015, Gender = F, Race = WHITE, AGE = 63 Years, TRT = Placebo\" \"Subject ID = 01-701-1015, Gender = F, Race = WHITE, AGE = 63 Years, TRT = Placebo\" \"Subject ID = 01-701-1015, Gender = F, Race = WHITE, AGE = 63 Years, TRT = Placebo\" \"Subject ID = 01-701-1023, Gender = M, Race = WHITE, AGE = 64 Years, TRT = Placebo\" ... #>   .. ..- attr(*, \"data_name\")= chr \"adae\" #>   ..$ plan            :Classes ‘meta_plan’ and 'data.frame':\t18 obs. of  5 variables: #>   .. ..$ mock       : num [1:18] 1 1 2 2 2 2 2 2 2 2 ... #>   .. ..$ analysis   : chr [1:18] \"ae_summary\" \"ae_summary\" \"ae_specific\" \"ae_specific\" ... #>   .. ..$ population : chr [1:18] \"apat\" \"apat\" \"apat\" \"apat\" ... #>   .. ..$ observation: chr [1:18] \"wk12\" \"wk24\" \"wk12\" \"wk24\" ... #>   .. ..$ parameter  : chr [1:18] \"any;rel;ser\" \"any;rel;ser\" \"any\" \"any\" ... #>   .. ..- attr(*, \"out.attrs\")=List of 2 #>   .. .. ..$ dim     : Named int [1:5] 1 1 1 2 1 #>   .. .. .. ..- attr(*, \"names\")= chr [1:5] \"mock\" \"analysis\" \"population\" \"observation\" ... #>   .. .. ..$ dimnames:List of 5 #>   .. .. .. ..$ mock       : chr \"mock=1\" #>   .. .. .. ..$ analysis   : chr \"analysis=ae_summary\" #>   .. .. .. ..$ population : chr \"population=apat\" #>   .. .. .. ..$ observation: chr [1:2] \"observation=wk12\" \"observation=wk24\" #>   .. .. .. ..$ parameter  : chr \"parameter=any;rel;ser\" #>   ..$ observation     :List of 2 #>   .. ..$ wk12:List of 6 #>   .. .. ..$ name  : chr \"wk12\" #>   .. .. ..$ id    : chr \"USUBJID\" #>   .. .. ..$ group : chr \"TRTA\" #>   .. .. ..$ var   : NULL #>   .. .. ..$ subset: language SAFFL == \"Y\" #>   .. .. ..$ label : chr \"Weeks 0 to 12\" #>   .. .. ..- attr(*, \"class\")= chr \"adam_mapping\" #>   .. ..$ wk24:List of 6 #>   .. .. ..$ name  : chr \"wk24\" #>   .. .. ..$ id    : chr \"USUBJID\" #>   .. .. ..$ group : chr \"TRTA\" #>   .. .. ..$ var   : NULL #>   .. .. ..$ subset: language AOCC01FL == \"Y\" #>   .. .. ..$ label : chr \"Weeks 0 to 24\" #>   .. .. ..- attr(*, \"class\")= chr \"adam_mapping\" #>   ..$ population      :List of 1 #>   .. ..$ apat:List of 6 #>   .. .. ..$ name  : chr \"apat\" #>   .. .. ..$ id    : chr \"USUBJID\" #>   .. .. ..$ group : chr \"TRTA\" #>   .. .. ..$ var   : NULL #>   .. .. ..$ subset: language SAFFL == \"Y\" #>   .. .. ..$ label : chr \"All Participants as Treated\" #>   .. .. ..- attr(*, \"class\")= chr \"adam_mapping\" #>   ..$ parameter       :List of 4 #>   .. ..$ rel  :List of 12 #>   .. .. ..$ name     : chr \"rel\" #>   .. .. ..$ id       : NULL #>   .. .. ..$ group    : NULL #>   .. .. ..$ var      : chr \"AEDECOD\" #>   .. .. ..$ subset   : language AEREL %in% c(\"POSSIBLE\", \"PROBABLE\") #>   .. .. ..$ label    : chr \"drug-related adverse events\" #>   .. .. ..$ soc      : chr \"AEBODSYS\" #>   .. .. ..$ seq      : num 200 #>   .. .. ..$ term1    : chr \"Drug-Related\" #>   .. .. ..$ term2    : chr \"\" #>   .. .. ..$ summ_row : chr \"with drug-related{^a} adverse events\" #>   .. .. ..$ summ_foot: chr \"{^a}Determined by the investigator to be related to the drug.\" #>   .. .. ..- attr(*, \"class\")= chr \"adam_mapping\" #>   .. ..$ aeosi:List of 9 #>   .. .. ..$ name  : chr \"aeosi\" #>   .. .. ..$ id    : NULL #>   .. .. ..$ group : NULL #>   .. .. ..$ var   : chr \"AEDECOD\" #>   .. .. ..$ subset: language AEOSI == \"Y\" #>   .. .. ..$ label : chr \"adverse events of special interest\" #>   .. .. ..$ soc   : chr \"AEBODSYS\" #>   .. .. ..$ term1 : chr \"\" #>   .. .. ..$ term2 : chr \"of special interest\" #>   .. .. ..- attr(*, \"class\")= chr \"adam_mapping\" #>   .. ..$ any  :List of 11 #>   .. .. ..$ name    : chr \"any\" #>   .. .. ..$ id      : NULL #>   .. .. ..$ group   : NULL #>   .. .. ..$ var     : chr \"AEDECOD\" #>   .. .. ..$ subset  : NULL #>   .. .. ..$ label   : chr \"any adverse events\" #>   .. .. ..$ soc     : chr \"AEBODSYS\" #>   .. .. ..$ seq     : num 100 #>   .. .. ..$ term1   : chr \"\" #>   .. .. ..$ term2   : chr \"\" #>   .. .. ..$ summ_row: chr \"with one or more adverse events\" #>   .. .. ..- attr(*, \"class\")= chr \"adam_mapping\" #>   .. ..$ ser  :List of 11 #>   .. .. ..$ name    : chr \"ser\" #>   .. .. ..$ id      : NULL #>   .. .. ..$ group   : NULL #>   .. .. ..$ var     : chr \"AEDECOD\" #>   .. .. ..$ subset  : language AESER == \"Y\" #>   .. .. ..$ label   : chr \"serious adverse events\" #>   .. .. ..$ soc     : chr \"AEBODSYS\" #>   .. .. ..$ seq     : num 401 #>   .. .. ..$ term1   : chr \"Serious\" #>   .. .. ..$ term2   : chr \"\" #>   .. .. ..$ summ_row: chr \"with serious adverse events\" #>   .. .. ..- attr(*, \"class\")= chr \"adam_mapping\" #>   ..$ analysis        :List of 4 #>   .. ..$ ae_summary :List of 7 #>   .. .. ..$ name  : chr \"ae_summary\" #>   .. .. ..$ id    : NULL #>   .. .. ..$ group : NULL #>   .. .. ..$ var   : NULL #>   .. .. ..$ subset: NULL #>   .. .. ..$ label : chr \"Table: adverse event summary\" #>   .. .. ..$ title : chr \"Summary of Adverse Events\" #>   .. .. ..- attr(*, \"class\")= chr \"adam_mapping\" #>   .. ..$ ae_listing :List of 11 #>   .. .. ..$ name      : chr \"ae_listing\" #>   .. .. ..$ id        : NULL #>   .. .. ..$ group     : NULL #>   .. .. ..$ var       : NULL #>   .. .. ..$ subset    : NULL #>   .. .. ..$ label     : chr \"Listing: adverse event\" #>   .. .. ..$ var_name  : chr [1:9] \"USUBJID\" \"ASTDY\" \"AEDECOD\" \"duration\" ... #>   .. .. ..$ subline_by: NULL #>   .. .. ..$ group_by  : chr [1:2] \"USUBJID\" \"ASTDY\" #>   .. .. ..$ page_by   : chr [1:2] \"TRTA\" \"subline\" #>   .. .. ..$ title     : chr \"Listing of Participants With {term1} Adverse Events {term2}\" #>   .. .. ..- attr(*, \"class\")= chr \"adam_mapping\" #>   .. ..$ ae_exp_adj :List of 7 #>   .. .. ..$ name  : chr \"ae_exp_adj\" #>   .. .. ..$ id    : NULL #>   .. .. ..$ group : NULL #>   .. .. ..$ var   : NULL #>   .. .. ..$ subset: NULL #>   .. .. ..$ label : chr \"Exposure Adjusted Incident Rate\" #>   .. .. ..$ title : chr \"Exposure-Adjusted Adverse Event Summary\" #>   .. .. ..- attr(*, \"class\")= chr \"adam_mapping\" #>   .. ..$ ae_specific:List of 7 #>   .. .. ..$ name  : chr \"ae_specific\" #>   .. .. ..$ id    : NULL #>   .. .. ..$ group : NULL #>   .. .. ..$ var   : NULL #>   .. .. ..$ subset: NULL #>   .. .. ..$ label : chr \"Table: specific adverse event\" #>   .. .. ..$ title : chr \"Participants With {term1} Adverse Events {term2}\" #>   .. .. ..- attr(*, \"class\")= chr \"adam_mapping\" #>   ..- attr(*, \"class\")= chr \"meta_adam\" #>  $ population     : chr \"apat\" #>  $ observation    : chr \"wk12\" #>  $ parameter      : chr \"ser\" #>  $ n              : NULL #>  $ order          : NULL #>  $ group          : NULL #>  $ reference_group: NULL #>  $ col_name       : Named chr [1:11] \"Unique Subject Identifier\" \"Analysis Start Relative Day\" \"Adverse Event\" \"Duration\" ... #>   ..- attr(*, \"names\")= chr [1:11] \"USUBJID\" \"ASTDY\" \"AEDECOD\" \"duration\" ... #>  $ tbl            :'data.frame':\t3 obs. of  11 variables: #>   ..$ USUBJID     : chr [1:3] \"01-709-1424\" \"01-718-1170\" \"01-718-1371\" #>   .. ..- attr(*, \"label\")= Named chr \"Unique Subject Identifier\" #>   .. .. ..- attr(*, \"names\")= chr \"USUBJID\" #>   ..$ ASTDY       : num [1:3] 5 27 38 #>   .. ..- attr(*, \"label\")= Named chr \"Analysis Start Relative Day\" #>   .. .. ..- attr(*, \"names\")= chr \"ASTDY\" #>   ..$ AEDECOD     : chr [1:3] \"SYNCOPE\" \"SYNCOPE\" \"PARTIAL SEIZURES WITH SECONDARY GENERALISATION\" #>   .. ..- attr(*, \"label\")= Named chr \"Adverse Event\" #>   .. .. ..- attr(*, \"names\")= chr \"AEDECOD\" #>   ..$ duration    : chr [1:3] \"1 Day\" \"2 Day\" \"4 Day\" #>   .. ..- attr(*, \"label\")= Named chr \"Duration\" #>   .. .. ..- attr(*, \"names\")= chr \"duration\" #>   ..$ AESEV       : chr [1:3] \"MODERATE\" \"SEVERE\" \"SEVERE\" #>   .. ..- attr(*, \"label\")= Named chr \"Intensity\" #>   .. .. ..- attr(*, \"names\")= chr \"AESEV\" #>   ..$ AESER       : chr [1:3] \"Y\" \"Y\" \"Y\" #>   .. ..- attr(*, \"label\")= Named chr \"Serious\" #>   .. .. ..- attr(*, \"names\")= chr \"AESER\" #>   ..$ related     : chr [1:3] \"Possible\" \"Probable\" \"None\" #>   .. ..- attr(*, \"label\")= Named chr \"Related\" #>   .. .. ..- attr(*, \"names\")= chr \"related\" #>   ..$ action_taken: chr [1:3] \"None\" \"None\" \"None\" #>   .. ..- attr(*, \"label\")= Named chr \"Action Taken\" #>   .. .. ..- attr(*, \"names\")= chr \"action_taken\" #>   ..$ outcome     : chr [1:3] \"Resolved\" \"Resolved\" \"Resolved\" #>   .. ..- attr(*, \"label\")= Named chr \"Outcome\" #>   .. .. ..- attr(*, \"names\")= chr \"outcome\" #>   ..$ TRTA        : Factor w/ 3 levels \"Placebo\",\"Low Dose\",..: 3 2 3 #>   .. ..- attr(*, \"label\")= Named chr \"TRTA\" #>   .. .. ..- attr(*, \"names\")= chr \"TRTA\" #>   ..$ subline     : chr [1:3] \"Subject ID = 01-709-1424, Gender = M, Race = WHITE, AGE = 77 Years, TRT = High Dose\" \"Subject ID = 01-718-1170, Gender = F, Race = WHITE, AGE = 80 Years, TRT = Low Dose\" \"Subject ID = 01-718-1371, Gender = F, Race = WHITE, AGE = 69 Years, TRT = High Dose\" #>   .. ..- attr(*, \"label\")= Named chr \"subline\" #>   .. .. ..- attr(*, \"names\")= chr \"subline\" #>  $ prepare_call   : language prepare_ae_listing(meta = meta, analysis = \"ae_listing\", population = \"apat\",      observation = \"wk12\", parameter = \"ser\") #>  - attr(*, \"class\")= chr \"outdata\""},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_specific.html","id":null,"dir":"Reference","previous_headings":"","what":"Prepare datasets for AE specific analysis — prepare_ae_specific","title":"Prepare datasets for AE specific analysis — prepare_ae_specific","text":"Prepare datasets AE specific analysis","code":""},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_specific.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Prepare datasets for AE specific analysis — prepare_ae_specific","text":"","code":"prepare_ae_specific(   meta,   population,   observation,   parameter,   components = c(\"soc\", \"par\"),   reference_group = NULL )"},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_specific.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Prepare datasets for AE specific analysis — prepare_ae_specific","text":"meta metadata object created metalite. population character value population term name. term name used key link information. observation character value observation term name. term name used key link information. parameter character value parameter term name. term name used key link information. components character vector components name. reference_group integer indicate reference group. Default 2 2 groups, otherwise, default 1.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_specific.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Prepare datasets for AE specific analysis — prepare_ae_specific","text":"list analysis raw datasets.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_specific.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Prepare datasets for AE specific analysis — prepare_ae_specific","text":"","code":"meta <- meta_ae_example() str(prepare_ae_specific(meta, \"apat\", \"wk12\", \"rel\")) #> List of 14 #>  $ meta           :List of 7 #>   ..$ data_population :'data.frame':\t254 obs. of  49 variables: #>   .. ..$ STUDYID : chr [1:254] \"CDISCPILOT01\" \"CDISCPILOT01\" \"CDISCPILOT01\" \"CDISCPILOT01\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Study Identifier\" #>   .. ..$ USUBJID : chr [1:254] \"01-701-1015\" \"01-701-1023\" \"01-701-1028\" \"01-701-1033\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Unique Subject Identifier\" #>   .. ..$ SUBJID  : chr [1:254] \"1015\" \"1023\" \"1028\" \"1033\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Subject Identifier for the Study\" #>   .. ..$ SITEID  : chr [1:254] \"701\" \"701\" \"701\" \"701\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Study Site Identifier\" #>   .. ..$ SITEGR1 : chr [1:254] \"701\" \"701\" \"701\" \"701\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Pooled Site Group 1\" #>   .. ..$ ARM     : chr [1:254] \"Placebo\" \"Placebo\" \"Xanomeline High Dose\" \"Xanomeline Low Dose\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Description of Planned Arm\" #>   .. ..$ TRT01P  : chr [1:254] \"Placebo\" \"Placebo\" \"Xanomeline High Dose\" \"Xanomeline Low Dose\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Planned Treatment for Period 01\" #>   .. ..$ TRT01PN : num [1:254] 0 0 81 54 81 0 54 54 54 0 ... #>   .. .. ..- attr(*, \"label\")= chr \"Planned Treatment for Period 01 (N)\" #>   .. ..$ TRT01A  : chr [1:254] \"Placebo\" \"Placebo\" \"Xanomeline High Dose\" \"Xanomeline Low Dose\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Actual Treatment for Period 01\" #>   .. ..$ TRT01AN : num [1:254] 0 0 81 54 81 0 54 54 54 0 ... #>   .. .. ..- attr(*, \"label\")= chr \"Actual Treatment for Period 01 (N)\" #>   .. ..$ TRTSDT  : Date[1:254], format: \"2014-01-02\" \"2012-08-05\" ... #>   .. ..$ TRTEDT  : Date[1:254], format: \"2014-07-02\" \"2012-09-01\" ... #>   .. ..$ TRTDUR  : num [1:254] 182 28 180 14 183 26 190 10 55 182 ... #>   .. .. ..- attr(*, \"label\")= chr \"Duration of Treatment (days)\" #>   .. ..$ AVGDD   : num [1:254] 0 0 77.7 54 76.9 0 54 54 54 0 ... #>   .. .. ..- attr(*, \"label\")= chr \"Avg Daily Dose (as planned)\" #>   .. ..$ CUMDOSE : num [1:254] 0 0 13986 756 14067 ... #>   .. .. ..- attr(*, \"label\")= chr \"Cumulative Dose (as planned)\" #>   .. ..$ AGE     : num [1:254] 63 64 71 74 77 85 68 81 84 52 ... #>   .. .. ..- attr(*, \"label\")= chr \"Age\" #>   .. ..$ AGEGR1  : chr [1:254] \"<65\" \"<65\" \"65-80\" \"65-80\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Pooled Age Group 1\" #>   .. ..$ AGEGR1N : num [1:254] 1 1 2 2 2 3 2 3 3 1 ... #>   .. .. ..- attr(*, \"label\")= chr \"Pooled Age Group 1 (N)\" #>   .. ..$ AGEU    : chr [1:254] \"YEARS\" \"YEARS\" \"YEARS\" \"YEARS\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Age Units\" #>   .. ..$ RACE    : chr [1:254] \"WHITE\" \"WHITE\" \"WHITE\" \"WHITE\" ... #>   .. ..$ RACEN   : num [1:254] 1 1 1 1 1 1 1 1 1 1 ... #>   .. .. ..- attr(*, \"label\")= chr \"Race (N)\" #>   .. ..$ SEX     : chr [1:254] \"F\" \"M\" \"M\" \"M\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Sex\" #>   .. ..$ ETHNIC  : chr [1:254] \"HISPANIC OR LATINO\" \"HISPANIC OR LATINO\" \"NOT HISPANIC OR LATINO\" \"NOT HISPANIC OR LATINO\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Ethnicity\" #>   .. ..$ SAFFL   : chr [1:254] \"Y\" \"Y\" \"Y\" \"Y\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Safety Population Flag\" #>   .. ..$ ITTFL   : chr [1:254] \"Y\" \"Y\" \"Y\" \"Y\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Intent-To-Treat Population Flag\" #>   .. ..$ EFFFL   : chr [1:254] \"Y\" \"Y\" \"Y\" \"Y\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Efficacy Population Flag\" #>   .. ..$ COMP8FL : chr [1:254] \"Y\" \"N\" \"Y\" \"N\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Completers of Week 8 Population Flag\" #>   .. ..$ COMP16FL: chr [1:254] \"Y\" \"N\" \"Y\" \"N\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Completers of Week 16 Population Flag\" #>   .. ..$ COMP24FL: chr [1:254] \"Y\" \"N\" \"Y\" \"N\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Completers of Week 24 Population Flag\" #>   .. ..$ DISCONFL: chr [1:254] \"\" \"Y\" \"\" \"Y\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Did the Subject Discontinue the Study?\" #>   .. ..$ DSRAEFL : chr [1:254] \"\" \"Y\" \"\" \"\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Discontinued due to AE?\" #>   .. ..$ DTHFL   : chr [1:254] \"\" \"\" \"\" \"\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Subject Died?\" #>   .. ..$ BMIBL   : num [1:254] 25.1 30.4 31.4 28.8 26.1 30.4 27.3 23.9 23.9 21.9 ... #>   .. .. ..- attr(*, \"label\")= chr \"Baseline BMI (kg/m^2)\" #>   .. ..$ BMIBLGR1: chr [1:254] \"25-<30\" \">=30\" \">=30\" \"25-<30\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Pooled Baseline BMI Group 1\" #>   .. ..$ HEIGHTBL: num [1:254] 147 163 178 175 155 ... #>   .. .. ..- attr(*, \"label\")= chr \"Baseline Height (cm)\" #>   .. ..$ WEIGHTBL: num [1:254] 54.4 80.3 99.3 88.5 62.6 67.1 78 59.9 78.9 71.2 ... #>   .. .. ..- attr(*, \"label\")= chr \"Baseline Weight (kg)\" #>   .. ..$ EDUCLVL : num [1:254] 16 14 16 12 9 8 18 22 12 14 ... #>   .. .. ..- attr(*, \"label\")= chr \"Years of Education\" #>   .. ..$ DISONSDT: Date[1:254], format: \"2010-04-30\" \"2006-03-11\" ... #>   .. ..$ DURDIS  : num [1:254] 43.9 76.4 42.8 55.3 32.9 ... #>   .. .. ..- attr(*, \"label\")= chr \"Duration of Disease (Months)\" #>   .. ..$ DURDSGR1: chr [1:254] \">=12\" \">=12\" \">=12\" \">=12\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Pooled Disease Duration Group 1\" #>   .. ..$ VISIT1DT: Date[1:254], format: \"2013-12-26\" \"2012-07-22\" ... #>   .. ..$ RFSTDTC : chr [1:254] \"2014-01-02\" \"2012-08-05\" \"2013-07-19\" \"2014-03-18\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Subject Reference Start Date/Time\" #>   .. ..$ RFENDTC : chr [1:254] \"2014-07-02\" \"2012-09-02\" \"2014-01-14\" \"2014-04-14\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Subject Reference End Date/Time\" #>   .. ..$ VISNUMEN: num [1:254] 12 5 12 5 12 6 12 4 8 12 ... #>   .. .. ..- attr(*, \"label\")= chr \"End of Trt Visit (Vis 12 or Early Term.)\" #>   .. ..$ RFENDT  : Date[1:254], format: \"2014-07-02\" \"2012-09-02\" ... #>   .. ..$ DCDECOD : chr [1:254] \"COMPLETED\" \"ADVERSE EVENT\" \"COMPLETED\" \"STUDY TERMINATED BY SPONSOR\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Standardized Disposition Term\" #>   .. ..$ DCREASCD: chr [1:254] \"Completed\" \"Adverse Event\" \"Completed\" \"Sponsor Decision\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Reason for Discontinuation\" #>   .. ..$ MMSETOT : num [1:254] 23 23 23 23 21 23 10 23 20 20 ... #>   .. .. ..- attr(*, \"label\")= chr \"MMSE Total\" #>   .. ..$ TRTA    : Factor w/ 3 levels \"Placebo\",\"Low Dose\",..: 1 1 3 2 3 1 2 2 2 1 ... #>   .. ..- attr(*, \"data_name\")= chr \"adsl\" #>   ..$ data_observation:'data.frame':\t1191 obs. of  60 variables: #>   .. ..$ STUDYID     : chr [1:1191] \"CDISCPILOT01\" \"CDISCPILOT01\" \"CDISCPILOT01\" \"CDISCPILOT01\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Study Identifier\" #>   .. ..$ SITEID      : chr [1:1191] \"701\" \"701\" \"701\" \"701\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Study Site Identifier\" #>   .. ..$ USUBJID     : chr [1:1191] \"01-701-1015\" \"01-701-1015\" \"01-701-1015\" \"01-701-1023\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Unique Subject Identifier\" #>   .. ..$ TRTA        : Factor w/ 3 levels \"Placebo\",\"Low Dose\",..: 1 1 1 1 1 1 1 3 3 3 ... #>   .. ..$ TRTAN       : num [1:1191] 0 0 0 0 0 0 0 81 81 81 ... #>   .. .. ..- attr(*, \"label\")= chr \"Actual Treatment (N)\" #>   .. ..$ AGE         : num [1:1191] 63 63 63 64 64 64 64 71 71 77 ... #>   .. .. ..- attr(*, \"label\")= chr \"Age\" #>   .. ..$ AGEGR1      : chr [1:1191] \"<65\" \"<65\" \"<65\" \"<65\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Pooled Age Group 1\" #>   .. ..$ AGEGR1N     : num [1:1191] 1 1 1 1 1 1 1 2 2 2 ... #>   .. .. ..- attr(*, \"label\")= chr \"Pooled Age Group 1 (N)\" #>   .. ..$ RACE        : chr [1:1191] \"WHITE\" \"WHITE\" \"WHITE\" \"WHITE\" ... #>   .. ..$ RACEN       : num [1:1191] 1 1 1 1 1 1 1 1 1 1 ... #>   .. .. ..- attr(*, \"label\")= chr \"Race (N)\" #>   .. ..$ SEX         : chr [1:1191] \"F\" \"F\" \"F\" \"M\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Sex\" #>   .. ..$ SAFFL       : chr [1:1191] \"Y\" \"Y\" \"Y\" \"Y\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Safety Population Flag\" #>   .. ..$ TRTSDT      : Date[1:1191], format: \"2014-01-02\" \"2014-01-02\" ... #>   .. ..$ TRTEDT      : Date[1:1191], format: \"2014-07-02\" \"2014-07-02\" ... #>   .. ..$ ASTDT       : Date[1:1191], format: \"2014-01-03\" \"2014-01-03\" ... #>   .. ..$ ASTDTF      : chr [1:1191] \"\" \"\" \"\" \"\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Analysis Start Date Imputation Flag\" #>   .. ..$ ASTDY       : num [1:1191] 2 2 8 3 3 22 3 3 21 58 ... #>   .. .. ..- attr(*, \"label\")= chr \"Analysis Start Relative Day\" #>   .. ..$ AENDT       : Date[1:1191], format: NA NA ... #>   .. ..$ AENDY       : num [1:1191] NA NA 10 26 NA NA 26 NA NA NA ... #>   .. .. ..- attr(*, \"label\")= chr \"Analysis End Relative Day\" #>   .. ..$ ADURN       : num [1:1191] NA NA 3 24 NA NA 24 NA NA NA ... #>   .. .. ..- attr(*, \"label\")= chr \"AE Duration (N)\" #>   .. ..$ ADURU       : chr [1:1191] \"\" \"\" \"DAY\" \"DAY\" ... #>   .. .. ..- attr(*, \"label\")= chr \"AE Duration Units\" #>   .. ..$ AETERM      : chr [1:1191] \"APPLICATION SITE ERYTHEMA\" \"APPLICATION SITE PRURITUS\" \"DIARRHOEA\" \"ERYTHEMA\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Reported Term for the Adverse Event\" #>   .. ..$ AELLT       : chr [1:1191] \"APPLICATION SITE REDNESS\" \"APPLICATION SITE ITCHING\" \"DIARRHEA\" \"ERYTHEMA\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Lowest Level Term\" #>   .. ..$ AELLTCD     : num [1:1191] NA NA NA NA NA NA NA NA NA NA ... #>   .. .. ..- attr(*, \"label\")= chr \"Lowest Level Term Code\" #>   .. ..$ AEDECOD     : chr [1:1191] \"APPLICATION SITE ERYTHEMA\" \"APPLICATION SITE PRURITUS\" \"DIARRHOEA\" \"ERYTHEMA\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Adverse Event\" #>   .. ..$ AEPTCD      : num [1:1191] NA NA NA NA NA NA NA NA NA NA ... #>   .. .. ..- attr(*, \"label\")= chr \"Preferred Term Code\" #>   .. ..$ AEHLT       : chr [1:1191] \"HLT_0617\" \"HLT_0317\" \"HLT_0148\" \"HLT_0284\" ... #>   .. .. ..- attr(*, \"label\")= chr \"High Level Term\" #>   .. ..$ AEHLTCD     : num [1:1191] NA NA NA NA NA NA NA NA NA NA ... #>   .. .. ..- attr(*, \"label\")= chr \"High Level Term Code\" #>   .. ..$ AEHLGT      : chr [1:1191] \"HLGT_0152\" \"HLGT_0338\" \"HLGT_0588\" \"HLGT_0192\" ... #>   .. .. ..- attr(*, \"label\")= chr \"High Level Group Term\" #>   .. ..$ AEHLGTCD    : num [1:1191] NA NA NA NA NA NA NA NA NA NA ... #>   .. .. ..- attr(*, \"label\")= chr \"High Level Group Term Code\" #>   .. ..$ AEBODSYS    : chr [1:1191] \"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\" \"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\" \"GASTROINTESTINAL DISORDERS\" \"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Body System or Organ Class\" #>   .. ..$ AESOC       : chr [1:1191] \"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\" \"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\" \"GASTROINTESTINAL DISORDERS\" \"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Primary System Organ Class\" #>   .. ..$ AESOCCD     : num [1:1191] NA NA NA NA NA NA NA NA NA NA ... #>   .. .. ..- attr(*, \"label\")= chr \"Primary System Organ Class Code\" #>   .. ..$ AESEV       : chr [1:1191] \"MILD\" \"MILD\" \"MILD\" \"MILD\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Intensity\" #>   .. ..$ AESER       : chr [1:1191] \"N\" \"N\" \"N\" \"N\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Serious\" #>   .. ..$ AESCAN      : chr [1:1191] \"N\" \"N\" \"N\" \"N\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Involves Cancer\" #>   .. ..$ AESCONG     : chr [1:1191] \"N\" \"N\" \"N\" \"N\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Congenital Anomaly or Birth Defect\" #>   .. ..$ AESDISAB    : chr [1:1191] \"N\" \"N\" \"N\" \"N\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Persist or Signif Disability/Incapacity\" #>   .. ..$ AESDTH      : chr [1:1191] \"N\" \"N\" \"N\" \"N\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Results in Death\" #>   .. ..$ AESHOSP     : chr [1:1191] \"N\" \"N\" \"N\" \"N\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Requires or Prolongs Hospitalization\" #>   .. ..$ AESLIFE     : chr [1:1191] \"N\" \"N\" \"N\" \"N\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Is Life Threatening\" #>   .. ..$ AESOD       : chr [1:1191] \"N\" \"N\" \"N\" \"N\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Occurred with Overdose\" #>   .. ..$ AEREL       : chr [1:1191] \"PROBABLE\" \"PROBABLE\" \"REMOTE\" \"POSSIBLE\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Causality\" #>   .. ..$ AEACN       : chr [1:1191] \"DOSE NOT CHANGED\" \"DOSE NOT CHANGED\" \"DOSE NOT CHANGED\" \"DOSE NOT CHANGED\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Action Taken with Study Treatment\" #>   .. ..$ AEOUT       : chr [1:1191] \"NOT RECOVERED/NOT RESOLVED\" \"NOT RECOVERED/NOT RESOLVED\" \"RECOVERED/RESOLVED\" \"NOT RECOVERED/NOT RESOLVED\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Outcome of Adverse Event\" #>   .. ..$ AESEQ       : num [1:1191] 1 2 3 1 2 3 4 1 2 1 ... #>   .. .. ..- attr(*, \"label\")= chr \"Sequence Number\" #>   .. ..$ TRTEMFL     : chr [1:1191] \"Y\" \"Y\" \"Y\" \"Y\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Treatment Emergent Analysis Flag\" #>   .. ..$ AOCCFL      : chr [1:1191] \"Y\" \"\" \"\" \"Y\" ... #>   .. .. ..- attr(*, \"label\")= chr \"1st Occurrence of Any AE Flag\" #>   .. ..$ AOCCSFL     : chr [1:1191] \"Y\" \"\" \"Y\" \"Y\" ... #>   .. .. ..- attr(*, \"label\")= chr \"1st Occurrence of SOC Flag\" #>   .. ..$ AOCCPFL     : chr [1:1191] \"Y\" \"Y\" \"Y\" \"Y\" ... #>   .. .. ..- attr(*, \"label\")= chr \"1st Occurrence of Preferred Term Flag\" #>   .. ..$ AOCC02FL    : chr [1:1191] \"\" \"\" \"\" \"\" ... #>   .. .. ..- attr(*, \"label\")= chr \"1st Occurrence 02 Flag for Serious\" #>   .. ..$ AOCC03FL    : chr [1:1191] \"\" \"\" \"\" \"\" ... #>   .. .. ..- attr(*, \"label\")= chr \"1st Occurrence 03 Flag for Serious SOC\" #>   .. ..$ AOCC04FL    : chr [1:1191] \"\" \"\" \"\" \"\" ... #>   .. .. ..- attr(*, \"label\")= chr \"1st Occurrence 04 Flag for Serious PT\" #>   .. ..$ CQ01NAM     : chr [1:1191] \"DERMATOLOGIC EVENTS\" \"DERMATOLOGIC EVENTS\" \"\" \"DERMATOLOGIC EVENTS\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Customized Query 01 Name\" #>   .. ..$ AOCC01FL    : chr [1:1191] \"Y\" \"\" \"\" \"Y\" ... #>   .. .. ..- attr(*, \"label\")= chr \"1st Occurrence 01 Flag for CQ01\" #>   .. ..$ related     : chr [1:1191] \"Probable\" \"Probable\" \"Remote\" \"Possible\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Related\" #>   .. ..$ outcome     : chr [1:1191] \"Resolved\" \"Resolved\" \"Resolved\" \"Resolved\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Outcome\" #>   .. ..$ action_taken: chr [1:1191] \"None\" \"None\" \"None\" \"None\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Action Taken\" #>   .. ..$ duration    : chr [1:1191] \"Continuing\" \"Continuing\" \"3 Day\" \"24 Day\" ... #>   .. .. ..- attr(*, \"label\")= chr \"Duration\" #>   .. ..$ subline     : chr [1:1191] \"Subject ID = 01-701-1015, Gender = F, Race = WHITE, AGE = 63 Years, TRT = Placebo\" \"Subject ID = 01-701-1015, Gender = F, Race = WHITE, AGE = 63 Years, TRT = Placebo\" \"Subject ID = 01-701-1015, Gender = F, Race = WHITE, AGE = 63 Years, TRT = Placebo\" \"Subject ID = 01-701-1023, Gender = M, Race = WHITE, AGE = 64 Years, TRT = Placebo\" ... #>   .. ..- attr(*, \"data_name\")= chr \"adae\" #>   ..$ plan            :Classes ‘meta_plan’ and 'data.frame':\t18 obs. of  5 variables: #>   .. ..$ mock       : num [1:18] 1 1 2 2 2 2 2 2 2 2 ... #>   .. ..$ analysis   : chr [1:18] \"ae_summary\" \"ae_summary\" \"ae_specific\" \"ae_specific\" ... #>   .. ..$ population : chr [1:18] \"apat\" \"apat\" \"apat\" \"apat\" ... #>   .. ..$ observation: chr [1:18] \"wk12\" \"wk24\" \"wk12\" \"wk24\" ... #>   .. ..$ parameter  : chr [1:18] \"any;rel;ser\" \"any;rel;ser\" \"any\" \"any\" ... #>   .. ..- attr(*, \"out.attrs\")=List of 2 #>   .. .. ..$ dim     : Named int [1:5] 1 1 1 2 1 #>   .. .. .. ..- attr(*, \"names\")= chr [1:5] \"mock\" \"analysis\" \"population\" \"observation\" ... #>   .. .. ..$ dimnames:List of 5 #>   .. .. .. ..$ mock       : chr \"mock=1\" #>   .. .. .. ..$ analysis   : chr \"analysis=ae_summary\" #>   .. .. .. ..$ population : chr \"population=apat\" #>   .. .. .. ..$ observation: chr [1:2] \"observation=wk12\" \"observation=wk24\" #>   .. .. .. ..$ parameter  : chr \"parameter=any;rel;ser\" #>   ..$ observation     :List of 2 #>   .. ..$ wk12:List of 6 #>   .. .. ..$ name  : chr \"wk12\" #>   .. .. ..$ id    : chr \"USUBJID\" #>   .. .. ..$ group : chr \"TRTA\" #>   .. .. ..$ var   : NULL #>   .. .. ..$ subset: language SAFFL == \"Y\" #>   .. .. ..$ label : chr \"Weeks 0 to 12\" #>   .. .. ..- attr(*, \"class\")= chr \"adam_mapping\" #>   .. ..$ wk24:List of 6 #>   .. .. ..$ name  : chr \"wk24\" #>   .. .. ..$ id    : chr \"USUBJID\" #>   .. .. ..$ group : chr \"TRTA\" #>   .. .. ..$ var   : NULL #>   .. .. ..$ subset: language AOCC01FL == \"Y\" #>   .. .. ..$ label : chr \"Weeks 0 to 24\" #>   .. .. ..- attr(*, \"class\")= chr \"adam_mapping\" #>   ..$ population      :List of 1 #>   .. ..$ apat:List of 6 #>   .. .. ..$ name  : chr \"apat\" #>   .. .. ..$ id    : chr \"USUBJID\" #>   .. .. ..$ group : chr \"TRTA\" #>   .. .. ..$ var   : NULL #>   .. .. ..$ subset: language SAFFL == \"Y\" #>   .. .. ..$ label : chr \"All Participants as Treated\" #>   .. .. ..- attr(*, \"class\")= chr \"adam_mapping\" #>   ..$ parameter       :List of 4 #>   .. ..$ rel  :List of 12 #>   .. .. ..$ name     : chr \"rel\" #>   .. .. ..$ id       : NULL #>   .. .. ..$ group    : NULL #>   .. .. ..$ var      : chr \"AEDECOD\" #>   .. .. ..$ subset   : language AEREL %in% c(\"POSSIBLE\", \"PROBABLE\") #>   .. .. ..$ label    : chr \"drug-related adverse events\" #>   .. .. ..$ soc      : chr \"AEBODSYS\" #>   .. .. ..$ seq      : num 200 #>   .. .. ..$ term1    : chr \"Drug-Related\" #>   .. .. ..$ term2    : chr \"\" #>   .. .. ..$ summ_row : chr \"with drug-related{^a} adverse events\" #>   .. .. ..$ summ_foot: chr \"{^a}Determined by the investigator to be related to the drug.\" #>   .. .. ..- attr(*, \"class\")= chr \"adam_mapping\" #>   .. ..$ aeosi:List of 9 #>   .. .. ..$ name  : chr \"aeosi\" #>   .. .. ..$ id    : NULL #>   .. .. ..$ group : NULL #>   .. .. ..$ var   : chr \"AEDECOD\" #>   .. .. ..$ subset: language AEOSI == \"Y\" #>   .. .. ..$ label : chr \"adverse events of special interest\" #>   .. .. ..$ soc   : chr \"AEBODSYS\" #>   .. .. ..$ term1 : chr \"\" #>   .. .. ..$ term2 : chr \"of special interest\" #>   .. .. ..- attr(*, \"class\")= chr \"adam_mapping\" #>   .. ..$ any  :List of 11 #>   .. .. ..$ name    : chr \"any\" #>   .. .. ..$ id      : NULL #>   .. .. ..$ group   : NULL #>   .. .. ..$ var     : chr \"AEDECOD\" #>   .. .. ..$ subset  : NULL #>   .. .. ..$ label   : chr \"any adverse events\" #>   .. .. ..$ soc     : chr \"AEBODSYS\" #>   .. .. ..$ seq     : num 100 #>   .. .. ..$ term1   : chr \"\" #>   .. .. ..$ term2   : chr \"\" #>   .. .. ..$ summ_row: chr \"with one or more adverse events\" #>   .. .. ..- attr(*, \"class\")= chr \"adam_mapping\" #>   .. ..$ ser  :List of 11 #>   .. .. ..$ name    : chr \"ser\" #>   .. .. ..$ id      : NULL #>   .. .. ..$ group   : NULL #>   .. .. ..$ var     : chr \"AEDECOD\" #>   .. .. ..$ subset  : language AESER == \"Y\" #>   .. .. ..$ label   : chr \"serious adverse events\" #>   .. .. ..$ soc     : chr \"AEBODSYS\" #>   .. .. ..$ seq     : num 401 #>   .. .. ..$ term1   : chr \"Serious\" #>   .. .. ..$ term2   : chr \"\" #>   .. .. ..$ summ_row: chr \"with serious adverse events\" #>   .. .. ..- attr(*, \"class\")= chr \"adam_mapping\" #>   ..$ analysis        :List of 4 #>   .. ..$ ae_summary :List of 7 #>   .. .. ..$ name  : chr \"ae_summary\" #>   .. .. ..$ id    : NULL #>   .. .. ..$ group : NULL #>   .. .. ..$ var   : NULL #>   .. .. ..$ subset: NULL #>   .. .. ..$ label : chr \"Table: adverse event summary\" #>   .. .. ..$ title : chr \"Summary of Adverse Events\" #>   .. .. ..- attr(*, \"class\")= chr \"adam_mapping\" #>   .. ..$ ae_listing :List of 11 #>   .. .. ..$ name      : chr \"ae_listing\" #>   .. .. ..$ id        : NULL #>   .. .. ..$ group     : NULL #>   .. .. ..$ var       : NULL #>   .. .. ..$ subset    : NULL #>   .. .. ..$ label     : chr \"Listing: adverse event\" #>   .. .. ..$ var_name  : chr [1:9] \"USUBJID\" \"ASTDY\" \"AEDECOD\" \"duration\" ... #>   .. .. ..$ subline_by: NULL #>   .. .. ..$ group_by  : chr [1:2] \"USUBJID\" \"ASTDY\" #>   .. .. ..$ page_by   : chr [1:2] \"TRTA\" \"subline\" #>   .. .. ..$ title     : chr \"Listing of Participants With {term1} Adverse Events {term2}\" #>   .. .. ..- attr(*, \"class\")= chr \"adam_mapping\" #>   .. ..$ ae_exp_adj :List of 7 #>   .. .. ..$ name  : chr \"ae_exp_adj\" #>   .. .. ..$ id    : NULL #>   .. .. ..$ group : NULL #>   .. .. ..$ var   : NULL #>   .. .. ..$ subset: NULL #>   .. .. ..$ label : chr \"Exposure Adjusted Incident Rate\" #>   .. .. ..$ title : chr \"Exposure-Adjusted Adverse Event Summary\" #>   .. .. ..- attr(*, \"class\")= chr \"adam_mapping\" #>   .. ..$ ae_specific:List of 7 #>   .. .. ..$ name  : chr \"ae_specific\" #>   .. .. ..$ id    : NULL #>   .. .. ..$ group : NULL #>   .. .. ..$ var   : NULL #>   .. .. ..$ subset: NULL #>   .. .. ..$ label : chr \"Table: specific adverse event\" #>   .. .. ..$ title : chr \"Participants With {term1} Adverse Events {term2}\" #>   .. .. ..- attr(*, \"class\")= chr \"adam_mapping\" #>   ..- attr(*, \"class\")= chr \"meta_adam\" #>  $ population     : chr \"apat\" #>  $ observation    : chr \"wk12\" #>  $ parameter      : chr \"rel\" #>  $ n              :'data.frame':\t138 obs. of  4 variables: #>   ..$ n_1: int [1:138] 86 44 42 NA 6 1 0 1 1 1 ... #>   ..$ n_2: int [1:138] 84 73 11 NA 7 0 1 0 0 0 ... #>   ..$ n_3: int [1:138] 84 70 14 NA 4 2 0 0 0 0 ... #>   ..$ n_4: int [1:138] 254 187 67 NA 17 3 1 1 1 1 ... #>  $ order          : num [1:138] 1 100 200 900 1000 ... #>  $ group          : chr [1:4] \"Placebo\" \"Low Dose\" \"High Dose\" \"Total\" #>  $ reference_group: num 1 #>  $ prop           :'data.frame':\t138 obs. of  4 variables: #>   ..$ prop_1: num [1:138] NA 51.16 48.84 NA 6.98 ... #>   ..$ prop_2: num [1:138] NA 86.9 13.1 NA 8.33 ... #>   ..$ prop_3: num [1:138] NA 83.33 16.67 NA 4.76 ... #>   ..$ prop_4: num [1:138] NA 73.62 26.38 NA 6.69 ... #>  $ diff           :'data.frame':\t138 obs. of  2 variables: #>   ..$ diff_2: num [1:138] NA 35.74 -35.74 NA 1.36 ... #>   ..$ diff_3: num [1:138] NA 32.17 -32.17 NA -2.21 ... #>  $ n_pop          :'data.frame':\t1 obs. of  4 variables: #>   ..$ n_1: int 86 #>   ..$ n_2: int 84 #>   ..$ n_3: int 84 #>   ..$ n_4: int 254 #>  $ name           : chr [1:138] \"Participants in population\" \"with one or more drug-related adverse events\" \"with no drug-related adverse events\" \"\" ... #>  $ components     : chr [1:2] \"soc\" \"par\" #>  $ prepare_call   : language prepare_ae_specific(meta = meta, population = \"apat\", observation = \"wk12\",      parameter = \"rel\") #>  - attr(*, \"class\")= chr \"outdata\"  # Allow to extract each components prepare_ae_specific(meta, \"apat\", \"wk12\", \"rel\", components = NULL)$data #> NULL prepare_ae_specific(meta, \"apat\", \"wk12\", \"rel\", components = \"soc\")$data #> NULL prepare_ae_specific(meta, \"apat\", \"wk12\", \"rel\", components = \"par\")$data #> Warning: no non-missing arguments to max; returning -Inf #> NULL"},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_specific_subgroup.html","id":null,"dir":"Reference","previous_headings":"","what":"Prepare datasets for AE specific analysis — prepare_ae_specific_subgroup","title":"Prepare datasets for AE specific analysis — prepare_ae_specific_subgroup","text":"Prepare datasets AE specific analysis","code":""},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_specific_subgroup.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Prepare datasets for AE specific analysis — prepare_ae_specific_subgroup","text":"","code":"prepare_ae_specific_subgroup(   meta,   population,   observation,   parameter,   subgroup_var,   subgroup_header = c(meta$population[[population]]$group, subgroup_var),   components = c(\"soc\", \"par\"),   display_subgroup_total = TRUE )"},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_specific_subgroup.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Prepare datasets for AE specific analysis — prepare_ae_specific_subgroup","text":"meta metadata object created metalite. population character value population term name. term name used key link information. observation character value observation term name. term name used key link information. parameter character value parameter term name. term name used key link information. subgroup_var character value subgroup variable name observation data saved meta$data_observation. subgroup_header character vector column header hierarchy. first element first level header second element second level header. components character vector components name. display_subgroup_total Logical. Display total column subgroup analysis .","code":""},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_specific_subgroup.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Prepare datasets for AE specific analysis — prepare_ae_specific_subgroup","text":"list analysis raw datasets.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_specific_subgroup.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Prepare datasets for AE specific analysis — prepare_ae_specific_subgroup","text":"","code":"meta <- meta_ae_example() prepare_ae_specific_subgroup(meta, \"apat\", \"wk12\", \"rel\", subgroup_var = \"SEX\")$data #> NULL"},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_summary.html","id":null,"dir":"Reference","previous_headings":"","what":"Prepare datasets for AE specific analysis — prepare_ae_summary","title":"Prepare datasets for AE specific analysis — prepare_ae_summary","text":"Prepare datasets AE specific analysis","code":""},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_summary.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Prepare datasets for AE specific analysis — prepare_ae_summary","text":"","code":"prepare_ae_summary(meta, population, observation, parameter, ...)"},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_summary.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Prepare datasets for AE specific analysis — prepare_ae_summary","text":"meta metadata object created metalite. population character value population term name. term name used key link information. observation character value observation term name. term name used key link information. parameter character value parameter term name. term name used key link information. ... Additional arguments passed prepare_ae_specific().","code":""},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_summary.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Prepare datasets for AE specific analysis — prepare_ae_summary","text":"list analysis raw datasets.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/prepare_ae_summary.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Prepare datasets for AE specific analysis — prepare_ae_summary","text":"","code":"meta <- meta_ae_example() prepare_ae_summary(   meta,   population = \"apat\",   observation = \"wk12\",   parameter = \"any;rel;ser\" ) #> any #> rel #> ser #> List of 13 #>  $ meta           :List of 7 #>  $ population     : chr \"apat\" #>  $ observation    : chr \"wk12\" #>  $ parameter      : chr \"any;rel;ser\" #>  $ n              :'data.frame':\t5 obs. of  4 variables: #>  $ order          : num [1:5] 1 100 200 300 400 #>  $ group          : chr [1:4] \"Placebo\" \"Low Dose\" \"High Dose\" \"Total\" #>  $ reference_group: num 1 #>  $ prop           :'data.frame':\t5 obs. of  4 variables: #>  $ diff           :'data.frame':\t5 obs. of  2 variables: #>  $ n_pop          :'data.frame':\t1 obs. of  4 variables: #>  $ name           : chr [1:5] \"Participants in population\" \"with one or more adverse events\" \"with no adverse events\" \"with drug-related{^a} adverse events\" ... #>  $ prepare_call   : language prepare_ae_summary(meta = meta, population = \"apat\", observation = \"wk12\",      parameter = \"any;rel;ser\")"},{"path":"https://merck.github.io/metalite.ae/reference/rate_compare.html","id":null,"dir":"Reference","previous_headings":"","what":"Unstratified and stratified  Miettinen and Nurminen test — rate_compare","title":"Unstratified and stratified  Miettinen and Nurminen test — rate_compare","text":"Unstratified stratified  Miettinen Nurminen test. Details can found vignette(\"rate-compare\").","code":""},{"path":"https://merck.github.io/metalite.ae/reference/rate_compare.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Unstratified and stratified  Miettinen and Nurminen test — rate_compare","text":"","code":"rate_compare(   formula,   strata,   data,   delta = 0,   weight = c(\"ss\", \"equal\", \"cmh\"),   test = c(\"one.sided\", \"two.sided\"),   bisection = 100,   eps = 1e-06,   alpha = 0.05 )"},{"path":"https://merck.github.io/metalite.ae/reference/rate_compare.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Unstratified and stratified  Miettinen and Nurminen test — rate_compare","text":"formula symbolic description model fitted, form y ~ x. , y numeric vector values 0 1. x group information. strata optional vector weights used analysis. specified, unstratified MN analysis used. specified, stratified MN analysis conducted. data optional data frame, list, environment containing variables model. found data, variables taken environment (formula), typically environment rate_compare called. delta numeric value set difference two group null. weight Weighting schema used stratified MN method. Default \"ss\": \"equal\" equal weighting. \"ss\" sample size weighting. \"cmh\" Cochran–Mantel–Haenszel's weights. test character string specifying side p-value, must one \"one.sided\", \"two.sided\". bisection number sections interval used bisection method. Default 100. eps level precision. Default 1e-06. alpha Pre-defined alpha level two-sided confidence interval.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/rate_compare.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Unstratified and stratified  Miettinen and Nurminen test — rate_compare","text":"data frame test results.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/rate_compare.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Unstratified and stratified  Miettinen and Nurminen test — rate_compare","text":"Miettinen, O. Nurminen, M, Comparative Analysis Two Rates. Statistics Medicine, 4(2):213--226, 1985.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/rate_compare.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Unstratified and stratified  Miettinen and Nurminen test — rate_compare","text":"","code":"# Conduct the stratified MN analysis with sample size weights treatment <- c(rep(\"pbo\", 100), rep(\"exp\", 100)) response <- c(rep(0, 80), rep(1, 20), rep(0, 40), rep(1, 60)) stratum <- c(rep(1:4, 12), 1, 3, 3, 1, rep(1:4, 12), rep(1:4, 25)) rate_compare(   response ~ factor(treatment, levels = c(\"pbo\", \"exp\")),   strata = stratum,   delta = 0,   weight = \"ss\",   test = \"one.sided\",   alpha = 0.05 ) #>         est  z_score            p     lower     upper #> 1 0.3998397 5.712797 5.556727e-09 0.2684383 0.5172779"},{"path":"https://merck.github.io/metalite.ae/reference/rate_compare_sum.html","id":null,"dir":"Reference","previous_headings":"","what":"Unstratified and stratified Miettinen and Nurminen test in\naggregate data level — rate_compare_sum","title":"Unstratified and stratified Miettinen and Nurminen test in\naggregate data level — rate_compare_sum","text":"Unstratified stratified Miettinen Nurminen test aggregate data level","code":""},{"path":"https://merck.github.io/metalite.ae/reference/rate_compare_sum.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Unstratified and stratified Miettinen and Nurminen test in\naggregate data level — rate_compare_sum","text":"","code":"rate_compare_sum(   n0,   n1,   x0,   x1,   strata = NULL,   delta = 0,   weight = c(\"ss\", \"equal\", \"cmh\"),   test = c(\"one.sided\", \"two.sided\"),   bisection = 100,   eps = 1e-06,   alpha = 0.05 )"},{"path":"https://merck.github.io/metalite.ae/reference/rate_compare_sum.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Unstratified and stratified Miettinen and Nurminen test in\naggregate data level — rate_compare_sum","text":"n0, n1 sample size control group experimental group, separately. length length x0/x1 strata. x0, x1 number events control group experimental group, separately. length length n0/n1 strata. strata vector stratum indication used analysis. NULL length unique values strata equals 1, unstratified MN analysis. Otherwise, stratified MN analysis. length strata length x0/x1 n0/n1. delta numeric value set difference two groups null. weight Weighting schema used stratified MN method. Default \"ss\": \"equal\" equal weighting. \"ss\" sample size weighting. \"cmh\" Cochran-Mantel-Haenszel's weights. test character string specifying side p-value, must one \"one.sided\", \"two.sided\". bisection number sections interval used bisection method. Default 100. eps level precision. Default 1e-06. alpha Pre-defined alpha level two-sided confidence interval.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/rate_compare_sum.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Unstratified and stratified Miettinen and Nurminen test in\naggregate data level — rate_compare_sum","text":"data frame test results.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/rate_compare_sum.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Unstratified and stratified Miettinen and Nurminen test in\naggregate data level — rate_compare_sum","text":"Miettinen, O. Nurminen, M, Comparative Analysis Two Rates. Statistics Medicine, 4(2):213--226, 1985.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/rate_compare_sum.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Unstratified and stratified Miettinen and Nurminen test in\naggregate data level — rate_compare_sum","text":"","code":"# Conduct the stratified MN analysis with sample size weights treatment <- c(rep(\"pbo\", 100), rep(\"exp\", 100)) response <- c(rep(0, 80), rep(1, 20), rep(0, 40), rep(1, 60)) stratum <- c(rep(1:4, 12), 1, 3, 3, 1, rep(1:4, 12), rep(1:4, 25)) n0 <- sapply(split(treatment[treatment == \"pbo\"], stratum[treatment == \"pbo\"]), length) n1 <- sapply(split(treatment[treatment == \"exp\"], stratum[treatment == \"exp\"]), length) x0 <- sapply(split(response[treatment == \"pbo\"], stratum[treatment == \"pbo\"]), sum) x1 <- sapply(split(response[treatment == \"exp\"], stratum[treatment == \"exp\"]), sum) strata <- c(\"a\", \"b\", \"c\", \"d\") rate_compare_sum(   n0, n1, x0, x1,   strata,   delta = 0,   weight = \"ss\",   test = \"one.sided\",   alpha = 0.05 ) #>         est  z_score            p     lower     upper #> 1 0.3998397 5.712797 5.556727e-09 0.2684383 0.5172779"},{"path":"https://merck.github.io/metalite.ae/reference/tlf_ae_listing.html","id":null,"dir":"Reference","previous_headings":"","what":"Specific adverse events table — tlf_ae_listing","title":"Specific adverse events table — tlf_ae_listing","text":"Specific adverse events table","code":""},{"path":"https://merck.github.io/metalite.ae/reference/tlf_ae_listing.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Specific adverse events table — tlf_ae_listing","text":"","code":"tlf_ae_listing(   outdata,   footnotes = NULL,   source = NULL,   col_rel_width = NULL,   text_font_size = 9,   orientation = \"landscape\",   path_outdata = NULL,   path_outtable = NULL )"},{"path":"https://merck.github.io/metalite.ae/reference/tlf_ae_listing.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Specific adverse events table — tlf_ae_listing","text":"outdata outdata object created prepare_ae_listing(). footnotes character vector table footnotes. source character value data source. col_rel_width Column relative width vector e.g. c(2,1,1) refers 2:1:1. Default NULL equal column width. text_font_size Text font size.  vary text font size column, use numeric vector length vector equal number columns displayed e.g. c(9,20,40). orientation Orientation 'portrait' 'landscape'. path_outdata character string outdata path. path_outtable character string outtable path.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/tlf_ae_listing.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Specific adverse events table — tlf_ae_listing","text":"RTF file source dataset AE listing.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/tlf_ae_listing.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Specific adverse events table — tlf_ae_listing","text":"","code":"library(r2rtf) library(metalite)  meta <- meta_ae_example() prepare_ae_listing(meta, \"ae_listing\", \"apat\", \"wk12\", \"ser\") |>   tlf_ae_listing(     footnotes = \"footnote1\",     source = \"Source:  [CDISCpilot: adam-adsl; adae]\",     path_outdata = tempfile(fileext = \".Rdata\"),     path_outtable = tempfile(fileext = \".rtf\")   ) #> The outdata is saved in/tmp/RtmpjrcS6p/file197558d00eea.Rdata #> The output is saved in/tmp/RtmpjrcS6p/file19757a0027e8.rtf"},{"path":"https://merck.github.io/metalite.ae/reference/tlf_ae_specific.html","id":null,"dir":"Reference","previous_headings":"","what":"Specific adverse events table — tlf_ae_specific","title":"Specific adverse events table — tlf_ae_specific","text":"Specific adverse events table","code":""},{"path":"https://merck.github.io/metalite.ae/reference/tlf_ae_specific.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Specific adverse events table — tlf_ae_specific","text":"","code":"tlf_ae_specific(   outdata,   meddra_version,   source,   col_rel_width = NULL,   text_font_size = 9,   orientation = \"portrait\",   footnotes = NULL,   title = c(\"analysis\", \"observation\", \"population\"),   path_outdata = NULL,   path_outtable = NULL )"},{"path":"https://merck.github.io/metalite.ae/reference/tlf_ae_specific.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Specific adverse events table — tlf_ae_specific","text":"outdata outdata object created prepare_ae_specific(). meddra_version character value MedDRA version dataset. source character value data source. col_rel_width Column relative width vector e.g. c(2,1,1) refers 2:1:1. Default NULL equal column width. text_font_size Text font size.  vary text font size column, use numeric vector length vector equal number columns displayed e.g. c(9,20,40). orientation Orientation 'portrait' 'landscape'. footnotes character vector table footnotes. title Term \"analysis\", \"observation\"\"population\") collecting title metadata character vector table titles. path_outdata character string outdata path. path_outtable character string outtable path.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/tlf_ae_specific.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Specific adverse events table — tlf_ae_specific","text":"RTF file source dataset AE specific table.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/tlf_ae_specific.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Specific adverse events table — tlf_ae_specific","text":"","code":"meta <- meta_ae_example()  meta |>   prepare_ae_specific(     population = \"apat\",     observation = \"wk12\",     parameter = \"rel\"   ) |>   format_ae_specific() |>   tlf_ae_specific(     source = \"Source:  [CDISCpilot: adam-adsl; adae]\",     meddra_version = \"24.0\",     path_outdata = tempfile(fileext = \".Rdata\"),     path_outtable = tempfile(fileext = \".rtf\")   ) #> The outdata is saved in/tmp/RtmpjrcS6p/file19756d9f2a23.Rdata #> The output is saved in/tmp/RtmpjrcS6p/file197539e25cde.rtf"},{"path":"https://merck.github.io/metalite.ae/reference/tlf_ae_specific_subgroup.html","id":null,"dir":"Reference","previous_headings":"","what":"Specific adverse events table for subgroup analysis — tlf_ae_specific_subgroup","title":"Specific adverse events table for subgroup analysis — tlf_ae_specific_subgroup","text":"Specific adverse events table subgroup analysis","code":""},{"path":"https://merck.github.io/metalite.ae/reference/tlf_ae_specific_subgroup.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Specific adverse events table for subgroup analysis — tlf_ae_specific_subgroup","text":"","code":"tlf_ae_specific_subgroup(   outdata,   meddra_version,   source,   col_rel_width = NULL,   text_font_size = 9,   orientation = \"landscape\",   footnotes = NULL,   title = NULL,   path_outdata = NULL,   path_outtable = NULL )"},{"path":"https://merck.github.io/metalite.ae/reference/tlf_ae_specific_subgroup.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Specific adverse events table for subgroup analysis — tlf_ae_specific_subgroup","text":"outdata outdata object created prepare_ae_specific(). meddra_version character value MedDRA version dataset. source character value data source. col_rel_width Column relative width vector e.g. c(2,1,1) refers 2:1:1. Default NULL equal column width. text_font_size Text font size.  vary text font size column, use numeric vector length vector equal number columns displayed e.g. c(9,20,40). orientation Orientation 'portrait' 'landscape'. footnotes character vector table footnotes. title Term \"analysis\", \"observation\"\"population\") collecting title metadata character vector table titles. path_outdata character string outdata path. path_outtable character string outtable path.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/tlf_ae_specific_subgroup.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Specific adverse events table for subgroup analysis — tlf_ae_specific_subgroup","text":"RTF file source dataset subgroup analysis AE specific table.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/tlf_ae_specific_subgroup.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Specific adverse events table for subgroup analysis — tlf_ae_specific_subgroup","text":"","code":"meta <- meta_ae_example() prepare_ae_specific_subgroup(meta,   population = \"apat\",   observation = \"wk12\",   parameter = \"rel\",   subgroup_var = \"SEX\",   display_subgroup_total = TRUE ) |>   format_ae_specific_subgroup() |>   tlf_ae_specific_subgroup(     meddra_version = \"24.0\",     source = \"Source:  [CDISCpilot: adam-adsl; adae]\",     path_outtable = tempfile(fileext = \".rtf\")   ) #> The output is saved in/tmp/RtmpjrcS6p/file197520fc0040.rtf"},{"path":"https://merck.github.io/metalite.ae/reference/tlf_ae_summary.html","id":null,"dir":"Reference","previous_headings":"","what":"AE summary table — tlf_ae_summary","title":"AE summary table — tlf_ae_summary","text":"AE summary table","code":""},{"path":"https://merck.github.io/metalite.ae/reference/tlf_ae_summary.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"AE summary table — tlf_ae_summary","text":"","code":"tlf_ae_summary(   outdata,   source,   col_rel_width = NULL,   text_font_size = 9,   orientation = \"portrait\",   title = c(\"analysis\", \"observation\", \"population\"),   footnotes = NULL,   path_outdata = NULL,   path_outtable = NULL )"},{"path":"https://merck.github.io/metalite.ae/reference/tlf_ae_summary.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"AE summary table — tlf_ae_summary","text":"outdata outdata object created prepare_ae_specific(). source character value data source. col_rel_width Column relative width vector e.g. c(2,1,1) refers 2:1:1. Default NULL equal column width. text_font_size Text font size.  vary text font size column, use numeric vector length vector equal number columns displayed e.g. c(9,20,40). orientation Orientation 'portrait' 'landscape'. title Term \"analysis\", \"observation\"\"population\") collecting title metadata character vector table titles. footnotes character vector table footnotes. path_outdata character string outdata path. path_outtable character string outtable path.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/tlf_ae_summary.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"AE summary table — tlf_ae_summary","text":"RTF file source dataset AE listing.","code":""},{"path":"https://merck.github.io/metalite.ae/reference/tlf_ae_summary.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"AE summary table — tlf_ae_summary","text":"","code":"meta <- meta_ae_example() outdata <- prepare_ae_summary(meta,   population = \"apat\",   observation = \"wk12\",   parameter = \"any;rel;ser\" ) #> any #> rel #> ser outdata |>   format_ae_summary() |>   tlf_ae_summary(     source = \"Source:  [CDISCpilot: adam-adsl; adae]\",     path_outdata = tempfile(fileext = \".Rdata\"),     path_outtable = tempfile(fileext = \".rtf\")   ) #> The outdata is saved in/tmp/RtmpjrcS6p/file1975569ef3e5.Rdata #> The output is saved in/tmp/RtmpjrcS6p/file197521375f8b.rtf"},{"path":"https://merck.github.io/metalite.ae/news/index.html","id":"metaliteae-012","dir":"Changelog","previous_headings":"","what":"metalite.ae 0.1.2","title":"metalite.ae 0.1.2","text":"Updated format_ae_specific avoid warning comparison variables requested.","code":""},{"path":"https://merck.github.io/metalite.ae/news/index.html","id":"metaliteae-011","dir":"Changelog","previous_headings":"","what":"metalite.ae 0.1.1","title":"metalite.ae 0.1.1","text":"CRAN release: 2023-02-24 Updated DESCRIPTION file reformat reference. Uncommented previously commented code example.","code":""},{"path":"https://merck.github.io/metalite.ae/news/index.html","id":"metaliteae-010","dir":"Changelog","previous_headings":"","what":"metalite.ae 0.1.0","title":"metalite.ae 0.1.0","text":"Initial submission CRAN. Added NEWS.md file track changes package.","code":""}]
